<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD000336.pub2" GROUP_ID="EPOC" ID="340300011807451519" MERGED_FROM="" MODIFIED="2010-12-01 17:40:36 +0100" MODIFIED_BY="Laura Nichol" REVIEW_NO="0001" REVMAN_SUB_VERSION="5.0.25" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="7.0">
<COVER_SHEET MODIFIED="2010-12-01 17:40:36 +0100" MODIFIED_BY="Laura Nichol">
<TITLE MODIFIED="2010-06-04 06:04:23 -0400" MODIFIED_BY="[Empty name]">Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns</TITLE>
<CONTACT MODIFIED="2010-12-01 17:40:36 +0100" MODIFIED_BY="Laura Nichol"><PERSON ID="7082" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Lisa</FIRST_NAME><LAST_NAME>Bero</LAST_NAME><POSITION>Director, US Cochrane Center, San Francisco Branch</POSITION><EMAIL_1>berol@pharmacy.ucsf.edu</EMAIL_1><ADDRESS><DEPARTMENT>Professor of Clinical Pharmacy &amp; Health Policy</DEPARTMENT><ORGANISATION>University of California San Francisco</ORGANISATION><ADDRESS_1>Suite 420, Box 0613</ADDRESS_1><ADDRESS_2>3333 California Street</ADDRESS_2><CITY>San Francisco</CITY><ZIP>94143-0613</ZIP><REGION>California</REGION><COUNTRY CODE="US">USA</COUNTRY><PHONE_1>+1 415 476 1067</PHONE_1><FAX_1>+1 415 502 0792</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2010-12-01 17:40:36 +0100" MODIFIED_BY="Laura Nichol"><PERSON ID="914024EE82E26AA200D5E26B3ACEF204" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Nancy</FIRST_NAME><LAST_NAME>Nkansah</LAST_NAME><SUFFIX>Pharm.D., MBA</SUFFIX><POSITION>Assistant Professor of Clinical Pharmacy</POSITION><EMAIL_1>nkansahn@pharmacy.ucsf.edu</EMAIL_1><ADDRESS><DEPARTMENT>Clinical Pharmacy</DEPARTMENT><ORGANISATION>University of California, San Francisco</ORGANISATION><ADDRESS_1>155 North Fresno Street, Suite 224</ADDRESS_1><CITY>Fresno</CITY><ZIP>93701</ZIP><REGION>California</REGION><COUNTRY CODE="US">USA</COUNTRY><PHONE_1>+1 559 4996514</PHONE_1><FAX_1>+1 559 4996513</FAX_1></ADDRESS></PERSON><PERSON ID="CB947C7882E26AA2012E60F35CCBC6D7" ROLE="AUTHOR"><FIRST_NAME>Olga</FIRST_NAME><LAST_NAME>Mostovetsky</LAST_NAME><POSITION>Student Pharmacist</POSITION><EMAIL_1>olga.mostovetsky@hpmg.com</EMAIL_1><ADDRESS><DEPARTMENT>Clinical Pharmacy</DEPARTMENT><ORGANISATION>University of California, San Francisco</ORGANISATION><ADDRESS_1>Suite 420, Box 0613</ADDRESS_1><ADDRESS_2>3333 California Street</ADDRESS_2><CITY>San Francisco</CITY><ZIP>94118</ZIP><REGION>California</REGION><COUNTRY CODE="US">USA</COUNTRY><PHONE_1>415-476-1067</PHONE_1><FAX_1>415-502-0792</FAX_1></ADDRESS></PERSON><PERSON ID="CB9B82CF82E26AA2012E60F368FD79E7" ROLE="AUTHOR"><FIRST_NAME>Christine</FIRST_NAME><LAST_NAME>Yu</LAST_NAME><POSITION>Student Pharmacist</POSITION><EMAIL_1>christine.yu@ucsf.edu</EMAIL_1><ADDRESS><DEPARTMENT>Clinical Pharmacy</DEPARTMENT><ORGANISATION>University of California, San Francisco</ORGANISATION><ADDRESS_1>Suite 420, Box 0613</ADDRESS_1><ADDRESS_2>3333 California Street</ADDRESS_2><CITY>San Francisco</CITY><ZIP>94118</ZIP><REGION>California</REGION><COUNTRY CODE="US">USA</COUNTRY><PHONE_1>415-476-1067</PHONE_1><FAX_1>415-502-0792</FAX_1></ADDRESS></PERSON><PERSON ID="CB99E3F482E26AA2012E60F33AE6A6CD" ROLE="AUTHOR"><FIRST_NAME>Tami</FIRST_NAME><LAST_NAME>Chheng</LAST_NAME><POSITION>Student Pharmacist</POSITION><EMAIL_1>tami.chheng@ucsf.edu</EMAIL_1><ADDRESS><DEPARTMENT>Clinical Pharmacy</DEPARTMENT><ORGANISATION>University of California, San Francisco</ORGANISATION><ADDRESS_1>Suite 420, Box 0613</ADDRESS_1><ADDRESS_2>3333 California Street</ADDRESS_2><CITY>San Francisco</CITY><ZIP>94118</ZIP><REGION>California</REGION><COUNTRY CODE="US">USA</COUNTRY><PHONE_1>415-476-1067</PHONE_1><FAX_1>415-502-0792</FAX_1></ADDRESS></PERSON><PERSON ID="13425" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Johnny</FIRST_NAME><LAST_NAME>Beney</LAST_NAME><POSITION>Hospital Pharmacist</POSITION><EMAIL_1>johnny.beney@ichv.ch</EMAIL_1><URL>http://www.ichv.vsnet.ch</URL><ADDRESS><DEPARTMENT>Pharmacy</DEPARTMENT><ORGANISATION>Institut Central des Hopitaux Valaisans</ORGANISATION><ADDRESS_1>Grand Champsec 86</ADDRESS_1><ADDRESS_2>CP 736</ADDRESS_2><CITY>Sion</CITY><ZIP>1951</ZIP><COUNTRY CODE="CH">Switzerland</COUNTRY><PHONE_1>+41 27 603 4739</PHONE_1><PHONE_2>+41 27 603 4730</PHONE_2><FAX_1>+41 27 603 4832</FAX_1></ADDRESS></PERSON><PERSON ID="7210" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Christine</FIRST_NAME><MIDDLE_INITIALS>M</MIDDLE_INITIALS><LAST_NAME>Bond</LAST_NAME><POSITION>Professor of Primary Care (Pharmacy)</POSITION><EMAIL_1>c.m.bond@abdn.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Department of General Practice and Primary Care</DEPARTMENT><ORGANISATION>University of Aberdeen</ORGANISATION><ADDRESS_1>Foresterhill Health Centre</ADDRESS_1><ADDRESS_2>Westburn Road</ADDRESS_2><CITY>Aberdeen</CITY><ZIP>AB25 2AY</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 1224 553973</PHONE_1><PHONE_2>+44 1224 558466</PHONE_2><FAX_1>+44 1224 550683</FAX_1></ADDRESS></PERSON><PERSON ID="7082" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Lisa</FIRST_NAME><LAST_NAME>Bero</LAST_NAME><POSITION>Director, US Cochrane Center, San Francisco Branch</POSITION><EMAIL_1>berol@pharmacy.ucsf.edu</EMAIL_1><ADDRESS><DEPARTMENT>Professor of Clinical Pharmacy &amp; Health Policy</DEPARTMENT><ORGANISATION>University of California San Francisco</ORGANISATION><ADDRESS_1>Suite 420, Box 0613</ADDRESS_1><ADDRESS_2>3333 California Street</ADDRESS_2><CITY>San Francisco</CITY><ZIP>94143-0613</ZIP><REGION>California</REGION><COUNTRY CODE="US">USA</COUNTRY><PHONE_1>+1 415 476 1067</PHONE_1><FAX_1>+1 415 502 0792</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2010-11-26 11:13:22 -0500" MODIFIED_BY="Laura Nichol">
<UP_TO_DATE>
<DATE DAY="18" MONTH="1" YEAR="2000"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="1" MONTH="4" YEAR="2008"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="11" MONTH="6" YEAR="2011"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="2" YEAR="1995"/>
<REVIEW_PUBLISHED ISSUE="4" YEAR="1997"/>
<LAST_CITATION_ISSUE ISSUE="7" YEAR="2010"/>
</DATES>
<WHATS_NEW MODIFIED="2010-12-01 08:29:04 -0500" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2010-12-01 08:29:04 -0500" MODIFIED_BY="[Empty name]">
<DATE DAY="1" MONTH="12" YEAR="2010"/>
<DESCRIPTION>
<P>Conflict of interest modified.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2010-12-01 08:28:09 -0500" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2010-12-01 08:28:00 -0500" MODIFIED_BY="[Empty name]">
<DATE DAY="16" MONTH="6" YEAR="2010"/>
<DESCRIPTION>
<P>New search, criteria for included studies changed to only include RCTs, new authors</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2010-12-01 08:28:09 -0500" MODIFIED_BY="[Empty name]">
<DATE DAY="16" MONTH="6" YEAR="2010"/>
<DESCRIPTION>
<P>Reconciled old and new studies</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2010-06-11 14:57:18 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="21" MONTH="8" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS">
<DATE DAY="18" MONTH="1" YEAR="2000"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>University of California, San Francisco</NAME>
<COUNTRY CODE="US">USA</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>University of Aberdeen</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Institut Central des Hôpitaux Valaisans, Sion</NAME>
<COUNTRY CODE="CH">Switzerland</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2010-11-26 11:24:27 -0500" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2010-06-04 11:11:17 -0400" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2010-05-21 00:19:42 -0400" MODIFIED_BY="[Empty name]">Non-traditional roles of outpatient pharmacists.</TITLE>
<SUMMARY_BODY MODIFIED="2010-06-04 11:11:17 -0400" MODIFIED_BY="[Empty name]">
<P>The role of pharmacists in the community includes more than dispensing medications. It involves identifying, preventing, and resolving drug-related problems, as well as encouraging proper use of medications and general health promotion and education.</P>
<P>This review found forty-three studies which evaluated non-traditional roles of pharmacists. In general, the data included in this review supported the roles of pharmacists in patient counseling, therapeutic management, and providing health professional education with the goal of improving patient process of care and clinical outcomes. Non-traditional roles of outpatient pharmacists improves health care outcomes. The data show that educational outreach visits may impact physician prescribing patterns.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2010-06-10 17:41:03 -0400" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2010-06-10 17:41:03 -0400" MODIFIED_BY="[Empty name]">
<P>The roles of pharmacists in patient care have expanded from the traditional tasks of dispensing medications and providing basic medication counseling to working with other health professionals and the public. Multiple reviews have evaluated the impact of pharmacist-provided patient care on health-related outcomes. Prior reviews have primarily focused on in-patient settings. This systematic review focuses on services provided by outpatient pharmacists in community or ambulatory care settings. This is an update of the Cochrane review published in 2000.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2010-06-04 10:49:10 -0400" MODIFIED_BY="[Empty name]">
<P>To examine the effect of outpatient pharmacists' non-dispensing roles on patient and health professional outcomes.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2010-06-04 10:51:49 -0400" MODIFIED_BY="[Empty name]">
<P>This review has been split into two phases. For Phase I, we searched the Cochrane Effective Practice and Organisation of Care (EPOC) Group Specialised Register (January 1966 through March 2007). For Phase II, we searched MEDLINE/EMBASE (January 1966 through March 2008). The Phase I results are reported in this review; Phase II will be summarized in the next update.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2010-06-04 11:03:15 -0400" MODIFIED_BY="[Empty name]">
<P>Randomized controlled trials comparing 1. Pharmacist services targeted at patients versus services delivered by other health professionals; 2. Pharmacist services targeted at patients versus the delivery of no comparable service; 3. Pharmacist services targeted at health professionals versus services delivered by other health professionals; 4. Pharmacist services targeted at health professionals versus the delivery of no comparable service.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2010-06-04 11:03:55 -0400" MODIFIED_BY="[Empty name]">
<P>Two authors independently reviewed studies for inclusion, extracted data, and assessed risk of bias of included studies.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2010-06-04 11:07:16 -0400" MODIFIED_BY="[Empty name]">
<P>Forty-three studies were included; 36 studies were pharmacist interventions targeting patients and seven studies were pharmacist interventions targeting health professionals. For comparison 1, the only included study showed a significant improvement in systolic blood pressure for patients receiving medication management from a pharmacist compared to usual care from a physician. For comparison 2, in the five studies evaluating process of care outcomes, pharmacist services reduced the incidence of therapeutic duplication and decreased the total number of medications prescribed. Twenty-nine of 36 studies reported clinical and humanistic outcomes. Pharmacist interventions resulted in improvement in most clinical outcomes, although these improvements were not always statistically significant. Eight studies reported patient quality of life outcomes; three studies showed improvement in at least three subdomains. For comparison 3, no studies were identified meeting the inclusion criteria. For comparison 4, two of seven studies demonstrated a clear statistically significant improvement in prescribing patterns.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2010-06-07 11:40:17 -0400" MODIFIED_BY="[Empty name]">
<P>Only one included study compared pharmacist services with other health professional services, hence we are unable to draw conclusions regarding comparisons 1 and 3. Most included studies supported the role of pharmacists in medication/therapeutic management, patient counseling, and providing health professional education with the goal of improving patient process of care and clinical outcomes, and of educational outreach visits on physician prescribing patterns. There was great heterogeneity in the types of outcomes measured across all studies. Therefore a standardized approach to measure and report clinical, humanistic, and process outcomes for future randomized controlled studies evaluating the impact of outpatient pharmacists is needed. Heterogeneity in study comparison groups, outcomes, and measures makes it challenging to make generalised statements regarding the impact of pharmacists in specific settings, disease states, and patient populations.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2010-06-11 14:22:47 -0400" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2010-06-10 17:41:16 -0400" MODIFIED_BY="[Empty name]">
<P>In the past three decades, the roles of pharmacists in patient care have expanded from the traditional tasks of dispensing medications to working with other health professionals and the public. Multiple systematic reviews and meta-analyses have evaluated the impact of pharmacist-provided patient care on health-related outcomes (<LINK REF="REF-Machado-2007a" TYPE="REFERENCE">Machado 2007a</LINK>; <LINK REF="REF-Machado-2007b" TYPE="REFERENCE">Machado 2007b</LINK>). It is important to conduct systematic reviews in this area because both the results and quality of the original studies vary. Thus, a rigorous review enables us to assess the best available evidence on the effects of pharmacist interventions.</P>
<P>The systematic reviews conducted thus far have focused on care rendered in specific practice settings (for example, ambulatory care, community pharmacy, acute care, long-term/intermediate care) (<LINK REF="REF-Beney-2000" TYPE="REFERENCE">Beney 2000</LINK>; <LINK REF="REF-Blenkinsopp-2003" TYPE="REFERENCE">Blenkinsopp 2003</LINK>; <LINK REF="REF-Christensen-2006" TYPE="REFERENCE">Christensen 2006</LINK>; <LINK REF="REF-Horn-2006" TYPE="REFERENCE">Horn 2006</LINK>; <LINK REF="REF-Kaboli-2006" TYPE="REFERENCE">Kaboli 2006</LINK>; <LINK REF="REF-Kane-2003" TYPE="REFERENCE">Kane 2003</LINK>; <LINK REF="REF-Royal-2006" TYPE="REFERENCE">Royal 2006</LINK>; <LINK REF="REF-Singhal-1999" TYPE="REFERENCE">Singhal 1999</LINK>; <LINK REF="REF-Tully-2000" TYPE="REFERENCE">Tully 2000</LINK>; <LINK REF="REF-Van-Wijk-2005" TYPE="REFERENCE">Van Wijk 2005</LINK>; <LINK REF="REF-Westerlund-2006" TYPE="REFERENCE">Westerlund 2006</LINK>), to specific patient populations (for example, geriatric, pediatric) (<LINK REF="REF-Hanlon-2004" TYPE="REFERENCE">Hanlon 2004</LINK>; <LINK REF="REF-Holland-2008" TYPE="REFERENCE">Holland 2008</LINK>; <LINK REF="REF-Rollason-2003" TYPE="REFERENCE">Rollason 2003</LINK>; <LINK REF="REF-Sanghera-2006" TYPE="REFERENCE">Sanghera 2006</LINK>; <LINK REF="REF-van-Eijken-2003" TYPE="REFERENCE">van Eijken 2003</LINK>), and in specified therapeutic areas (for example, anticoagulation, antibiotic utilization, asthma, diabetes, depression, heart failure, hypertension, immunizations, mental health, Parkinson's disease, tobacco cessation) (<LINK REF="REF-Dent-2007" TYPE="REFERENCE">Dent 2007</LINK>; <LINK REF="REF-Donovan-2006" TYPE="REFERENCE">Donovan 2006</LINK>; <LINK REF="REF-Finley-2003" TYPE="REFERENCE">Finley 2003</LINK>; <LINK REF="REF-Hogue-2006" TYPE="REFERENCE">Hogue 2006</LINK>; <LINK REF="STD-Holland-2005" TYPE="STUDY">Holland 2005</LINK>; <LINK REF="REF-Jenkins-1996" TYPE="REFERENCE">Jenkins 1996</LINK>; <LINK REF="REF-Lindenmeyer-2006" TYPE="REFERENCE">Lindenmeyer 2006</LINK>; <LINK REF="REF-Machado-2007a" TYPE="REFERENCE">Machado 2007a</LINK>; <LINK REF="REF-Machado-2007b" TYPE="REFERENCE">Machado 2007b</LINK>; <LINK REF="REF-Manley-2002" TYPE="REFERENCE">Manley 2002</LINK>; <LINK REF="REF-McLean-2005" TYPE="REFERENCE">McLean 2005</LINK>; <LINK REF="REF-Ponniah-2007" TYPE="REFERENCE">Ponniah 2007</LINK>; <LINK REF="REF-Simonson-2007" TYPE="REFERENCE">Simonson 2007</LINK>; <LINK REF="REF-von-Gunten-2007" TYPE="REFERENCE">von Gunten 2007</LINK>). A few reviews have been conducted to evaluate the impact of pharmacist-provided care on specific health outcome criteria (for example, humanistic) (<LINK REF="REF-Pickard-1999" TYPE="REFERENCE">Pickard 1999</LINK>; <LINK REF="REF-Pickard-2006" TYPE="REFERENCE">Pickard 2006</LINK>; <LINK REF="REF-Schumock-1996" TYPE="REFERENCE">Schumock 1996</LINK>; <LINK REF="REF-Schumock-2003" TYPE="REFERENCE">Schumock 2003</LINK>). Although there is some overlap in the focus of previous reviews, there are also gaps in the types of interventions assessed (for example, pharmacist-care provided to socio-economically, ethnically, or linguistically diverse patient populations or patients with low health literacy). To our knowledge, there are no comprehensive systematic reviews thoroughly evaluating randomized controlled trials studying the impact of pharmacist-provided care in outpatient practice settings.</P>
<P>Because the impact of pharmacist-provided services in the hospital setting has been well-studied, this systematic review focused on services provided by outpatient pharmacists in community or ambulatory care settings. This review encompassed all outpatient pharmacist services targeted toward patients and health professionals, as well as all types of clinical disease states and health care process measures. This was an update to the previous Cochrane systematic review (<LINK REF="REF-Beney-2000" TYPE="REFERENCE">Beney 2000</LINK>) that incorporated the studies that have been published since 2000 as well as studies not included in the original review.</P>
</BACKGROUND>
<OBJECTIVES MODIFIED="2010-06-07 11:40:16 -0400" MODIFIED_BY="[Empty name]">
<P>The objective of this review was to examine the effect of outpatient pharmacists' roles on patient and health professional outcomes. Relevant health professional outcomes or healthcare practice measures included changes in prescribing patterns (for example, appropriateness of or prescribing, therapeutic duplication) and disease control (for example, disease-specific test ordering). Relevant patient outcomes included changes in clinical disease markers (for example, blood pressure) and humanistic quality of life outcomes.</P>
<P>We examined the following main hypotheses:</P>
<P>1. Does the delivery of patient-targeted services by pharmacists improve patient or health professional outcomes compared to the delivery of the same services by other health professionals?</P>
<P>2. Does the delivery of patient-targeted services by pharmacists improve patient or health professional outcomes compared to the delivery of no comparable services?</P>
<P>3. Does the delivery of health professional-targeted services by pharmacists improve patient or health professional outcomes compared to the delivery of the same services by other health professionals?</P>
<P>4. Does the delivery of health professional-targeted services by pharmacists improve patient or health professional outcomes compared to the delivery of no comparable services?</P>
<P>To test the above hypotheses, we examined the following comparisons.</P>
<P>1. Pharmacist services targeted at patients versus services delivered by other health professionals.</P>
<P>2. Pharmacist services targeted at patients versus the delivery of no comparable services.</P>
<P>3. Pharmacist services targeted at health professionals versus services delivered by other health professionals.</P>
<P>4. Pharmacist services targeted at health professionals versus the delivery of no comparable services.</P>
</OBJECTIVES>
<METHODS MODIFIED="2010-06-10 18:42:48 -0400" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2010-06-10 18:42:48 -0400" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2010-06-10 18:42:48 -0400" MODIFIED_BY="[Empty name]">
<P>Study designs that meet Effective Practice and Organization of Care Group (EPOC) inclusion criteria are randomized controlled trial (RCT), controlled clinical trial (CCT), controlled before and after study (CBA) and interrupted time series (ITS). In this area of research, it has historically been challenging to identify a substantial number of RCTs in the literature. In the original review and 2000 update, all study designs mentioned above were included. Due to the substantial increase in the number of published RCTs studying the effect of pharmacists' interventions on patient and health professional outcomes, we limited the current update to RCT study designs.</P>
<P>We included</P>
<P>RCTs randomizing:<BR/>patients;<BR/>pharmacists;<BR/>practices (pharmacies or medical clinics); or<BR/>geographical areas.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2010-05-21 00:20:04 -0400" MODIFIED_BY="[Empty name]">
<P>The participants for all comparative studies we included in this review were pharmacists (or pharmacies) who deliver services in outpatient settings other than, or in addition to, drug compounding and dispensing. We excluded studies involving services to patients in hospitals or skilled nursing facilities. We included studies of pharmacists delivering services to outpatients in a clinic attached to a hospital or a day hospital.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2010-05-21 00:20:04 -0400" MODIFIED_BY="[Empty name]">
<P>The types of interventions we included were any services delivered by pharmacists other than drug compounding and dispensing. When available we collected additional data on the content of each intervention including recipients, format, source, timing, setting, and cost.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2010-06-04 11:23:52 -0400" MODIFIED_BY="[Empty name]">
<P>We included studies only if 1) reported primary outcomes were objective with respect to measurement of health care process measures or patient outcomes and 2) relevant and interpretable data were presented. We therefore excluded subjective outcomes (for example, self-reporting of symptoms, medication knowledge, satisfaction with pharmacist services) or outcomes for which reporting was incomplete (for example no numerical values reported, no baseline data provided). To minimize reporting bias, we excluded outcomes that were not primary. For studies that did not explicitly report which outcomes were primary, we included all objective and relevant outcomes.</P>
<P>We excluded adherence outcomes because there is another Cochrane review that assessed interventions to improve adherence (<LINK REF="REF-Haynes-2008" TYPE="REFERENCE">Haynes 2008</LINK>). We also excluded resource-utilization and cost outcomes because these endpoints were recently assessed in another systematic review (<LINK REF="REF-Perez-2009" TYPE="REFERENCE">Perez 2009</LINK>).</P>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2010-06-07 11:40:15 -0400" MODIFIED_BY="[Empty name]">
<P>When the original review was performed, there were few randomized controlled trials evaluating non-dispensing roles of outpatient pharmacists. Studies were identified by electronically searching the EPOC Specialised Register, MEDLINE, EMBASE, PHARMLINE and International Pharmaceutical Abstracts from January 1,1966 through December, 1995. Professional librarians were consulted to advise on a broad search strategy for each database. In MEDLINE, broad searches using the MeSH headings 'pharmacy' and 'pharmacist' and each of the following publication types 'randomized controlled trial', 'controlled clinical trial', 'comparative study', 'follow up study', 'prospective study', and 'evaluation study' were performed.</P>
<P>The following journals were hand searched: <I>American Journal of Hospital Pharmacy</I> (1985 through 1995), <I>International Journal of Pharmacy Practice Research</I> (1987 through 1995), <I>Journal of Social and Administrative Pharmacy</I> (1987 through 1995), <I>Scanner</I> (a pharmacy abstract journal) (1987 through1995), and <I>The Pharmaceutical Journal</I> (1960 through1997). <I>The Pharmacy Practice Research Literature Index</I> (1984 through1994) compiled by Peter Abel and published by the UK Pharmacy Practice Research Resource Centre, University of Manchester, England, was also searched.</P>
<P>The reference lists of trials identified for the review, as well as other review articles on the extended roles of pharmacists, were checked. Non-English language publications, if found, were to be included in the review.</P>
<P>An attempt was made to identify unpublished studies and works in progress by searching, for 1990 through 1995, the published abstracts of the annual meetings of the American Society of Hospital Pharmacists, Health Service and Pharmacy Practice Research Conference (UK), Pharmacy Practice Research Sessions of the Royal Pharmaceutical Society of Great Britain Annual Conference, and proceedings of the UK Clinical Research Association.</P>
<P>For the 2000 update, relevant studies were located by searching the EPOC Specialised Register, electronically searching MEDLINE, and ongoing handsearching of the <I>International Journal of Pharmacy Practice Research</I> and <I>The Pharmaceutical Journal</I>.</P>
<P>Given the significant increase in publications in this area over the past several years, we split the search for this update. We will complete this update in two phases. Phase I (the current update) consists of studies identified in prior versions of this review and studies identified in the EPOC Specialised Register search (January 1966 through March 2007). Phase II (in progress) will include studies identified in prior versions of this review, the Phase I update, and studies identified through a MEDLINE and EMBASE (January 1966 through March 2008) search. Specific search criteria are included in <LINK TAG="APPENDICES" TYPE="SECTION">Appendices</LINK>.</P>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2010-06-07 11:40:14 -0400" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2010-06-04 11:31:39 -0400" MODIFIED_BY="[Empty name]">
<P>Two review authors independently selected the trials to be included in the review. We resolved disagreements by discussion of the articles by at least two of the authors of the review.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2010-06-04 11:33:36 -0400" MODIFIED_BY="[Empty name]">
<P>We collected data using the EPOC Data Extraction Checklist. To streamline the data collection process, we built an online database on the Quesgen platform using the Data Extraction Checklist questionnaire. Two review authors independently extracted data for each study with a focus on outcomes and characteristics aimed at reducing bias. We discussed and reconciled differences in coding.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2010-06-04 11:34:50 -0400" MODIFIED_BY="[Empty name]">
<P>Two review authors independently assessed the risk of bias of all studies eligible for the review using the EPOC Data Extraction Checklist. We adjudicated discrepancies by discussion of the studies. We assessed allocation concealment, blinding, follow-up of patients or health professionals (when applicable), baseline measurement, reliability of outcome measures, and protection against contamination. For included studies, the risk of bias characteristics are described in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table. We identified studies with unit of analysis errors. No pooled data included unit of analysis errors.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2010-06-03 13:47:06 -0400" MODIFIED_BY="[Empty name]">
<P>We reported results for baseline (pre-intervention) and end-of-study (post-intervention) periods if available (see 'Outcomes Table' under <LINK TAG="ANALYSES_AND_DATA" TYPE="SECTION">Data and analyses</LINK>). Where possible, we calculated pre-post intervention differences for each outcome for control and intervention groups, and the difference of pre-post intervention change between study groups (result interval). In all cases, we reported a more favorable outcome in the intervention group as a positive finding (that is where changes from baseline are in the intended direction) and vice versa as a negative finding. For quality of life outcomes, we did not report raw data for each quality of life domain; instead we listed each domain measured under the 'primary outcomes' column in the 'Outcomes Table' (under <LINK TAG="ANALYSES_AND_DATA" TYPE="SECTION">Data and analyses</LINK>) and indicated in the 'significance' column which domains were significantly improved in intervention versus control groups during the course of the study. All outcomes included in this review are listed under the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> and <LINK TAG="ANALYSES_AND_DATA" TYPE="SECTION">Data and analyses</LINK> tables.</P>
</EFFECT_MEASURES>
<HETEROGENEITY_ASSESSMENT MODIFIED="2010-06-04 11:38:55 -0400" MODIFIED_BY="[Empty name]">
<P>Among the included studies, there was great heterogeneity in comparison groups, intervention type, outcomes assessed, duration of intervention, length of follow-up, and measurement used for outcomes.</P>
<P>We attempted to perform a meta-analysis by subgrouping studies based on clinical disease state and outcome type. Unfortunately, there were insufficient data across the 43 included trials to perform subgroup analyses on all disease states.</P>
<P>There was a high degree of heterogeneity in the types of outcomes measured for each disease state. For example, in the four studies assessing disease control in patients with depression, one study used Brief Inventory of Depressive Symptoms (BIDs), Beck Depression Inventory (BDI), and Work and Social Disability Scale (WSDS) (<LINK REF="STD-Finley-2003" TYPE="STUDY">Finley 2003</LINK>), one study used BDI (<LINK REF="STD-Rickles-2005" TYPE="STUDY">Rickles 2005</LINK>) and two studies used the self-rating Hopkins Symptom Checklist (SCL) (<LINK REF="STD-Brook-2003b" TYPE="STUDY">Brook 2003b</LINK>; <LINK REF="STD-Capoccia-2004" TYPE="STUDY">Capoccia 2004</LINK>). Due to the different outcome measures and measurement units, we were unable to pool these outcomes into one analysis. The same issue was present in studies targeting patients with asthma, chronic obstructive pulmonary disease (COPD), heart failure, hyperlipidemia and anticoagulation therapy. In these cases, we were unable to perform a meta-analysis due to the reasons described above, as well as the small number of studies performed with these disease states. We present data separately for each of these studies.</P>
</HETEROGENEITY_ASSESSMENT>
<SUBGROUP_ANALYSIS MODIFIED="2010-06-07 11:40:14 -0400" MODIFIED_BY="[Empty name]">
<P>For studies measuring blood pressure and glycosylated hemoglobin (HbA1C), we collected enough data points to potentially perform a pooled analysis. Although these groups of studies were comparable in terms of disease state studied and outcomes assessed, there was variability in intervention type and length of follow-up. To minimize heterogeneity in these pooled analyses, we included in the meta-analysis only studies with similar disease state, intervention type, and length of study.</P>
<P>Performing a pooled analysis for continuous outcomes requires pre- and post- means and standard deviations for outcome measures for both control and intervention groups. Reporting of standard deviations was incomplete; only three of the seven studies measuring systolic and diastolic blood pressures and one of the five studies measuring HbA1C reported standard deviations.</P>
<P>We considered two methods to yield a standard deviation for data pooling purposes: 1) calculating a standard deviation from a P value and 2) imputation (using the standard deviation reported in other studies included in the analysis). Standard deviations derived from P values resulted in a high degree of study heterogeneity (I<SUP>2 </SUP>&gt; 80%). Imputation had the least effect on study heterogeneity (I<SUP>2 </SUP>= 0). Given these observations, we chose the imputation method.</P>
</SUBGROUP_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2010-06-10 18:44:00 -0400" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2010-06-10 18:44:00 -0400" MODIFIED_BY="[Empty name]">
<P>The prior update to this review (<LINK REF="REF-Beney-2000" TYPE="REFERENCE">Beney 2000</LINK>) identified 25 studies that met inclusion criteria. Six of the 25 included studies were pre-post designs, controlled by a separate site (<LINK REF="STD-Cody-1998" TYPE="STUDY">Cody 1998</LINK>; <LINK REF="STD-Lai-1998" TYPE="STUDY">Lai 1998</LINK>; <LINK REF="STD-Peterson-1995" TYPE="STUDY">Peterson 1995</LINK>; <LINK REF="STD-Peterson-1997" TYPE="STUDY">Peterson 1997</LINK>; <LINK REF="STD-Schaffner-1983" TYPE="STUDY">Schaffner 1983</LINK>; <LINK REF="STD-Tamai-1987" TYPE="STUDY">Tamai 1987</LINK>), two were quasi randomized controlled trials (<LINK REF="STD-Erickson-1997" TYPE="STUDY">Erickson 1997</LINK>; <LINK REF="STD-McKenney-1973" TYPE="STUDY">McKenney 1973</LINK>), and the remainder were randomized controlled trials.</P>
<P>In Phase I of this update, we identified 107 publications that met our search criteria. Of these, 64 were excluded from the final analysis (see <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> and <LINK TAG="EXCLUDED_STUDIES" TYPE="SECTION">Excluded studies</LINK>). All included studies were randomized controlled trials. One study was a before-and-after pragmatic randomized controlled trial (<LINK REF="STD-Hall-2001" TYPE="STUDY">Hall 2001</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="3">Characteristics of interventions</HEADING>
<P>For study details see the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table.</P>
<P>Of the 43 included studies, seven studied pharmacist interventions targeted at health professionals (<LINK REF="STD-Diwan-1995" TYPE="STUDY">Diwan 1995</LINK>; <LINK REF="STD-Freemantle-2002" TYPE="STUDY">Freemantle 2002</LINK>; <LINK REF="STD-Hall-2001" TYPE="STUDY">Hall 2001</LINK>; <LINK REF="STD-Ilett-2000" TYPE="STUDY">Ilett 2000</LINK>; <LINK REF="STD-Stergachis-1987" TYPE="STUDY">Stergachis 1987</LINK>; <LINK REF="STD-Turner-2000" TYPE="STUDY">Turner 2000</LINK>; <LINK REF="STD-Watson-2001" TYPE="STUDY">Watson 2001</LINK>) and 36 reported on pharmacist interventions targeted at patients. In 11 of the 36 studies targeted at patients, the pharmacist intervention also targeted health professionals (<LINK REF="STD-Borenstein-2003" TYPE="STUDY">Borenstein 2003</LINK>; <LINK REF="STD-Choe-2005" TYPE="STUDY">Choe 2005</LINK>; <LINK REF="STD-Gattis-1999" TYPE="STUDY">Gattis 1999</LINK>; <LINK REF="STD-Hanlon-1996" TYPE="STUDY">Hanlon 1996</LINK>; <LINK REF="STD-Jackson-2004" TYPE="STUDY">Jackson 2004</LINK>; <LINK REF="STD-Mehos-2000" TYPE="STUDY">Mehos 2000</LINK>; <LINK REF="STD-Sadik-2005" TYPE="STUDY">Sadik 2005</LINK>; <LINK REF="STD-Schneider-1982" TYPE="STUDY">Schneider 1982</LINK>; <LINK REF="STD-Sookaneknun-2004" TYPE="STUDY">Sookaneknun 2004</LINK>; <LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>; <LINK REF="STD-Tsuyuki-2002" TYPE="STUDY">Tsuyuki 2002</LINK>). In most of these studies, pharmacists provided: a) oral or written recommendations to physicians regarding therapy modifications or resolution of medication-related problems and b) multiple follow-up visits with patients spanning several months (range: 1 month to 12 months). All but one of the included studies compared pharmacist services targeted at patients or health professionals versus provision of no comparable services (or usual care). One study (<LINK REF="STD-Hawkins-1979" TYPE="STUDY">Hawkins 1979</LINK>) compared pharmacist services with services provided by other health professionals. Eight of the 43 studies were randomized by clinical practice or region, with the remainder randomizing by individual patient or health professional.</P>
<P>In all seven studies targeted at health professionals, pharmacists conducted educational outreach visits at physician practices to promote guideline-based prescribing for certain medication classes including antibiotics (<LINK REF="STD-Ilett-2000" TYPE="STUDY">Ilett 2000</LINK>) and nonsteroidal anti-inflammatory drugs (NSAIDs) (<LINK REF="STD-Freemantle-2002" TYPE="STUDY">Freemantle 2002</LINK>; <LINK REF="STD-Stergachis-1987" TYPE="STUDY">Stergachis 1987</LINK>; <LINK REF="STD-Watson-2001" TYPE="STUDY">Watson 2001</LINK>), and for certain disease states including <I>Helicobacter pylori</I> infection (<LINK REF="STD-Hall-2001" TYPE="STUDY">Hall 2001</LINK>), heart failure (<LINK REF="STD-Freemantle-2002" TYPE="STUDY">Freemantle 2002</LINK>; <LINK REF="STD-Turner-2000" TYPE="STUDY">Turner 2000</LINK>), and cardiovascular disease (<LINK REF="STD-Diwan-1995" TYPE="STUDY">Diwan 1995</LINK>). Overall, pharmacists conducted one or two visits lasting 10 to 15 minutes within a study period ranging from 3 months to 24 months. Educational outreach visits are the focus of a Cochrane review (<LINK REF="REF-O_x0027_Brien-2007" TYPE="REFERENCE">O'Brien 2007</LINK>). This review evaluated all but two (<LINK REF="STD-Stergachis-1987" TYPE="STUDY">Stergachis 1987</LINK>; <LINK REF="STD-Turner-2000" TYPE="STUDY">Turner 2000</LINK>) of the seven studies identified above.</P>
<P>In 8 of 36 studies targeted at patients, the main focus of the pharmacist intervention was patient education (<LINK REF="STD-Barbanel-2003" TYPE="STUDY">Barbanel 2003</LINK>; <LINK REF="STD-Brook-2003a" TYPE="STUDY">Brook 2003a</LINK>; <LINK REF="STD-Gonzalez_x002d_Martin-2003" TYPE="STUDY">Gonzalez-Martin 2003</LINK>; <LINK REF="STD-Goodyer-1995" TYPE="STUDY">Goodyer 1995</LINK>; <LINK REF="STD-Paulos-2005" TYPE="STUDY">Paulos 2005</LINK>; <LINK REF="STD-Rickles-2005" TYPE="STUDY">Rickles 2005</LINK>; <LINK REF="STD-Sarkadi-2004" TYPE="STUDY">Sarkadi 2004</LINK>; <LINK REF="STD-Van-Veldhuizen-1995" TYPE="STUDY">Van Veldhuizen 1995</LINK>). One study evaluated the effect of home blood pressure monitoring on blood pressure control with the pharmacist providing telephone follow-up to assess blood pressures and response to therapy (<LINK REF="STD-Mehos-2000" TYPE="STUDY">Mehos 2000</LINK>). In the rest of the patient-targeted studies, pharmacist interventions were complex and commonly involved pharmaceutical therapy management consisting of pharmaceutical therapy optimization, monitoring of disease control and adverse drug reactions, identification of drug-drug interactions, compliance assessment, and patient education. Twenty-two studies took place in outpatient medical clinics, ten studies took place in community pharmacies (<LINK REF="STD-Barbanel-2003" TYPE="STUDY">Barbanel 2003</LINK>; <LINK REF="STD-Brook-2003a" TYPE="STUDY">Brook 2003a</LINK>; <LINK REF="STD-Cody-1998" TYPE="STUDY">Cody 1998</LINK>; <LINK REF="STD-Park-1996" TYPE="STUDY">Park 1996</LINK>; <LINK REF="STD-Paulos-2005" TYPE="STUDY">Paulos 2005</LINK>; <LINK REF="STD-Rickles-2005" TYPE="STUDY">Rickles 2005</LINK>; <LINK REF="STD-Sarkadi-2004" TYPE="STUDY">Sarkadi 2004</LINK>; <LINK REF="STD-Sookaneknun-2004" TYPE="STUDY">Sookaneknun 2004</LINK>; <LINK REF="STD-Tsuyuki-2002" TYPE="STUDY">Tsuyuki 2002</LINK>; <LINK REF="STD-Weinberger-2002" TYPE="STUDY">Weinberger 2002</LINK>), one study took place at a home care agency (<LINK REF="STD-Meredith-2002" TYPE="STUDY">Meredith 2002</LINK>), and two studies involved hospital pharmacists following recently discharged patients at home (<LINK REF="STD-Jackson-2004" TYPE="STUDY">Jackson 2004</LINK>; <LINK REF="STD-Peterson-2004" TYPE="STUDY">Peterson 2004</LINK>). The duration of the intervention ranged from 14 to 120 minutes with 1 to 22 intervention events conducted over the study period of 6 weeks to 23 months. Post-intervention follow-up was performed in two trials to assess duration of intervention effect after the studies were completed (<LINK REF="STD-Odegard-2005" TYPE="STUDY">Odegard 2005</LINK>; <LINK REF="STD-Sarkadi-2004" TYPE="STUDY">Sarkadi 2004</LINK>).</P>
<P>In most patient-targeted studies, controls were 'usual care' groups in which patients continued to receive standard care from primary care health professionals; the usual care differed from the service provided by the pharmacist to the intervention group. In three of the seven studies targeting health professionals, control groups received no intervention (<LINK REF="STD-Diwan-1995" TYPE="STUDY">Diwan 1995</LINK>; <LINK REF="STD-Ilett-2000" TYPE="STUDY">Ilett 2000</LINK>; <LINK REF="STD-Turner-2000" TYPE="STUDY">Turner 2000</LINK>). In two of the other health professional-targeted studies, control groups received a non-pharmacist intervention. In one study, the control group received a non-targeted intervention (<LINK REF="STD-Freemantle-2002" TYPE="STUDY">Freemantle 2002</LINK>), and in the other study, the control group received mailed practice guidelines, but not the educational outreach visit by the pharmacist (<LINK REF="STD-Hall-2001" TYPE="STUDY">Hall 2001</LINK>). Two studies had more than one control group (<LINK REF="STD-Watson-2001" TYPE="STUDY">Watson 2001</LINK>; <LINK REF="STD-Weinberger-2002" TYPE="STUDY">Weinberger 2002</LINK>). In the first study, which targeted health professionals to study the effect of an intervention composed of mailed practice guidelines and education outreach visits by the pharmacist, the first control group received no intervention while the second control group received mailed practice guidelines (<LINK REF="STD-Watson-2001" TYPE="STUDY">Watson 2001</LINK>). In the second trial, which targeted patients with asthma and COPD, the first control group received usual care while the second control group received home peak flow monitors but not follow-up by the pharmacist (<LINK REF="STD-Weinberger-2002" TYPE="STUDY">Weinberger 2002</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Characteristics of health professionals delivering the intervention</HEADING>
<P>In all studies, interventions were performed by either practicing pharmacists, pharmacy residents, or doctor of pharmacy students. In most studies, 1 to 4 pharmacists performed the intervention, but some studies involved more than 10 pharmacists across multiple practices (<LINK REF="STD-Bond-2000" TYPE="STUDY">Bond 2000</LINK>; <LINK REF="STD-Brook-2003b" TYPE="STUDY">Brook 2003b</LINK>; <LINK REF="STD-Diwan-1995" TYPE="STUDY">Diwan 1995</LINK>; <LINK REF="STD-Freemantle-2002" TYPE="STUDY">Freemantle 2002</LINK>; <LINK REF="STD-Malone-2001" TYPE="STUDY">Malone 2001</LINK>; <LINK REF="STD-Rickles-2005" TYPE="STUDY">Rickles 2005</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Target population</HEADING>
<P>In six of seven studies targeted at health professionals, participants were selected based on location. Two studies selected participants from general practices within one or more health authorities (<LINK REF="STD-Freemantle-2002" TYPE="STUDY">Freemantle 2002</LINK>; <LINK REF="STD-Hall-2001" TYPE="STUDY">Hall 2001</LINK>) and four studies selected participants within a specific region (<LINK REF="STD-Diwan-1995" TYPE="STUDY">Diwan 1995</LINK>; <LINK REF="STD-Ilett-2000" TYPE="STUDY">Ilett 2000</LINK>; <LINK REF="STD-Stergachis-1987" TYPE="STUDY">Stergachis 1987</LINK>; <LINK REF="STD-Turner-2000" TYPE="STUDY">Turner 2000</LINK>). In one of seven studies, participating practices were selected based on their use of a specific computer system (<LINK REF="STD-Watson-2001" TYPE="STUDY">Watson 2001</LINK>).</P>
<P>Of the 36 studies targeting patients, 27 studies selected participants based on the clinical disease state; some studies included patients from more than one disease state. The following clinical disease states were represented across the included studies: asthma (<LINK REF="STD-Barbanel-2003" TYPE="STUDY">Barbanel 2003</LINK>; <LINK REF="STD-Gonzalez_x002d_Martin-2003" TYPE="STUDY">Gonzalez-Martin 2003</LINK>; <LINK REF="STD-Weinberger-2002" TYPE="STUDY">Weinberger 2002</LINK>), COPD (<LINK REF="STD-Solomon-1998" TYPE="STUDY">Solomon 1998</LINK>; <LINK REF="STD-Weinberger-2002" TYPE="STUDY">Weinberger 2002</LINK>), depression (<LINK REF="STD-Brook-2003a" TYPE="STUDY">Brook 2003a</LINK>; <LINK REF="STD-Capoccia-2004" TYPE="STUDY">Capoccia 2004</LINK>; <LINK REF="STD-Finley-2003" TYPE="STUDY">Finley 2003</LINK>, <LINK REF="STD-Rickles-2005" TYPE="STUDY">Rickles 2005</LINK>), diabetes (<LINK REF="STD-Choe-2005" TYPE="STUDY">Choe 2005</LINK>; <LINK REF="STD-Clifford-2005" TYPE="STUDY">Clifford 2005</LINK>; <LINK REF="STD-Hawkins-1979" TYPE="STUDY">Hawkins 1979</LINK>; <LINK REF="STD-Jaber-1996" TYPE="STUDY">Jaber 1996</LINK>; <LINK REF="STD-Odegard-2005" TYPE="STUDY">Odegard 2005</LINK>; <LINK REF="STD-Sarkadi-2004" TYPE="STUDY">Sarkadi 2004</LINK>; <LINK REF="STD-Van-Veldhuizen-1995" TYPE="STUDY">Van Veldhuizen 1995</LINK>), heart failure (<LINK REF="STD-Gattis-1999" TYPE="STUDY">Gattis 1999</LINK>; <LINK REF="STD-Goodyer-1995" TYPE="STUDY">Goodyer 1995</LINK>), hyperlipidemia (<LINK REF="STD-Bogden-1997" TYPE="STUDY">Bogden 1997</LINK>; <LINK REF="STD-Paulos-2005" TYPE="STUDY">Paulos 2005</LINK>; <LINK REF="STD-Peterson-2004" TYPE="STUDY">Peterson 2004</LINK>; <LINK REF="STD-Tsuyuki-2002" TYPE="STUDY">Tsuyuki 2002</LINK>) and hypertension (<LINK REF="STD-Borenstein-2003" TYPE="STUDY">Borenstein 2003</LINK>; <LINK REF="STD-Hawkins-1979" TYPE="STUDY">Hawkins 1979</LINK>; <LINK REF="STD-Mehos-2000" TYPE="STUDY">Mehos 2000</LINK>; <LINK REF="STD-Okamoto-2001" TYPE="STUDY">Okamoto 2001</LINK>; <LINK REF="STD-Park-1996" TYPE="STUDY">Park 1996</LINK>; <LINK REF="STD-Schneider-1982" TYPE="STUDY">Schneider 1982</LINK>; <LINK REF="STD-Solomon-1998" TYPE="STUDY">Solomon 1998</LINK>; <LINK REF="STD-Sookaneknun-2004" TYPE="STUDY">Sookaneknun 2004</LINK>). Additionally, five studies selected participants based on characteristics other than the clinical disease state; these studies focused on patients with high risk of medication related problems (<LINK REF="STD-Malone-2001" TYPE="STUDY">Malone 2001</LINK>; <LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>), home care patients (<LINK REF="STD-Meredith-2002" TYPE="STUDY">Meredith 2002</LINK>), patients with repeat prescriptions (<LINK REF="STD-Bond-2000" TYPE="STUDY">Bond 2000</LINK>), and patients on warfarin therapy (<LINK REF="STD-Jackson-2004" TYPE="STUDY">Jackson 2004</LINK>).</P>
<P>The number of participants ranged from 21 to 6000 patients and 17 to 112 health professionals. Nine studies included fewer than 50 participants, 14 studies had between 50 and 100 participants, 12 studies had between 101 and 500 participants and eight studies had more than 500 participants. One study targeted pediatric patients (<LINK REF="STD-Gonzalez_x002d_Martin-2003" TYPE="STUDY">Gonzalez-Martin 2003</LINK>) and the rest of the studies targeted adults, with nine studies focusing on elderly patients 65 years of age and older.</P>
</SUBSECTION>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2010-06-10 17:39:48 -0400" MODIFIED_BY="[Empty name]">
<P>Characteristics aimed at reducing bias are listed in the 'risk of bias' table under each study table in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> section. See <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK> and <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK> for graphic representations of the data presented below.</P>
<P>There were no major differences in the risk of bias of studies targeted at patients versus studies targeted at health professionals. Three of 43 studies had no risk of bias (<LINK REF="STD-Malone-2001" TYPE="STUDY">Malone 2001</LINK>; <LINK REF="STD-Meredith-2002" TYPE="STUDY">Meredith 2002</LINK>; <LINK REF="STD-Peterson-2004" TYPE="STUDY">Peterson 2004</LINK>). Only 15 of 43 studies adequately concealed allocation. Adequate follow-up of patients or health professionals (depending on target subject of study) was done in 27 of 43 studies. Baseline measures of primary outcomes were performed and were similar between intervention versus control groups in 27 of 43 studies, and protection against contamination was adequate in 12 of 43 studies. Because we only included objective primary outcomes in our review, most studies (41) were coded as having reliable outcomes and blinded assessment of outcomes.</P>
<P>Four studies had a unit of analysis mismatch. Of the four studies, three did not correct for clustering in the study analyses (<LINK REF="STD-Freemantle-2002" TYPE="STUDY">Freemantle 2002</LINK>; <LINK REF="STD-Turner-2000" TYPE="STUDY">Turner 2000</LINK>; <LINK REF="STD-Weinberger-2002" TYPE="STUDY">Weinberger 2002</LINK>). In two of these studies, the unit of allocation was practice while the unit of analysis was patient (<LINK REF="STD-Turner-2000" TYPE="STUDY">Turner 2000</LINK>; <LINK REF="STD-Weinberger-2002" TYPE="STUDY">Weinberger 2002</LINK>) and in the third study, unit of allocation was health authority while unit of analysis was practice (<LINK REF="STD-Freemantle-2002" TYPE="STUDY">Freemantle 2002</LINK>). One study corrected for clustering in the analysis (<LINK REF="STD-Bond-2000" TYPE="STUDY">Bond 2000</LINK>).</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2010-06-07 11:40:06 -0400" MODIFIED_BY="[Empty name]">
<P>All included outcomes are listed under the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> and <LINK TAG="ANALYSES_AND_DATA" TYPE="SECTION">Data and analyses</LINK> sections.</P>
<SUBSECTION>
<HEADING LEVEL="3">Comparison 1. Pharmacist services targeted at patients versus services delivered by other health professionals</HEADING>
<P>For detailed descriptions of outcomes see <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>.</P>
<P>One study evaluating the effect of pharmacist directed medication management versus physician medication management showed a small, but statistically significant increase in systolic blood pressure in the intervention group (-2mmHg in intervention group versus 2mmHg in control group). No statistically significant difference was noted in diastolic blood pressure and blood glucose levels (<LINK REF="STD-Hawkins-1979" TYPE="STUDY">Hawkins 1979</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Comparison 2. Pharmacist services targeted at patients versus the delivery of no comparable service</HEADING>
<P>For detailed descriptions of outcomes see <LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>, <LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>, <LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>, <LINK REF="CMP-002.04" TYPE="ANALYSIS">Analysis 2.4</LINK>.</P>
<P>Five of the 36 studies targeting patients reported process of care outcomes (<LINK REF="STD-Bond-2000" TYPE="STUDY">Bond 2000</LINK>; <LINK REF="STD-Jameson-1995" TYPE="STUDY">Jameson 1995</LINK>; <LINK REF="STD-Meredith-2002" TYPE="STUDY">Meredith 2002</LINK>; <LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>; <LINK REF="STD-Tsuyuki-2002" TYPE="STUDY">Tsuyuki 2002</LINK>). These studies measured the effect of pharmacist interventions on prescribing, with one study showing improvement in eliminating therapeutic duplication (<LINK REF="STD-Meredith-2002" TYPE="STUDY">Meredith 2002</LINK>), three studies showing a decrease in the total number of medications prescribed (<LINK REF="STD-Bond-2000" TYPE="STUDY">Bond 2000</LINK>; <LINK REF="STD-Jameson-1995" TYPE="STUDY">Jameson 1995</LINK>; <LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>), and one study showing an improvement in testing and statin prescribing for patients with hyperlipidemia (<LINK REF="STD-Tsuyuki-2002" TYPE="STUDY">Tsuyuki 2002</LINK>). Despite showing improvement in therapeutic duplication, Meredith et al were unable to demonstrate improvement for overall, cardiovascular, NSAID and psychotropic medication use.</P>
<P>Twenty-nine of the 36 studies targeting patients reported clinical and humanistic patient outcomes (including one study which reported process of care outcomes mentioned above (<LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>)). Pharmacist interventions resulted in improvement in most clinical outcomes, although these improvements were not always statistically significant. A meta-analysis was performed on studies with similar disease state, outcome, type of pharmacist intervention, duration of intervention, and length of follow-up. Hypertension and diabetes were the only disease states with a sufficient number of studies of comparable design; thus meta-analyses were performed only on studies evaluating these disease states.</P>
<P>Seven studies demonstrated improvement in systolic blood pressure ranging from 3.8 mmHg to 12.3 mmHg (<LINK REF="STD-Borenstein-2003" TYPE="STUDY">Borenstein 2003</LINK>; <LINK REF="STD-Mehos-2000" TYPE="STUDY">Mehos 2000</LINK>; <LINK REF="STD-Okamoto-2001" TYPE="STUDY">Okamoto 2001</LINK>; <LINK REF="STD-Park-1996" TYPE="STUDY">Park 1996</LINK>; <LINK REF="STD-Schneider-1982" TYPE="STUDY">Schneider 1982</LINK>; <LINK REF="STD-Solomon-1998" TYPE="STUDY">Solomon 1998</LINK>; <LINK REF="STD-Sookaneknun-2004" TYPE="STUDY">Sookaneknun 2004</LINK>), with two of these studies showing an increase in the proportion of patients controlled for blood pressure (<LINK REF="STD-Borenstein-2003" TYPE="STUDY">Borenstein 2003</LINK>; <LINK REF="STD-Sookaneknun-2004" TYPE="STUDY">Sookaneknun 2004</LINK>). Four of the seven hypertension studies (<LINK REF="STD-Mehos-2000" TYPE="STUDY">Mehos 2000</LINK>; <LINK REF="STD-Okamoto-2001" TYPE="STUDY">Okamoto 2001</LINK>; <LINK REF="STD-Solomon-1998" TYPE="STUDY">Solomon 1998</LINK>; <LINK REF="STD-Sookaneknun-2004" TYPE="STUDY">Sookaneknun 2004</LINK>) were included in a meta-analysis; these studies yielded an effect size of -6.32 mmHg (95% confidence interval (CI) -8.8 to -3.83) for systolic blood pressure and -3.12 (95% CI -4.57 to -1.67) for diastolic blood pressure (P &lt; 0.001 for both measures).</P>
<P>Seven studies targeted diabetic patients (<LINK REF="STD-Choe-2005" TYPE="STUDY">Choe 2005</LINK>; <LINK REF="STD-Clifford-2005" TYPE="STUDY">Clifford 2005</LINK>; <LINK REF="STD-Hawkins-1979" TYPE="STUDY">Hawkins 1979</LINK>; <LINK REF="STD-Jaber-1996" TYPE="STUDY">Jaber 1996</LINK>; <LINK REF="STD-Odegard-2005" TYPE="STUDY">Odegard 2005</LINK>; <LINK REF="STD-Sarkadi-2004" TYPE="STUDY">Sarkadi 2004</LINK>; <LINK REF="STD-Van-Veldhuizen-1995" TYPE="STUDY">Van Veldhuizen 1995</LINK>). Three of the five studies that assessed HbA1c demonstrated significant improvements in HbA1C between 0.5% and 2.1% (<LINK REF="STD-Choe-2005" TYPE="STUDY">Choe 2005</LINK>; <LINK REF="STD-Clifford-2005" TYPE="STUDY">Clifford 2005</LINK>; <LINK REF="STD-Jaber-1996" TYPE="STUDY">Jaber 1996</LINK>). Two of the three studies that assessed blood glucose levels demonstrated improvements in blood glucose between 7 mg/dL and 15 mg/dL compared to control (<LINK REF="STD-Jaber-1996" TYPE="STUDY">Jaber 1996</LINK>; <LINK REF="STD-Van-Veldhuizen-1995" TYPE="STUDY">Van Veldhuizen 1995</LINK>). Two comparable studies were included in a meta-analysis (<LINK REF="STD-Choe-2005" TYPE="STUDY">Choe 2005</LINK>; <LINK REF="STD-Clifford-2005" TYPE="STUDY">Clifford 2005</LINK>); these studies yielded an effect size of -0.75% for HbA1c (P = 0.03; 95% CI -1.41 to -0.09) .</P>
<P>Three trials (<LINK REF="STD-Bogden-1997" TYPE="STUDY">Bogden 1997</LINK>; <LINK REF="STD-Paulos-2005" TYPE="STUDY">Paulos 2005</LINK>; <LINK REF="STD-Peterson-2004" TYPE="STUDY">Peterson 2004</LINK>) targeting patients with hyperlipidemia demonstrated reductions in total cholesterol (-15.47 mg/dl to -37 mg/dl), triglyceride levels (-50.5 mg/dl), and the proportion of patients with decreased cholesterol and triglyceride levels. It was not clear, however, whether these findings were statistically significant in two of the three studies (<LINK REF="STD-Paulos-2005" TYPE="STUDY">Paulos 2005</LINK>; <LINK REF="STD-Peterson-2004" TYPE="STUDY">Peterson 2004</LINK>). The improvement in total cholesterol was significant in women in one study (<LINK REF="STD-Bogden-1997" TYPE="STUDY">Bogden 1997</LINK>). In three studies evaluating heart failure patients, pharmacist interventions were effective in decreasing all-cause mortality (odds ratio = 0.22, P &lt; 0.05) (<LINK REF="STD-Gattis-1999" TYPE="STUDY">Gattis 1999</LINK>), increasing mean distance walked in a two-minute test (16.1 meters in intervention group versus -3.6 meters in control group) (<LINK REF="STD-Sadik-2005" TYPE="STUDY">Sadik 2005</LINK>), and increasing mean distance walked in 6 min/distance till breathless (21 meters in intervention group versus -22 meters in control group) (<LINK REF="STD-Goodyer-1995" TYPE="STUDY">Goodyer 1995</LINK>). In patients with asthma, pharmacist interventions significantly improved asthma symptom score on the North of England asthma scale (-6.0 in intervention group versus 0.3 in control group) (<LINK REF="STD-Barbanel-2003" TYPE="STUDY">Barbanel 2003</LINK>), but did not significantly improve forced expiratory volume in one second (FEV1) (0.07 in intervention group versus 0.17 in control group) and forced vital capacity (FVC) (0.07 in intervention group versus 0.19 in control group) spirometry testing (<LINK REF="STD-Gonzalez_x002d_Martin-2003" TYPE="STUDY">Gonzalez-Martin 2003</LINK>). One study examined anticoagulation, diabetes, dyslipidemia, and hypertension control in patients with a high risk of medication related problems and found a significant increase in the proportion of patients at goal for these conditions as a result of the pharmacist intervention (<LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>). In one study targeting patients on warfarin therapy, the pharmacist intervention resulted in a decreased incidence of total bleeding and improved anticoagulation control (67% of intervention group versus 41% of control group with a therapeutic international normalized ratio (INR)) although the median INR was not shown to be significantly different between the intervention and control groups (<LINK REF="STD-Jackson-2004" TYPE="STUDY">Jackson 2004</LINK>). Pharmacist interventions did not result in significant improvements in clinical outcomes for patients with COPD (<LINK REF="STD-Solomon-1998" TYPE="STUDY">Solomon 1998</LINK>; <LINK REF="STD-Weinberger-2002" TYPE="STUDY">Weinberger 2002</LINK>) and depression (<LINK REF="STD-Brook-2003a" TYPE="STUDY">Brook 2003a</LINK>; <LINK REF="STD-Capoccia-2004" TYPE="STUDY">Capoccia 2004</LINK>; <LINK REF="STD-Finley-2003" TYPE="STUDY">Finley 2003</LINK>; <LINK REF="STD-Rickles-2005" TYPE="STUDY">Rickles 2005</LINK>).</P>
<P>Eight of the 36 studies that reported patient outcomes collected data on quality of life outcomes using SF-36 and other questionnaires (<LINK REF="STD-Cody-1998" TYPE="STUDY">Cody 1998</LINK>; <LINK REF="STD-Gonzalez_x002d_Martin-2003" TYPE="STUDY">Gonzalez-Martin 2003</LINK>; <LINK REF="STD-Hanlon-1996" TYPE="STUDY">Hanlon 1996</LINK>; <LINK REF="STD-Malone-2001" TYPE="STUDY">Malone 2001</LINK>; <LINK REF="STD-Okamoto-2001" TYPE="STUDY">Okamoto 2001</LINK>; <LINK REF="STD-Sadik-2005" TYPE="STUDY">Sadik 2005</LINK>; <LINK REF="STD-Solomon-1998" TYPE="STUDY">Solomon 1998</LINK>; <LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>). Three studies showed improvement in three or more quality of life subdomains in patients with asthma (<LINK REF="STD-Gonzalez_x002d_Martin-2003" TYPE="STUDY">Gonzalez-Martin 2003</LINK>), heart failure (<LINK REF="STD-Sadik-2005" TYPE="STUDY">Sadik 2005</LINK>) and high risk of medication related problems (<LINK REF="STD-Malone-2001" TYPE="STUDY">Malone 2001</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Comparison 3: Pharmacist services targeted at health professionals versus services delivered by other health professionals</HEADING>
<P>None included.</P>
<P> </P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Comparison 4: Pharmacist services targeted at health professionals versus delivery of no comparable service</HEADING>
<P>For detailed descriptions of outcomes see <LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>.</P>
<P>In all seven studies targeting health professionals, the effect of the intervention was measured by changes in prescribing of specific medications for specific disease states. In one study, educational outreach visits by a pharmacist to promote guideline-based prescribing for two of four disease states (aspirin as antiplatelet therapy, angiotensin converting enzyme inhibitors (ACEIs) in heart failure, NSAIDs in osteoarthritis pain, antidepressants for depression) resulted in a statistically significant 5.2% increase in overall guideline adherence (<LINK REF="STD-Freemantle-2002" TYPE="STUDY">Freemantle 2002</LINK>). In one study, the number of total antibiotic prescriptions decreased as a result of the pharmacist intervention, although the significance for this outcome was not reported (<LINK REF="STD-Ilett-2000" TYPE="STUDY">Ilett 2000</LINK>). Another study showed that pharmacist-provided academic detailing related to cholesterol treatment significantly increased the number of lipid-treatment prescriptions in females (<LINK REF="STD-Diwan-1995" TYPE="STUDY">Diwan 1995</LINK>). In three studies evaluating prescribing of appropriate medications for <I>H. pylori</I> infection (<LINK REF="STD-Hall-2001" TYPE="STUDY">Hall 2001</LINK>), ACEIs for heart failure (<LINK REF="STD-Turner-2000" TYPE="STUDY">Turner 2000</LINK>), and NSAIDs (<LINK REF="STD-Watson-2001" TYPE="STUDY">Watson 2001</LINK>), educational outreach visits by pharmacists failed to produce statistically significant changes in prescribing. Only one of three measured outcomes showed a significant increase in an additional study evaluating the effect of educational outreach visits by pharmacists prescribing NSAIDs (<LINK REF="STD-Stergachis-1987" TYPE="STUDY">Stergachis 1987</LINK>).</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2010-06-11 14:22:47 -0400" MODIFIED_BY="[Empty name]">
<P>Overall, pharmacist interventions are beneficial in improving patient and health professional outcomes. Study design and intervention heterogeneity make it challenging to summarize overall benefit. Heterogeneity was noted in the type of pharmacist interventions delivered in individual studies as well as outcome variables measured. Interventions differed by site of delivery (for example, primary care clinic, community pharmacy, specialized clinic setting), length of each intervention session (for example, one hour long session with pharmacist, 15 minute session with pharmacist), and frequency of intervention (for example, three sessions per year, monthly session). The most common interventions provided involved: a) oral or written recommendations to physicians regarding therapy modifications or resolution of medication-related problems and b) multiple follow-up visits with patients spanning several months; these interventions showed mostly positive outcomes.</P>
<P>An attempt was made to summarize data by therapeutic area, but variability in the type of intervention provided, length of intervention, frequency of intervention, type of outcome measures collected, and time of collection precluded our ability to pool data for each area. Meta-analyses were performed on hypertension and glycemic control studies with similar study characteristics. The meta-analyses performed for systolic blood pressure, diastolic blood pressure, and HbA1c showed a beneficial effect of -6.32 (95% CI -8.8 to -3.83), -3.12 (95% CI -4.57 to -1.67), and -0.75% (95% CI -1.41 to -0.09) for each outcome respectively.</P>
<P>Of the studies reviewed, pharmacist interventions showed the largest effect in blood pressure measures and the smallest effect in improving COPD and depression outcomes. Several reasons may explain the lack of effect of pharmacist interventions treating depression and COPD outcomes. It is possible that the studies did not have enough participants to detect the true impact of the intervention. All studies targeting depression recruited fewer than 150 patients. Two studies performed power calculations for medication adherence outcomes only, so it is possible that these studies were not adequately powered to detect differences in clinical outcomes (<LINK REF="STD-Finley-2003" TYPE="STUDY">Finley 2003</LINK>; <LINK REF="STD-Rickles-2005" TYPE="STUDY">Rickles 2005</LINK>). Two studies failed to recruit the number of patients needed to detect the specified effect size (13% to 28% difference in depression outcomes between intervention and control groups) at the 0.05 significance level (<LINK REF="STD-Brook-2003a" TYPE="STUDY">Brook 2003a</LINK>; <LINK REF="STD-Capoccia-2004" TYPE="STUDY">Capoccia 2004</LINK>). It is unlikely that the study period was too short to detect the clinical benefit of the pharmacist interventions as study duration ranged from 3 months to 12 months for all depression studies. Similarly, two of the COPD studies had fewer than 100 patients, which may not have yielded an adequate sample size to detect the effect of the pharmacist intervention. Although one COPD study recruited more than 200 patients, the intervention was performed in a community pharmacy setting and may not have been as rigorous as interventions performed in outpatient clinics and, as a result, failed to produce a significant improvement in COPD disease control (<LINK REF="STD-Weinberger-2002" TYPE="STUDY">Weinberger 2002</LINK>).</P>
<P>The impact of pharmacist interventions on healthcare practice measures is mixed. Few studies (12) in this review evaluated the effect of pharmacist interventions on healthcare practice measures, with prescribing practices being the most common primary outcome reported. The studies yielded conflicting results, with six studies showing a beneficial effect (<LINK REF="STD-Diwan-1995" TYPE="STUDY">Diwan 1995</LINK>; <LINK REF="STD-Freemantle-2002" TYPE="STUDY">Freemantle 2002</LINK>; <LINK REF="STD-Jameson-1995" TYPE="STUDY">Jameson 1995</LINK>; <LINK REF="STD-Meredith-2002" TYPE="STUDY">Meredith 2002</LINK>; <LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>; <LINK REF="STD-Tsuyuki-2002" TYPE="STUDY">Tsuyuki 2002</LINK>), another study not reporting statistical significance (<LINK REF="STD-Ilett-2000" TYPE="STUDY">Ilett 2000</LINK>), and the other four studies failing to show a statistically significant difference between study groups (<LINK REF="STD-Hall-2001" TYPE="STUDY">Hall 2001</LINK>; <LINK REF="STD-Stergachis-1987" TYPE="STUDY">Stergachis 1987</LINK>; <LINK REF="STD-Turner-2000" TYPE="STUDY">Turner 2000</LINK>; <LINK REF="STD-Watson-2001" TYPE="STUDY">Watson 2001</LINK>).</P>
<P>Study quality could have impacted study results. Although most studies were blinded, many did not explicitly report methods to conceal allocation of subjects to intervention or control groups. Given the nature of practice-based interventions, it is not always possible to blind patients or conceal allocation to an intervention group. The impact of concealment of allocation on study results was likely minimal as outcome variables included in this review were objective (for example, validated clinical scales, labs). Patient or health professional follow-up was done in 27 of 43 studies; follow-up was inadequate in seven studies and unclear or not reported in nine studies. This could have impacted individual study outcomes. For example, poor patient follow-up could reflect patient satisfaction or dissatisfaction with the intervention. Follow-up rate may also reflect typical attrition shown in healthcare practice settings (for example, patient transfer to new health professionals). Only objective primary outcomes were included in this review and as such, most studies were coded as having reliable outcomes and blinded assessment of outcomes. Few studies (12 of 43) met protection against contamination criteria. This is challenging to accomplish in studies of this nature; most studies occur within one clinic setting or one healthcare practice group (with multiple health professionals). Bidirectional communication (for example, verbal, written, medical charts) between clinic staff (for example, health professionals, other staff), changing practice environments, and staff/patient transfers make it possible for health professionals to improve upon the level of care provided or incorporate new knowledge acquired through informal consultation and educational sessions into practice. Given continuous improvement in the delivery of care, contamination would have likely reduced the difference in effect seen between interventions.</P>
<P>To simplify intervention delivery and minimize contamination between intervention groups, it is often easier for study investigators to randomize clinics/institutions based on location. This does, however, introduce the possibility of unit of analysis errors associated with cluster randomization. It is important to ensure that the appropriate unit of analysis is used in cluster randomization studies. There were few unit of analysis errors in this review. Of the four unit of analysis errors noted, two were in studies targeting health professionals. No studies with unit of analysis errors were included in meta-analyses.</P>
<P>A limitation of Phase I of this update is that it included only studies in the EPOC Specialised Register. The EPOC Specialised Register includes studies identified from MEDLINE back to 1966, HealthSTAR back to 1975, EMBASE back to 1980, and CINAHL back to 1982, for studies that meet the EPOC inclusion criteria. The CENTRAL database in <I>The Cochrane Library</I> is also searched on a regular basis. For more information see <A HREF="http://www.epoc.cochrane.org/en/newPage1.html">EPOC Specialised Register</A>. Phase II will include both MEDLINE and EMBASE (January 1966 to March 2008).</P>
<P>Overall, this review indicates that pharmacist interventions can lead to improved patient outcomes for multiple disease states, although effect size may not always be substantial or statistically significant. Pooling data from multiple studies to perform a meta-analysis could help to better determine the true effect and magnitude of pharmacist interventions. However, the ability to perform meta-analyses is limited by heterogeneity in comparison groups, clinical conditions, outcomes variables, and type of pharmacist intervention studied. In addition, poor reporting of variance in outcome variables further complicates the ability to perform accurate meta-analyses. Practice-based interventions are challenging to evaluate and are often limited by available data in the practice setting or the ability to collect data without impeding care or both. Standardization of outcome variables assessed could facilitate comparisons of pharmacist interventions across multiple studies. Standardizing outcome variables for specific disease states and outcome data reporting in study manuscripts to include measures of variance (for example, standard deviation) would facilitate comparison of pharmacist interventions across multiple studies.</P>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2010-06-10 16:49:40 -0400" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2010-06-10 16:49:40 -0400" MODIFIED_BY="[Empty name]">
<P>1. Does the delivery of patient-targeted services by pharmacists improve patient or health professional outcomes compared to the delivery of the same services by other health professionals?</P>
<P>There is not enough quality evidence available to make a conclusion in this area. The study included in this review that evaluated this comparison was of low quality (<LINK REF="STD-Hawkins-1979" TYPE="STUDY">Hawkins 1979</LINK>).</P>
<P>2. Does the delivery of patient-targeted services by pharmacists improve patient or health professional outcomes compared to the delivery of no comparable services?</P>
<P>The majority of included studies supported the roles of pharmacists in medication/therapeutic management and patient counseling.</P>
<P>3. Does the delivery of health professional-targeted services by pharmacists improve patient or health professional outcomes compared to the delivery of the same services by other health professionals?</P>
<P>There is not enough evidence available to make a conclusion in this area. None of the studies that met the review inclusion criteria evaluated this comparison.</P>
<P>4. Does the delivery of health professional-targeted services by pharmacists improve patient or health professional outcomes compared to the delivery of no comparable services?</P>
<P>Prescribing practice was the most common outcome reported in these studies. These studies showed mixed results, with three of the studies showing improvement and the other four showing no significant difference between groups. This is consistent with the results found in the Cochrane Review evaluating the effects of educational outreach visits (<LINK REF="REF-O_x0027_Brien-2007" TYPE="REFERENCE">O'Brien 2007</LINK>). The clinical relevance of these effects is unknown and should be further studied.</P>
<P>The evidence supports continued integration of pharmacists providing medication/therapeutic management of patients independent of or in collaboration with other health professionals and delivering patient counseling regarding drug therapy and other public health issues. There may be some benefit in providing educational outreach visits to health professionals as well.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2010-06-04 13:50:10 -0400" MODIFIED_BY="[Empty name]">
<P>Recommendations should be made on a standardized approach to measuring and reporting clinical, humanistic, and process outcomes for future randomized controlled trials evaluating the impact of outpatient pharmacists. Heterogeneity in study design, outcomes, and measures make it challenging to make generalized statements regarding the impact of pharmacists in specific settings, disease states, and patient populations. Future studies should continue to use a randomized controlled trial design with explicit reporting on factors that impact study quality (for example, concealment of allocation, blinding, follow-up) in the study manuscript. Steps should be taken to minimize risk of bias in studies; to accomplish this, investigators can measure objective outcome variables, collect baseline measurements, and minimize contamination. In study reports/manuscripts, authors should address both internal and external threats to study validity.</P>
<P>As expected in this type of research, the type of interventions will differ across studies. This is typically unavoidable as many of the interventions tested in this review are innovative practices or modifications of previously studied practices or both. Investigators should explicitly describe the type of intervention, format/content of intervention, individuals delivering/receiving the intervention, the length of intervention, and the frequency of sessions/visits within the intervention in the study manuscript. Thorough reporting of details related to the study intervention allows other individuals or organizations to replicate beneficial models and make health care decisions based on comparing the best available evidence.</P>
<P>One of the challenges in summarizing the evidence in this area is the large degree of heterogeneity between studies. To facilitate the ability to make comparisons between studies, investigators should attempt to model the design of new studies after other well-designed studies (for example, selected outcome variables, time points to collect outcome variables). Studies should include clinically relevant outcome measures and strive, when possible, to measure clinical endpoints. This is often challenging in RCTs of shorter duration as it often takes years to see the effect of interventions on some outcomes (for example, stroke, myocardial infarction). Studies assessing the effect of educational outreach visits should include clinically relevant outcomes as opposed to surrogate markers such as physician prescribing habits. Few studies that assess the effects of pharmacists on patient outcomes include measures of the intervention's impact on preventing adverse drug events and medication errors. More studies should be performed in this area.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2010-06-03 13:49:21 -0400" MODIFIED_BY="[Empty name]">
<P>We thank Kaveh Barjesteh, Nick Mays, and Christine Bond who were authors of the initial version of this review (see <LINK TAG="CONTRIBUTIONS" TYPE="SECTION">Contributions of authors</LINK>). We thank Stacey Misakian, Veronica Yank and our peer referees for useful comments. In addition, we thank Erika Campbell and Grace Carlson for their efforts in retrieving and organizing studies evaluated for the update to this review.<BR/>
</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2010-11-26 11:24:27 -0500" MODIFIED_BY="[Empty name]">
<P>Christine Bond is involved in a study that could be eligible for inclusion in a future update to this review.<BR/>
</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2010-06-02 07:24:24 -0400" MODIFIED_BY="[Empty name]">
<P>LB conceived of the idea for the review.<BR/>For the first version of this review (1997), LB, NM (see <LINK TAG="ACKNOWLEDGEMENTS" TYPE="SECTION">Acknowledgements</LINK>) and CB developed the search strategy, decided which studies should be included, extracted data from the studies, and developed the tables. KB (see <LINK TAG="ACKNOWLEDGEMENTS" TYPE="SECTION">Acknowledgements</LINK>) conducted hand searches and extracted data. LB drafted the paper and all authors commented on the manuscript. LB is guarantor for the review.</P>
<P>For the last update of this review (2000), JB and LB, decided which studies should be included. JB, LB, and CB extracted data from the studies. JB drafted the review and all authors commented on the draft. LB is guarantor for the review.</P>
<P>For this update (2010), OM, NN, and LB reviewed studies for inclusion. OM, NN, TC, CY, and JB extracted data from the studies. NN and OM wrote the review, with contributions from TC, CY, and LB. NN is the guarantor for the review.<BR/>
</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES MODIFIED="2010-06-04 13:51:07 -0400" MODIFIED_BY="[Empty name]">
<P>This is Phase I of a two-part review. Phase I includes results from the EPOC search. Phase II will include results from the MEDLINE/EMBASE searches.</P>
</PUBLIC_NOTES>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2010-12-01 08:35:01 -0500" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2010-12-01 08:35:01 -0500" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2010-06-11 14:20:31 -0400" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Barbanel-2003" MODIFIED="2009-01-26 23:21:50 -0500" MODIFIED_BY="Olga Mostovetsky" NAME="Barbanel 2003" YEAR="2003">
<REFERENCE MODIFIED="2009-01-26 23:21:50 -0500" MODIFIED_BY="Olga Mostovetsky" NOTES="0040-6376 (Print)" NOTES_MODIFIED="2009-01-26 23:21:50 -0500" NOTES_MODIFIED_BY="Olga Mostovetsky" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Barbanel D, Eldridge S, Griffiths C</AU>
<TI>Can a self-management programme delivered by a community pharmacist improve asthma control? A randomised trial</TI>
<SO>Thorax</SO>
<YR>2003</YR>
<VL>58</VL>
<NO>10</NO>
<PG>851-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bogden-1997" MODIFIED="2009-07-04 14:39:23 -0400" MODIFIED_BY="[Empty name]" NAME="Bogden 1997" YEAR="1997">
<REFERENCE MODIFIED="2009-07-04 14:39:23 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Bogden PE, Koontz LM, Williamson P, Abbott RD</AU>
<TI>The physician and pharmacist team. An effective approach to cholesterol reduction</TI>
<SO>Journal of General Internal Medicine</SO>
<YR>1997</YR>
<VL>12</VL>
<NO>3</NO>
<PG>158-64</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bond-2000" MODIFIED="2009-11-24 17:52:00 -0500" MODIFIED_BY="[Empty name]" NAME="Bond 2000" YEAR="2000">
<REFERENCE MODIFIED="2009-11-24 17:52:00 -0500" MODIFIED_BY="[Empty name]" NOTES="0960-1643 (Print)" NOTES_MODIFIED="2009-11-24 17:52:00 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bond C, Matheson C, Williams S, Williams P, Donnan P</AU>
<TI>Repeat prescribing: A role for community pharmacists in controlling and monitoring repeat prescriptions</TI>
<SO>British Journal of General Practice</SO>
<YR>2000</YR>
<VL>50</VL>
<NO>453</NO>
<PG>271-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Borenstein-2003" MODIFIED="2009-11-24 17:51:03 -0500" MODIFIED_BY="[Empty name]" NAME="Borenstein 2003" YEAR="2003">
<REFERENCE MODIFIED="2009-11-24 17:51:03 -0500" MODIFIED_BY="[Empty name]" NOTES="0277-0008 (Print)" NOTES_MODIFIED="2009-11-24 17:51:03 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Borenstein JE, Graber G, Saltiel E, Wallace J, Ryu S, Archi J, et al</AU>
<TI>Physician-pharmacist co management of hypertension: A randomised, comparative trial</TI>
<SO>Pharmacotherapy</SO>
<YR>2003</YR>
<VL>23</VL>
<NO>2</NO>
<PG>209-16</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brook-2003a" MODIFIED="2010-06-07 09:00:01 -0400" MODIFIED_BY="[Empty name]" NAME="Brook 2003a" YEAR="2003">
<REFERENCE MODIFIED="2010-06-07 09:00:01 -0400" MODIFIED_BY="[Empty name]" NOTES="0924-977X (Print)" NOTES_MODIFIED="2010-06-07 09:00:01 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brook OH, Van Hout HP, Nieuwenhuysea H, De Haan M</AU>
<TI>Effects of coaching by community pharmacists on psychological symptoms of antidepressant users: A randomised controlled trial</TI>
<SO>European Neuropsychopharmacology</SO>
<YR>2003</YR>
<VL>13</VL>
<NO>5</NO>
<PG>347-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Capoccia-2004" MODIFIED="2010-06-07 09:03:07 -0400" MODIFIED_BY="[Empty name]" NAME="Capoccia 2004" YEAR="2004">
<REFERENCE MODIFIED="2010-06-07 09:01:55 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Boudreau DM, Capoccia KL, Sullivan SD, Blough DK, Ellsworth AJ, Clark DL, et al</AU>
<TI>Collaborative care model to improve outcomes in major depression</TI>
<SO>Annals of Pharmacotherapy</SO>
<YR>2002</YR>
<VL>36</VL>
<NO>4</NO>
<PG>585-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-06-07 09:03:07 -0400" MODIFIED_BY="[Empty name]" NOTES="1079-2082 (Print)" NOTES_MODIFIED="2010-06-07 09:03:07 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Capoccia KL, Boudreau DM, Blough DK, Ellsworth AJ, Clark DR, Stevens NG, et al</AU>
<TI>Randomized trial of pharmacist interventions to improve depression care and outcomes in primary care</TI>
<SO>American Journal of Health-System Pharmacy</SO>
<YR>2004</YR>
<VL>61</VL>
<NO>4</NO>
<PG>364-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Choe-2005" MODIFIED="2010-06-07 09:03:58 -0400" MODIFIED_BY="[Empty name]" NAME="Choe 2005" YEAR="2005">
<REFERENCE MODIFIED="2010-06-07 09:03:58 -0400" MODIFIED_BY="[Empty name]" NOTES="1088-0224 (Print)" NOTES_MODIFIED="2010-06-07 09:03:58 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Choe HM, Mitrovich S, Dubay D, Hayward RA, Krein SL, Vijan S</AU>
<TI>Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: A randomised controlled trial</TI>
<SO>American Journal of Managed Care</SO>
<YR>2005</YR>
<VL>11</VL>
<NO>4</NO>
<PG>253-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Clifford-2005" MODIFIED="2009-03-08 03:48:16 -0400" MODIFIED_BY="[Empty name]" NAME="Clifford 2005" YEAR="2005">
<REFERENCE MODIFIED="2009-03-08 03:48:16 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Clifford RM, Davis WA, Batty KT, Davis TM</AU>
<TI>Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: The Fremantle Diabetes Study</TI>
<SO>Diabetes Care</SO>
<YR>2005</YR>
<VL>28</VL>
<NO>4</NO>
<PG>771-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cody-1998" MODIFIED="2010-05-20 17:27:52 -0400" MODIFIED_BY="[Empty name]" NAME="Cody 1998" YEAR="1998">
<REFERENCE MODIFIED="2010-05-20 17:17:08 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Cody M, McCombs JS, Parker JP. The Kaiser Permanente/USC Patient Consultation Study: change in quality of life. University of Southern California. Am J Health Syst Pharm. 1998;55:2615-20.&lt;/p&gt;" NOTES_MODIFIED="2010-05-20 17:17:08 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Cody M, McCombs JS, Parker JP</AU>
<TI>The Kaiser Permanente/USC Patient Consultation Study: change in quality of life. University of Southern California</TI>
<SO>American Journal of Health-System Pharmacy</SO>
<YR>1998</YR>
<VL>55</VL>
<NO>24</NO>
<PG>2615-20</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="99087735"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-05-20 17:27:52 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McCombs JS, Liu G, Shi J, Feng W, Cody M, Parker JP, et al</AU>
<TI>The Kaiser Permanente/USC Patient Consultation Study: change in use and cost of health care services</TI>
<SO>American Journal of Health-System Pharmacy</SO>
<YR>1998</YR>
<VL>55</VL>
<NO>23</NO>
<PG>2485-99</PG>
<IDENTIFIERS MODIFIED="2010-05-20 17:27:52 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-05-20 17:27:52 -0400" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="99068522"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2010-05-20 17:12:27 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-05-20 17:12:27 -0400" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE=""/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Diwan-1995" MODIFIED="2009-11-24 17:51:21 -0500" MODIFIED_BY="[Empty name]" NAME="Diwan 1995" YEAR="1995">
<REFERENCE MODIFIED="2009-11-24 17:51:21 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Diwan VK., Wahlstrom R, Tomson G, Beermann B, Sterky G, Eriksson B.  Effects of &amp;quot;group detailing&amp;quot; on the prescribing of lipid-lowering drugs: a randomized controlled trial in Swedish primary care. J Clin Epidemiol 1995;48:705-11.&lt;/p&gt;" NOTES_MODIFIED="2009-11-24 17:51:21 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Diwan VK, Wahlstrom R, Tomson G, Beermann B, Sterky G, Eriksson B</AU>
<TI>Effects of "group detailing" on the prescribing of lipid-lowering drugs: a randomised controlled trial in Swedish primary care</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>1995</YR>
<VL>48</VL>
<NO>5</NO>
<PG>705-11</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="95248412"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Finley-2003" MODIFIED="2009-01-26 23:21:50 -0500" MODIFIED_BY="Olga Mostovetsky" NAME="Finley 2003" YEAR="2003">
<REFERENCE MODIFIED="2009-01-26 23:21:50 -0500" MODIFIED_BY="Olga Mostovetsky" NOTES="0277-0008 (Print)" NOTES_MODIFIED="2009-01-26 23:21:50 -0500" NOTES_MODIFIED_BY="Olga Mostovetsky" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Finley PR, Rens HR, Pont JT, Gess SL, Louie C, Bull SA, et al</AU>
<TI>Impact of a collaborative care model on depression in a primary care setting: A randomized controlled trial</TI>
<SO>Pharmacotherapy</SO>
<YR>2003</YR>
<VL>23</VL>
<NO>9</NO>
<PG>1175-85</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Freemantle-2002" MODIFIED="2010-06-07 09:06:29 -0400" MODIFIED_BY="[Empty name]" NAME="Freemantle 2002" YEAR="2002">
<REFERENCE MODIFIED="2010-06-07 09:06:29 -0400" MODIFIED_BY="[Empty name]" NOTES="0960-1643 (Print)" NOTES_MODIFIED="2010-06-07 09:06:29 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Freemantle N, Nazareth I, Eccles M, Wood J, Haines A</AU>
<TI>A randomised controlled trial of the effect of educational outreach by community pharmacists on prescribing in UK general practice</TI>
<SO>British Journal of General Practice</SO>
<YR>2002</YR>
<VL>52</VL>
<NO>477</NO>
<PG>290-5</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gattis-1999" MODIFIED="2010-06-07 09:07:24 -0400" MODIFIED_BY="[Empty name]" NAME="Gattis 1999" YEAR="1999">
<REFERENCE MODIFIED="2010-06-07 09:07:24 -0400" MODIFIED_BY="[Empty name]" NOTES="0003-9926 (Print)" NOTES_MODIFIED="2010-06-07 09:07:24 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gattis WA, Hasselblad V, Whellan DJ, O'Connor CM</AU>
<TI>Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: Results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study</TI>
<SO>Archives of Internal Medicine</SO>
<YR>1999</YR>
<VL>159</VL>
<NO>16</NO>
<PG>1939-45</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gonzalez_x002d_Martin-2003" MODIFIED="2010-06-07 09:07:52 -0400" MODIFIED_BY="[Empty name]" NAME="Gonzalez-Martin 2003" YEAR="2003">
<REFERENCE MODIFIED="2010-06-07 09:07:52 -0400" MODIFIED_BY="[Empty name]" NOTES="0738-3991 (Print)" NOTES_MODIFIED="2010-06-07 09:07:52 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gonzalez-Martin G, Joo I, Sanchez I</AU>
<TI>Evaluation of the impact of a pharmaceutical care program in children with asthma</TI>
<SO>Patient Education and Counselling</SO>
<YR>2003</YR>
<VL>49</VL>
<NO>1</NO>
<PG>13-8</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Goodyer-1995" MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]" NAME="Goodyer 1995" YEAR="1995">
<REFERENCE MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Goodyer LI, Miskelly F, Milligan P. Does encouraging good compliance improve patients' clinical condition in heart failure? Br J Clin Pract. 1995;49:173-6.&lt;/p&gt;" NOTES_MODIFIED="2009-03-02 19:43:13 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Goodyer LI, Miskelly F, Milligan P</AU>
<TI>Does encouraging good compliance improve patients' clinical condition in heart failure?</TI>
<SO>British Journal of Clinical Practice</SO>
<YR>1995</YR>
<VL>49</VL>
<NO>4</NO>
<PG>173-6</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="96004938"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hall-2001" MODIFIED="2010-06-07 09:09:59 -0400" MODIFIED_BY="[Empty name]" NAME="Hall 2001" YEAR="2001">
<REFERENCE MODIFIED="2010-06-07 09:09:59 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hall L, Eccles M, Barton R, Steen N, Campbell M</AU>
<TI>Is untargeted outreach visiting in primary care effective? A pragmatic randomized controlled trial</TI>
<SO>Journal of Public Health Medicine</SO>
<YR>2001</YR>
<VL>23</VL>
<NO>2</NO>
<PG>109-13</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hanlon-1996" MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]" NAME="Hanlon 1996" YEAR="1996">
<REFERENCE MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Hanlon JT, Weinberger M, Samsa GP, et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med. 1996;100:428-37.&lt;/p&gt;" NOTES_MODIFIED="2009-03-02 19:43:13 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hanlon JT, Weinberger M, Samsa GP, Schmader KE, Uttech KM, Lewis IK, et al</AU>
<TI>A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy</TI>
<SO>American Journal of Medicine</SO>
<YR>1996</YR>
<VL>100</VL>
<NO>4</NO>
<PG>428-37</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="96194605"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hawkins-1979" MODIFIED="2009-04-05 17:56:03 -0400" MODIFIED_BY="[Empty name]" NAME="Hawkins 1979" YEAR="1981">
<REFERENCE MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Hawkins DW, Fiedler FP, Douglas HL, Eschbach RC.  Evaluation of a clinical pharmacist in caring for hypertensive and diabetic patients.  Am J Hosp Pharm 1979;36:1321-5.&lt;/p&gt;" NOTES_MODIFIED="2009-03-02 19:43:13 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hawkins DW, Fiedler FP, Douglas HL, Eschbach RC</AU>
<TI>Evaluation of a clinical pharmacist in caring for hypertensive and diabetic patients</TI>
<SO>American Journal of Hospital Pharmacy</SO>
<YR>1979</YR>
<VL>36</VL>
<NO>10</NO>
<PG>1321-5</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="80062510"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ilett-2000" MODIFIED="2010-06-07 09:10:48 -0400" MODIFIED_BY="[Empty name]" NAME="Ilett 2000" YEAR="2000">
<REFERENCE MODIFIED="2010-06-07 09:10:48 -0400" MODIFIED_BY="[Empty name]" NOTES="0306-5251 (Print)" NOTES_MODIFIED="2010-06-07 09:10:48 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ilett KF, Johnson S, Greenhill G, Mullen L, Brockis J, Golledge CL, et al</AU>
<TI>Modification of general practitioner prescribing of antibiotics by use of a therapeutics adviser (academic detailer)</TI>
<SO>British Journal of Clinical Pharmacology</SO>
<YR>2000</YR>
<VL>49</VL>
<NO>2</NO>
<PG>168-73</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jaber-1996" MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]" NAME="Jaber 1996" YEAR="1996">
<REFERENCE MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Jaber LA, Halapy H, Fernet M, Tummalapalli S, Diwakaran H.  Evaluation of a pharmaceutical care model on diabetes management.  Ann Pharmacother 1996;30:238-43.&lt;/p&gt;" NOTES_MODIFIED="2009-03-02 19:43:13 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jaber LA, Halapy H, Fernet M, Tummalapalli S, Diwakaran H</AU>
<TI>Evaluation of a pharmaceutical care model on diabetes management</TI>
<SO>Annals of Pharmacotherapy</SO>
<YR>1996</YR>
<VL>30</VL>
<NO>3</NO>
<PG>238-43</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="96430432"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jackson-2004" MODIFIED="2010-06-07 09:11:30 -0400" MODIFIED_BY="[Empty name]" NAME="Jackson 2004" YEAR="2004">
<REFERENCE MODIFIED="2010-06-07 09:11:30 -0400" MODIFIED_BY="[Empty name]" NOTES="0954-6820 (Print)" NOTES_MODIFIED="2010-06-07 09:11:30 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jackson SL, Peterson GM, Vial JH, Jupe DM</AU>
<TI>Improving the outcomes of anticoagulation: An evaluation of home follow-up of warfarin initiation</TI>
<SO>Journal of Internal Medicine</SO>
<YR>2004</YR>
<VL>256</VL>
<NO>2</NO>
<PG>137-44</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jameson-1995" MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]" NAME="Jameson 1995" YEAR="1995">
<REFERENCE MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Jameson J, VanNoord G, Vanderwoud K.  The impact of a pharmacotherapy consultation on the cost and outcome of medical therapy.  J Fam Pract 1995;41:469-72.&lt;/p&gt;" NOTES_MODIFIED="2009-03-02 19:43:13 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jameson J, VanNoord G, Vanderwoud K</AU>
<TI>The impact of a pharmacotherapy consultation on the cost and outcome of medical therapy</TI>
<SO>Journal of Family Practice</SO>
<YR>1995</YR>
<VL>41</VL>
<NO>5</NO>
<PG>469-72</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="96067264"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Malone-2001" MODIFIED="2010-06-07 09:12:13 -0400" MODIFIED_BY="[Empty name]" NAME="Malone 2001" YEAR="2001">
<REFERENCE MODIFIED="2010-05-20 17:42:26 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ellis SL, Carter BL, Malone DC, Billups SJ, Okano GJ, Valuck RJ, et al</AU>
<TI>Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: The IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers</TI>
<SO>Pharmacotherapy</SO>
<YR>2000</YR>
<VL>20</VL>
<NO>12</NO>
<PG>1508-16</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-06-07 09:12:13 -0400" MODIFIED_BY="[Empty name]" NOTES="0025-7079 (Print)" NOTES_MODIFIED="2010-06-07 09:12:13 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Malone DC, Carter BL, Billups SJ, Valuck RJ, Barnette DJ, Sintek CD, et al</AU>
<TI>Can clinical pharmacists affect SF-36 scores in veterans at high risk for medication-related problems?</TI>
<SO>Medical Care</SO>
<YR>2001</YR>
<VL>39</VL>
<NO>2</NO>
<PG>113-22</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mehos-2000" MODIFIED="2009-01-26 23:21:50 -0500" MODIFIED_BY="Olga Mostovetsky" NAME="Mehos 2000" YEAR="2000">
<REFERENCE MODIFIED="2009-01-26 23:21:50 -0500" MODIFIED_BY="Olga Mostovetsky" NOTES="0277-0008 (Print)" NOTES_MODIFIED="2009-01-26 23:21:50 -0500" NOTES_MODIFIED_BY="Olga Mostovetsky" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mehos BM, Saseen JJ, MacLaughlin EJ</AU>
<TI>Effect of pharmacist intervention and initiation of home blood pressure monitoring in patients with uncontrolled hypertension</TI>
<SO>Pharmacotherapy</SO>
<YR>2000</YR>
<VL>20</VL>
<NO>11</NO>
<PG>1384-9</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Meredith-2002" MODIFIED="2010-06-07 09:13:03 -0400" MODIFIED_BY="[Empty name]" NAME="Meredith 2002" YEAR="2002">
<REFERENCE MODIFIED="2010-06-07 09:13:03 -0400" MODIFIED_BY="[Empty name]" NOTES="0002-8614 (Print)" NOTES_MODIFIED="2010-06-07 09:13:03 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Meredith S, Feldman P, Frey D, Giammarco L, Hall K, Arnold K, et al</AU>
<TI>Improving medication use in newly admitted home healthcare patients: A randomized controlled trial</TI>
<SO>Journal of the American Geriatrics Society</SO>
<YR>2002</YR>
<VL>50</VL>
<NO>9</NO>
<PG>1484-91</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Odegard-2005" MODIFIED="2010-06-07 09:13:54 -0400" MODIFIED_BY="[Empty name]" NAME="Odegard 2005" YEAR="2005">
<REFERENCE MODIFIED="2010-06-07 09:13:54 -0400" MODIFIED_BY="[Empty name]" NOTES="1060-0280 (Print)" NOTES_MODIFIED="2010-06-07 09:13:54 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Odegard PS, Goo A, Hummel J, Williams KL, Gray SL</AU>
<TI>Caring for poorly controlled diabetes mellitus: A randomised pharmacist intervention</TI>
<SO>Annals of Pharmacotherapy</SO>
<YR>2005</YR>
<VL>39</VL>
<NO>3</NO>
<PG>433-40</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Okamoto-2001" MODIFIED="2009-01-26 23:21:50 -0500" MODIFIED_BY="Olga Mostovetsky" NAME="Okamoto 2001" YEAR="2001">
<REFERENCE MODIFIED="2009-01-26 23:21:50 -0500" MODIFIED_BY="Olga Mostovetsky" NOTES="0277-0008 (Print)" NOTES_MODIFIED="2009-01-26 23:21:50 -0500" NOTES_MODIFIED_BY="Olga Mostovetsky" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Okamoto MP, Nakahiro RK</AU>
<TI>Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic</TI>
<SO>Pharmacotherapy</SO>
<YR>2001</YR>
<VL>21</VL>
<NO>11</NO>
<PG>1337-44</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Park-1996" MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]" NAME="Park 1996" YEAR="1996">
<REFERENCE MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Park JJ, Kelly P, Carter BL, Burgess PP. Comprehensive pharmaceutical care in the chain setting. J Am Pharm Assoc (Wash). 1996;NS36:443-51.&lt;/p&gt;" NOTES_MODIFIED="2009-03-02 19:43:13 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Park JJ, Kelly P, Carter BL, Burgess PP</AU>
<TI>Comprehensive pharmaceutical care in the chain setting</TI>
<SO>Journal of the American Pharmaceutical Association</SO>
<YR>1996</YR>
<VL>NS36</VL>
<NO>7</NO>
<PG>443-51</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Paulos-2005" MODIFIED="2010-06-07 09:14:22 -0400" MODIFIED_BY="[Empty name]" NAME="Paulos 2005" YEAR="2005">
<REFERENCE MODIFIED="2010-06-07 09:14:22 -0400" MODIFIED_BY="[Empty name]" NOTES="1060-0280 (Print)" NOTES_MODIFIED="2010-06-07 09:14:22 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Paulos CP, Nygren CE, Celedon C, Carcamo CA</AU>
<TI>Impact of a pharmaceutical care program in a community pharmacy on patients with dyslipidemia</TI>
<SO>Annals of Pharmacotherapy</SO>
<YR>2005</YR>
<VL>39</VL>
<NO>5</NO>
<PG>939-43</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Peterson-2004" MODIFIED="2010-06-07 09:15:07 -0400" MODIFIED_BY="[Empty name]" NAME="Peterson 2004" YEAR="2004">
<REFERENCE MODIFIED="2010-06-07 09:15:07 -0400" MODIFIED_BY="[Empty name]" NOTES="0269-4727 (Print)" NOTES_MODIFIED="2010-06-07 09:15:07 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Peterson GM, Fitzmaurice KD, Naunton M, Vial JH, Stewart K, Krum H</AU>
<TI>Impact of pharmacist-conducted home visits on the outcomes of lipid-lowering drug therapy</TI>
<SO>Journal of Clinical Pharmacy and Therapeutics</SO>
<YR>2004</YR>
<VL>29</VL>
<NO>1</NO>
<PG>23-30</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rickles-2005" MODIFIED="2010-06-07 09:16:04 -0400" MODIFIED_BY="[Empty name]" NAME="Rickles 2005" YEAR="2005">
<REFERENCE MODIFIED="2010-06-07 09:16:04 -0400" MODIFIED_BY="[Empty name]" NOTES="1544-3191 (Print)" NOTES_MODIFIED="2010-06-07 09:16:04 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rickles NM, Svarstad BL, Statz-Paynter JL, Taylor LV, Kobak KA</AU>
<TI>Pharmacist telemonitoring of antidepressant use: Effects on pharmacist-patient collaboration</TI>
<SO>Journal of the American Pharmacists Association</SO>
<YR>2005</YR>
<VL>45</VL>
<NO>3</NO>
<PG>344-53</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sadik-2005" MODIFIED="2010-06-07 09:17:01 -0400" MODIFIED_BY="[Empty name]" NAME="Sadik 2005" YEAR="2005">
<REFERENCE MODIFIED="2010-06-07 09:17:01 -0400" MODIFIED_BY="[Empty name]" NOTES="0306-5251 (Print)" NOTES_MODIFIED="2010-06-07 09:17:01 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sadik A, Yousif M, McElnay JC</AU>
<TI>Pharmaceutical care of patients with heart failure</TI>
<SO>British Journal of Clinical Pharmacology</SO>
<YR>2005</YR>
<VL>60</VL>
<NO>2</NO>
<PG>183-93</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sarkadi-2004" MODIFIED="2010-06-07 09:17:50 -0400" MODIFIED_BY="[Empty name]" NAME="Sarkadi 2004" YEAR="2004">
<REFERENCE MODIFIED="2010-06-07 09:17:50 -0400" MODIFIED_BY="[Empty name]" NOTES="0738-3991 (Print)" NOTES_MODIFIED="2010-06-07 09:17:50 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sarkadi A, Rosenqvist U</AU>
<TI>Experience-based group education in Type 2 diabetes: A randomised controlled trial</TI>
<SO>Patient Education and Counseling</SO>
<YR>2004</YR>
<VL>53</VL>
<NO>3</NO>
<PG>291-8</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schneider-1982" MODIFIED="2010-06-07 09:20:40 -0400" MODIFIED_BY="[Empty name]" NAME="Schneider 1982" YEAR="1982">
<REFERENCE MODIFIED="2010-06-07 09:20:40 -0400" MODIFIED_BY="[Empty name]" NOTES="0162-3761 (Print)" NOTES_MODIFIED="2010-06-07 09:20:40 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schneider PJ, Larrimer JN, Visconti JA, Miller WA</AU>
<TI>Role effectiveness of a pharmacist in the maintenance of patients with hypertension and congestive heart failure</TI>
<SO>Contemporary Pharmacy Practice</SO>
<YR>1982</YR>
<VL>5</VL>
<NO>2</NO>
<PG>74-9</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Solomon-1998" MODIFIED="2010-06-07 09:24:57 -0400" MODIFIED_BY="[Empty name]" NAME="Solomon 1998" YEAR="1998">
<REFERENCE MODIFIED="2010-06-07 09:24:57 -0400" MODIFIED_BY="[Empty name]" NOTES="1086-5802 (Print)" NOTES_MODIFIED="2010-06-07 09:24:57 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Solomon DK, Portner TS, Bass GE, Gourley DR, Gourley GA, Holt JM, et al</AU>
<TI>Clinical and economic outcomes in the hypertension and COPD arms of a multicenter outcomes study</TI>
<SO>Journal of the American Pharmacists Association</SO>
<YR>1998</YR>
<VL>38</VL>
<NO>5</NO>
<PG>574-85</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sookaneknun-2004" MODIFIED="2010-06-07 09:25:18 -0400" MODIFIED_BY="[Empty name]" NAME="Sookaneknun 2004" YEAR="2004">
<REFERENCE MODIFIED="2010-06-07 09:25:18 -0400" MODIFIED_BY="[Empty name]" NOTES="1060-0280 (Print)" NOTES_MODIFIED="2010-06-07 09:25:18 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sookaneknun P, Richards RM, Sanguansermsri J, Teerasut C</AU>
<TI>Pharmacist involvement in primary care improves hypertensive patient clinical outcomes</TI>
<SO>Annals of Pharmacotherapy</SO>
<YR>2004</YR>
<VL>38</VL>
<NO>12</NO>
<PG>2023-8</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stergachis-1987" MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]" NAME="Stergachis 1987" YEAR="1987">
<REFERENCE MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Stergachis A, Fors M, Wagner EH, Sims DD, Penna P.  Effect of clinical pharmacists on drug prescribing in a primary-care clinic. Am J Hosp Pharm 1987;44:525-9.&lt;/p&gt;" NOTES_MODIFIED="2009-03-02 19:43:13 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stergachis A, Fors M, Wagner EH, Sims DD, Penna P</AU>
<TI>Effect of clinical pharmacists on drug prescribing in a primary-care clinic</TI>
<SO>American Journal of Hospital Pharmacy</SO>
<YR>1987</YR>
<VL>44</VL>
<NO>3</NO>
<PG>525-9</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="87181708"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Taylor-2003" MODIFIED="2010-06-07 09:27:19 -0400" MODIFIED_BY="[Empty name]" NAME="Taylor 2003" YEAR="2003">
<REFERENCE MODIFIED="2010-06-07 09:27:19 -0400" MODIFIED_BY="[Empty name]" NOTES="1079-2082 (Print)" NOTES_MODIFIED="2010-06-07 09:27:19 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Taylor CT, Byrd DC, Krueger K</AU>
<TI>Improving primary care in rural Alabama with a pharmacy initiative</TI>
<SO>American Journal of Health-System Pharmacy</SO>
<YR>2003</YR>
<VL>60</VL>
<NO>11</NO>
<PG>1123-9</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tsuyuki-2002" MODIFIED="2010-06-11 14:20:31 -0400" MODIFIED_BY="[Empty name]" NAME="Tsuyuki 2002" YEAR="2002">
<REFERENCE MODIFIED="2010-06-11 14:20:31 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tsuyuki RT, Johnson JA, Teo KK, Ackman ML, Biggs RS, Cave A, et al</AU>
<TI>Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP): A randomized trial design of the effect of a community pharmacist intervention program on serum cholesterol risk</TI>
<SO>Annals of Pharmacotherapy</SO>
<YR>1999</YR>
<VL>33</VL>
<NO>9</NO>
<PG>910-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-06-07 09:30:27 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Tsuyuki RT, Johnson JA, Teo KK, Simpson SH, Ackman ML, Biggs RS, et al</AU>
<TI>A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: The Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP)</TI>
<SO>Archives of Internal Medicine</SO>
<YR>2002</YR>
<VL>162</VL>
<NO>10</NO>
<PG>1149-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Turner-2000" MODIFIED="2010-06-07 09:30:59 -0400" MODIFIED_BY="[Empty name]" NAME="Turner 2000" YEAR="2000">
<REFERENCE MODIFIED="2010-06-07 09:30:59 -0400" MODIFIED_BY="[Empty name]" NOTES="1079-2082 (Print)" NOTES_MODIFIED="2010-06-07 09:30:59 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Turner CJ, Parfrey P, Ryan K, Miller R, Brown A</AU>
<TI>Community pharmacist outreach program directed at physicians treating congestive heart failure</TI>
<SO>American Journal of Health-System Pharmacy</SO>
<YR>2000</YR>
<VL>57</VL>
<NO>8</NO>
<PG>747-52</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Van-Veldhuizen-1995" MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]" NAME="Van Veldhuizen 1995" YEAR="1995">
<REFERENCE MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Van Veldhuizen-Scott MK, Widmer LB, Stacey SA, Popovich NG.  Developing and implementing a pharmaceutical care model in an ambulatory care setting for patients with diabetes ... the Regional Diabetes Center (RDC) in Lafayette, Indiana.  Diabetes Educator 1995;21:117-23.&lt;/p&gt;" NOTES_MODIFIED="2009-03-02 19:43:13 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Van Veldhuizen-Scott MK, Widmer LB, Stacey SA, Popovich NG</AU>
<TI>Developing and implementing a pharmaceutical care model in an ambulatory care setting for patients with diabetes</TI>
<SO>Diabetes Educator</SO>
<YR>1995</YR>
<VL>21</VL>
<NO>2</NO>
<PG>117-23</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="95212208"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Watson-2001" MODIFIED="2010-06-07 09:38:26 -0400" MODIFIED_BY="[Empty name]" NAME="Watson 2001" YEAR="2001">
<REFERENCE MODIFIED="2010-06-07 09:38:26 -0400" MODIFIED_BY="[Empty name]" NOTES="1355-8196 (Print)" NOTES_MODIFIED="2010-06-07 09:38:26 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Watson M, Gunnell D, Peters T, Brookes S, Sharp D</AU>
<TI>Guidelines and educational outreach visits from community pharmacists to improve prescribing in general practice: A randomised controlled trial</TI>
<SO>Journal of Health Services Research and Policy</SO>
<YR>2001</YR>
<VL>6</VL>
<NO>4</NO>
<PG>207-13</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Weinberger-2002" MODIFIED="2010-06-07 09:39:07 -0400" MODIFIED_BY="[Empty name]" NAME="Weinberger 2002" YEAR="2002">
<REFERENCE MODIFIED="2010-06-07 09:39:07 -0400" MODIFIED_BY="[Empty name]" NOTES="0098-7484 (Print)" NOTES_MODIFIED="2010-06-07 09:39:07 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Weinberger M, Murray MD, Marrero DG, Brewer N, Lykens M, Harris LE, et al</AU>
<TI>Effectiveness of pharmacist care for patients with reactive airways disease: A randomized controlled trial</TI>
<SO>JAMA</SO>
<YR>2002</YR>
<VL>288</VL>
<NO>13</NO>
<PG>1594-602</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2010-06-07 11:44:20 -0400" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Abramowitz-1982" MODIFIED="2010-06-07 09:42:01 -0400" MODIFIED_BY="[Empty name]" NAME="Abramowitz 1982" YEAR="1982">
<REFERENCE MODIFIED="2010-06-07 09:42:01 -0400" MODIFIED_BY="[Empty name]" NOTES="0002-9289 (Print)" NOTES_MODIFIED="2010-06-07 09:42:01 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Abramowitz PW, Nold EG, Hatfield SM</AU>
<TI>Use of clinical pharmacists to reduce cefamandole, cefoxitin, and ticarcillin costs</TI>
<SO>American Journal of Hospital Pharmacy</SO>
<YR>1982</YR>
<VL>39</VL>
<NO>7</NO>
<PG>1176-80</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bogden-1998" MODIFIED="2010-06-07 09:42:54 -0400" MODIFIED_BY="[Empty name]" NAME="Bogden 1998" YEAR="1998">
<REFERENCE MODIFIED="2010-06-07 09:42:54 -0400" MODIFIED_BY="[Empty name]" NOTES="0884-8734 (Print)" NOTES_MODIFIED="2010-06-07 09:42:54 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bogden PE, Abbott RD, Williamson P, Onopa JK, Koontz LM</AU>
<TI>Comparing standard care with a physician and pharmacist team approach for uncontrolled hypertension</TI>
<SO>Journal of General Internal Medicine</SO>
<YR>1998</YR>
<VL>13</VL>
<NO>11</NO>
<PG>740-5</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bolas-2004" MODIFIED="2010-06-07 09:43:31 -0400" MODIFIED_BY="[Empty name]" NAME="Bolas 2004" YEAR="2004">
<REFERENCE MODIFIED="2010-06-07 09:43:31 -0400" MODIFIED_BY="[Empty name]" NOTES="0928-1231 (Print)" NOTES_MODIFIED="2010-06-07 09:43:31 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bolas H, Brookes K, Scott M, McElnay J</AU>
<TI>Evaluation of a hospital-based community liaison pharmacy service in Northern Ireland</TI>
<SO>Pharmacy World and Science</SO>
<YR>2004</YR>
<VL>26</VL>
<NO>2</NO>
<PG>114-20</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bouvy-2003" MODIFIED="2010-06-07 09:44:10 -0400" MODIFIED_BY="[Empty name]" NAME="Bouvy 2003" YEAR="2003">
<REFERENCE MODIFIED="2010-06-07 09:44:10 -0400" MODIFIED_BY="[Empty name]" NOTES="1071-9164 (Print)" NOTES_MODIFIED="2010-06-07 09:44:10 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bouvy ML, Heerdink ER, Urquhart J, Grobbee DE, Hoes AW, Leufkens HG</AU>
<TI>Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: A randomized controlled study</TI>
<SO>Journal of Cardiac Failure</SO>
<YR>2003</YR>
<VL>9</VL>
<NO>5</NO>
<PG>404-11</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bozovich-2000" MODIFIED="2009-01-26 23:21:50 -0500" MODIFIED_BY="Olga Mostovetsky" NAME="Bozovich 2000" YEAR="2000">
<REFERENCE MODIFIED="2009-01-26 23:21:50 -0500" MODIFIED_BY="Olga Mostovetsky" NOTES="0277-0008 (Print)" NOTES_MODIFIED="2009-01-26 23:21:50 -0500" NOTES_MODIFIED_BY="Olga Mostovetsky" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bozovich M, Rubino CM, Edmunds J</AU>
<TI>Effect of a clinical pharmacist-managed lipid clinic on achieving National Cholesterol Education Program low-density lipoprotein goals</TI>
<SO>Pharmacotherapy</SO>
<YR>2000</YR>
<VL>20</VL>
<NO>11</NO>
<PG>1375-83</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brook-2003b" MODIFIED="2010-06-07 09:44:33 -0400" MODIFIED_BY="[Empty name]" NAME="Brook 2003b" YEAR="2003">
<REFERENCE MODIFIED="2010-06-07 09:44:33 -0400" MODIFIED_BY="[Empty name]" NOTES="0924-977X (Print)" NOTES_MODIFIED="2010-06-07 09:44:33 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brook O, van Hout H, Nieuwenhuyse H, Heerdink E</AU>
<TI>Impact of coaching by community pharmacists on drug attitude of depressive primary care patients and acceptability to patients: A randomized controlled trial</TI>
<SO>European Neuropsychopharmacology</SO>
<YR>2003</YR>
<VL>13</VL>
<NO>1</NO>
<PG>1-9</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brook-2005" MODIFIED="2010-06-07 09:45:31 -0400" MODIFIED_BY="[Empty name]" NAME="Brook 2005" YEAR="2005">
<REFERENCE MODIFIED="2010-06-07 09:45:30 -0400" MODIFIED_BY="[Empty name]" NOTES="1075-2730 (Print)" NOTES_MODIFIED="2010-06-07 09:45:30 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brook OH, van Hout H, Stalman W, Nieuwenhuyse H, Bakker B, Heerdink E, et al</AU>
<TI>A pharmacy-based coaching program to improve adherence to antidepressant treatment among primary care patients</TI>
<SO>Psychiatric Services</SO>
<YR>2005</YR>
<VL>56</VL>
<NO>4</NO>
<PG>487-9</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bucci-2003" MODIFIED="2010-06-07 09:46:10 -0400" MODIFIED_BY="[Empty name]" NAME="Bucci 2003" YEAR="2003">
<REFERENCE MODIFIED="2010-06-07 09:46:10 -0400" MODIFIED_BY="[Empty name]" NOTES="0828-282X (Print)" NOTES_MODIFIED="2010-06-07 09:46:10 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bucci C, Jackevicius C, McFarlane K, Liu P</AU>
<TI>Pharmacist's contribution in a heart function clinic: Patient perception and medication appropriateness</TI>
<SO>Canadian Journal of Cardiology</SO>
<YR>2003</YR>
<VL>19</VL>
<NO>4</NO>
<PG>391-6</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Charrois-2004" MODIFIED="2010-06-07 09:46:52 -0400" MODIFIED_BY="[Empty name]" NAME="Charrois 2004" YEAR="2004">
<REFERENCE MODIFIED="2010-06-07 09:46:52 -0400" MODIFIED_BY="[Empty name]" NOTES="0197-2456 (Print)" NOTES_MODIFIED="2010-06-07 09:46:52 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Charrois T, Newman S, Sin D, Senthilselvan A, Tsuyuki RT</AU>
<TI>Improving asthma symptom control in rural communities: The design of the Better Respiratory Education and Asthma Treatment in Hinton and Edson study</TI>
<SO>Controlled Clinical Trials</SO>
<YR>2004</YR>
<VL>25</VL>
<NO>5</NO>
<PG>502-14</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chisholm-2001" MODIFIED="2010-06-07 09:47:21 -0400" MODIFIED_BY="[Empty name]" NAME="Chisholm 2001" YEAR="2001">
<REFERENCE MODIFIED="2010-06-07 09:47:21 -0400" MODIFIED_BY="[Empty name]" NOTES="0902-0063 (Print)" NOTES_MODIFIED="2010-06-07 09:47:21 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chisholm MA, Mulloy LL, Jagadeesan M, DiPiro JT</AU>
<TI>Impact of clinical pharmacy services on renal transplant patients' compliance with immunosuppressive medications</TI>
<SO>Clinical Transplantation</SO>
<YR>2001</YR>
<VL>15</VL>
<NO>5</NO>
<PG>330-6</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cowper-1998" MODIFIED="2009-01-26 23:21:50 -0500" MODIFIED_BY="Olga Mostovetsky" NAME="Cowper 1998" YEAR="1998">
<REFERENCE MODIFIED="2009-01-26 23:21:50 -0500" MODIFIED_BY="Olga Mostovetsky" NOTES="0277-0008 (Print)" NOTES_MODIFIED="2009-01-26 23:21:50 -0500" NOTES_MODIFIED_BY="Olga Mostovetsky" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cowper PA, Weinberger M, Hanlon JT, Landsman PB, Samsa GP, Uttech KM, et al</AU>
<TI>The cost-effectiveness of a clinical pharmacist intervention among elderly outpatients</TI>
<SO>Pharmacotherapy</SO>
<YR>1998</YR>
<VL>18</VL>
<NO>2</NO>
<PG>327-32</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Davidson-2000" MODIFIED="2010-06-07 09:48:08 -0400" MODIFIED_BY="[Empty name]" NAME="Davidson 2000" YEAR="2000">
<REFERENCE MODIFIED="2010-06-07 09:48:08 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Davidson MB, Karlan VJ, Hair TL</AU>
<TI>Effect of a pharmacist-managed diabetes care program in a free medical clinic</TI>
<SO>American Journal of Medical Quality</SO>
<YR>2000</YR>
<VL>15</VL>
<NO>4</NO>
<PG>137-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-de-Maat-2004" MODIFIED="2010-06-07 09:48:51 -0400" MODIFIED_BY="[Empty name]" NAME="de Maat 2004" YEAR="2004">
<REFERENCE MODIFIED="2010-06-07 09:48:51 -0400" MODIFIED_BY="[Empty name]" NOTES="0269-4727 (Print)" NOTES_MODIFIED="2010-06-07 09:48:51 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>de Maat MM, de Boer A, Koks CH, Mulder JW, Meenhorst PL, van Gorp EC, et al</AU>
<TI>Evaluation of clinical pharmacist interventions on drug interactions in outpatient pharmaceutical HIV-care</TI>
<SO>Journal of Clinical Pharmacy and Therapeutics</SO>
<YR>2004</YR>
<VL>29</VL>
<NO>2</NO>
<PG>121-30</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-De-Tullio-1987a" MODIFIED="2010-06-07 09:49:28 -0400" MODIFIED_BY="[Empty name]" NAME="De Tullio 1987a" YEAR="1987">
<REFERENCE MODIFIED="2010-06-07 09:49:28 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>De Tullio PL, Kirking DM, Arslanian C, Olson DE</AU>
<TI>Compliance measure development and assessment of theophylline therapy in ambulatory patients</TI>
<SO>Journal of Clinical Pharmacy and Therapeutics</SO>
<YR>1987</YR>
<VL>12</VL>
<NO>1</NO>
<PG>19-26</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="88213490"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-De-Tullio-1987b" MODIFIED="2010-05-21 00:38:49 -0400" MODIFIED_BY="[Empty name]" NAME="De Tullio 1987b" YEAR="1987">
<REFERENCE MODIFIED="2010-05-21 00:38:49 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;De Tullio PL, Corson ME. Effect of pharmacist counseling on ambulatory patients' use of aerosolized bronchodilators. Am J Hosp Pharm. 1987;44:1802-6.&lt;/p&gt;" NOTES_MODIFIED="2010-05-21 00:38:49 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>De Tullio PL, Corson ME</AU>
<TI>Effect of pharmacist counselling on ambulatory patients' use of aerosolized bronchodilators</TI>
<SO>American Journal of Hospital Pharmacy</SO>
<YR>1987</YR>
<VL>44</VL>
<NO>8</NO>
<PG>1802-6</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="87323268"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Erickson-1997" MODIFIED="2009-01-26 19:18:38 -0500" MODIFIED_BY="Olga Mostovetsky" NAME="Erickson 1997" YEAR="1997">
<REFERENCE MODIFIED="2009-01-26 19:18:38 -0500" MODIFIED_BY="Olga Mostovetsky" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Erickson SR, Slaughter R, Halapy H</AU>
<TI>Pharmacists' ability to influence outcomes of hypertension therapy</TI>
<SO>Pharmacotherapy</SO>
<YR>1997</YR>
<VL>17</VL>
<NO>1</NO>
<PG>140-7</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="97170246"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fischer-2002" MODIFIED="2010-06-07 09:51:17 -0400" MODIFIED_BY="[Empty name]" NAME="Fischer 2002" YEAR="2002">
<REFERENCE MODIFIED="2010-06-07 09:51:17 -0400" MODIFIED_BY="[Empty name]" NOTES="1099-8128 (Print)" NOTES_MODIFIED="2010-06-07 09:51:17 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fischer LR, Defor TA, Cooper S, Scott LM, Boonstra DM, Eelkema MA, et al</AU>
<TI>Pharmaceutical care and health care utilization in an HMO</TI>
<SO>Effective Clinical Practice</SO>
<YR>2002</YR>
<VL>5</VL>
<NO>2</NO>
<PG>49-57</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fornos-2004" MODIFIED="2010-06-07 09:53:41 -0400" MODIFIED_BY="[Empty name]" NAME="Fornos 2004" YEAR="2004">
<REFERENCE MODIFIED="2010-06-07 09:53:41 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fornos Perez JA, Guerra Garcia MM, Andres Rodriguez NF, Egea Ibernon B</AU>
<TI>[Evaluation of a programme to monitor drug therapy in type-2 diabetics]</TI>
<SO>Atencion Primaria</SO>
<YR>2004</YR>
<VL>34</VL>
<NO>1</NO>
<PG>48-54</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Forstrom-1990" MODIFIED="2010-06-07 09:54:57 -0400" MODIFIED_BY="[Empty name]" NAME="Forstrom 1990" YEAR="1990">
<REFERENCE MODIFIED="2010-06-07 09:54:57 -0400" MODIFIED_BY="[Empty name]" NOTES="1042-9611 (Print)" NOTES_MODIFIED="2010-06-07 09:54:57 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Forstrom MJ, Ried LD, Stergachis AS, Corliss DA</AU>
<TI>Effect of a clinical pharmacist program on the cost of hypertension treatment in an HMO family practice clinic</TI>
<SO>DICP</SO>
<YR>1990</YR>
<VL>24</VL>
<NO>3</NO>
<PG>304-9</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Garnett-1981" MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]" NAME="Garnett 1981" YEAR="1981">
<REFERENCE MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Garnett WR, Davis LJ, McKenney JM, Steiner KC. Effect of telephone follow-up on medication compliance. Am J Hosp Pharm. 1981;38:676-9&lt;/p&gt;" NOTES_MODIFIED="2009-03-02 19:43:13 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Garnett WR, Davis LJ, McKenney JM, Steiner KC</AU>
<TI>Effect of telephone follow-up on medication compliance</TI>
<SO>American Jounal of Hospital Pharmacy</SO>
<YR>1981</YR>
<VL>38</VL>
<NO>5</NO>
<PG>676-9</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="82021105"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gourley-1998" MODIFIED="2009-07-13 19:25:01 -0400" MODIFIED_BY="[Empty name]" NAME="Gourley 1998" YEAR="1998">
<REFERENCE MODIFIED="2009-07-13 19:25:01 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gourley GA, Portner TS, Gourley DR, Rigolosi EL, Holt JM, Solomon DK, et al</AU>
<TI>Humanistic outcomes in the hypertension and COPD arms of a multicenter outcomes study</TI>
<SO>Journal of the American Pharmaceutical Association</SO>
<YR>1998</YR>
<VL>38</VL>
<NO>5</NO>
<PG>586-97</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Helling-1979" MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]" NAME="Helling 1979" YEAR="1979">
<REFERENCE MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Helling DK, Hepler CD, Jones, ME.  Effect of direct clinical pharmaceutical services on patients' perceptions of health care quality.  Am J Hosp Pharm 1979;36:325-9.&lt;/p&gt;" NOTES_MODIFIED="2009-03-02 19:43:13 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Helling DK, Hepler CD, Jones ME</AU>
<TI>Effect of direct clinical pharmaceutical services on patients' perceptions of health care quality</TI>
<SO>American Journal of Hospital Pharmacy</SO>
<YR>1979</YR>
<VL>36</VL>
<NO>3</NO>
<PG>325-9</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="79121929"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Holland-2005" MODIFIED="2010-06-07 09:56:03 -0400" MODIFIED_BY="[Empty name]" NAME="Holland 2005" YEAR="2005">
<REFERENCE MODIFIED="2010-06-07 09:56:03 -0400" MODIFIED_BY="[Empty name]" NOTES="1468-5833 (Electronic)" NOTES_MODIFIED="2010-06-07 09:56:03 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Holland R, Lenaghan E, Harvey I, Smith R, Shepstone L, Lipp A, et al</AU>
<TI>Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial</TI>
<SO>BMJ</SO>
<YR>2005</YR>
<VL>330</VL>
<NO>7486</NO>
<PG>293</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ibrahim-1990" MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]" NAME="Ibrahim 1990" YEAR="1990">
<REFERENCE MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Ibrahim OM, Catania PN, Mergener MA, Supernaw RB.  Outcome of cholesterol screening in a community pharmacy.  DICP 1990;24:817-21.&lt;/p&gt;" NOTES_MODIFIED="2009-03-02 19:43:13 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ibrahim OM, Catania PN, Mergener MA, Supernaw RB</AU>
<TI>Outcome of cholesterol screening in a community pharmacy</TI>
<SO>DICP</SO>
<YR>1990</YR>
<VL>24</VL>
<NO>9</NO>
<PG>817-21</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="91082517"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jameson-2001" MODIFIED="2010-06-07 09:56:18 -0400" MODIFIED_BY="[Empty name]" NAME="Jameson 2001" YEAR="2001">
<REFERENCE MODIFIED="2010-06-07 09:56:18 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jameson JP, VanNoord GR</AU>
<TI>Pharmacotherapy consultation on polypharmacy patients in ambulatory care</TI>
<SO>Annals of Pharmacotherapy</SO>
<YR>2001</YR>
<VL>35</VL>
<NO>7-8</NO>
<PG>835-40</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Johnson-1998" MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]" NAME="Johnson 1998" YEAR="1998">
<REFERENCE MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Johnson KA, Parker JP, McCombs JS, Cody M. The Kaiser Permanente/USC Patient Consultation Study: patient satisfaction with pharmaceutical services. University of Southern California. Am J Health Syst Pharm. 1998;55:2621-9.&lt;/p&gt;" NOTES_MODIFIED="2009-03-02 19:43:13 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Johnson KA, Parker JP, McCombs JS, Cody M</AU>
<TI>The Kaiser Permanente/USC Patient Consultation Study: patient satisfaction with pharmaceutical services. University of Southern California</TI>
<SO>American Journal of Health-System Pharmacy</SO>
<YR>1998</YR>
<VL>55</VL>
<NO>24</NO>
<PG>2621-9</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="99087736"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jones-1991" MODIFIED="2010-06-07 09:57:19 -0400" MODIFIED_BY="[Empty name]" NAME="Jones 1991" YEAR="1991">
<REFERENCE MODIFIED="2010-06-07 09:57:19 -0400" MODIFIED_BY="[Empty name]" NOTES="0018-5787 (Print)" NOTES_MODIFIED="2010-06-07 09:57:19 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jones RA, Lopez LM, Beall DG</AU>
<TI>Cost-effective implementation of clinical pharmacy services in an ambulatory care clinic</TI>
<SO>Hospital Pharmacy</SO>
<YR>1991</YR>
<VL>26</VL>
<NO>9</NO>
<PG>778-82</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Karki-1988" MODIFIED="2009-01-26 23:21:50 -0500" MODIFIED_BY="Olga Mostovetsky" NAME="Karki 1988" YEAR="1988">
<REFERENCE MODIFIED="2009-01-26 23:21:50 -0500" MODIFIED_BY="Olga Mostovetsky" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Karki SD, Chandra P, Holden JMC, Shehata H</AU>
<TI>Impact of team approach on reducing drug costs</TI>
<SO>International Journal of Geriatric Psychiatry</SO>
<YR>1988</YR>
<VL>3</VL>
<PG>89-93</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Knoell-1998" MODIFIED="2009-01-26 23:21:50 -0500" MODIFIED_BY="Olga Mostovetsky" NAME="Knoell 1998" YEAR="1998">
<REFERENCE MODIFIED="2009-01-26 23:21:50 -0500" MODIFIED_BY="Olga Mostovetsky" NOTES="0277-0008 (Print)" NOTES_MODIFIED="2009-01-26 23:21:50 -0500" NOTES_MODIFIED_BY="Olga Mostovetsky" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Knoell DL, Pierson JF, Marsh CB, Allen JN, Pathak DS</AU>
<TI>Measurement of outcomes in adults receiving pharmaceutical care in a comprehensive asthma outpatient clinic</TI>
<SO>Pharmacotherapy</SO>
<YR>1998</YR>
<VL>18</VL>
<NO>6</NO>
<PG>1365-74</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Krska-2001" MODIFIED="2009-02-22 20:00:59 -0500" MODIFIED_BY="Olga Mostovetsky" NAME="Krska 2001" YEAR="2001">
<REFERENCE MODIFIED="2009-02-22 20:00:59 -0500" MODIFIED_BY="Olga Mostovetsky" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Krska J, Cromarty JA, Arris F, Jamieson D, Hansford D, Duffus PR, et al</AU>
<TI>Pharmacist-led medication review in patients over 65: A randomized, controlled trial in primary care</TI>
<SO>Age &amp; Ageing</SO>
<YR>2001</YR>
<VL>30</VL>
<PG>205-11</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lai-1998" MODIFIED="2009-01-26 19:16:18 -0500" MODIFIED_BY="Olga Mostovetsky" NAME="Lai 1998" YEAR="1998">
<REFERENCE MODIFIED="2009-01-26 19:16:18 -0500" MODIFIED_BY="Olga Mostovetsky" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lai LL</AU>
<TI>Effects of a pharmaceutical care intervention in primary care ambulatory settings among Medicaid population</TI>
<SO>Journal of Pharmaceutical Care</SO>
<YR>1998</YR>
<VL>2</VL>
<NO>2</NO>
<PG>1-13</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Law-2003" MODIFIED="2010-06-07 10:34:07 -0400" MODIFIED_BY="[Empty name]" NAME="Law 2003" YEAR="2003">
<REFERENCE MODIFIED="2010-06-07 10:34:07 -0400" MODIFIED_BY="[Empty name]" NOTES="1482-1826 (Electronic)" NOTES_MODIFIED="2010-06-07 10:34:07 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Law S, Wu W</AU>
<TI>Cost-savings from subsidized pro-active pharmacist interventions</TI>
<SO>Journal of Pharmacy and Pharmaceutical Sciences</SO>
<YR>2003</YR>
<VL>6</VL>
<NO>1</NO>
<PG>84-94</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lim-2004" MODIFIED="2010-06-07 10:42:32 -0400" MODIFIED_BY="[Empty name]" NAME="Lim 2004" YEAR="2004">
<REFERENCE MODIFIED="2010-06-07 10:42:32 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lim WS, Low HN, Chan SP, Chen HN, Ding YY, Tan TL</AU>
<TI>Impact of a pharmacist consult clinic on a hospital-based geriatric outpatient clinic in Singapore</TI>
<SO>Annals of the Academy of Medicine, Singapore</SO>
<YR>2004</YR>
<VL>33</VL>
<NO>2</NO>
<PG>220-7</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Malone-2000" MODIFIED="2009-01-26 23:21:50 -0500" MODIFIED_BY="Olga Mostovetsky" NAME="Malone 2000" YEAR="2000">
<REFERENCE MODIFIED="2009-01-26 23:21:50 -0500" MODIFIED_BY="Olga Mostovetsky" NOTES="0277-0008 (Print)" NOTES_MODIFIED="2009-01-26 23:21:50 -0500" NOTES_MODIFIED_BY="Olga Mostovetsky" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Malone DC, Carter BL, Billups SJ, Valuck RJ, Barnette DJ, Sintek CD, et al</AU>
<TI>An economic analysis of a randomized, controlled, multicenter study of clinical pharmacist interventions for high-risk veterans: The IMPROVE study. Impact of Managed Pharmaceutical Care Resource Utilization and Outcomes in Veterans Affairs Medical Centers</TI>
<SO>Pharmacotherapy</SO>
<YR>2000</YR>
<VL>20</VL>
<NO>10</NO>
<PG>1149-58</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Malone-2003" MODIFIED="2010-06-07 10:44:48 -0400" MODIFIED_BY="[Empty name]" NAME="Malone 2003" YEAR="2003">
<REFERENCE MODIFIED="2010-06-07 10:44:48 -0400" MODIFIED_BY="[Empty name]" NOTES="1060-0280 (Print)" NOTES_MODIFIED="2010-06-07 10:44:48 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Malone M, Alger-Mayer SA</AU>
<TI>Pharmacist intervention enhances adherence to orlistat therapy</TI>
<SO>Annals of Pharmacotherapy</SO>
<YR>2003</YR>
<VL>37</VL>
<NO>11</NO>
<PG>1598-602</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McKenney-1973" MODIFIED="2009-07-04 19:34:32 -0400" MODIFIED_BY="[Empty name]" NAME="McKenney 1973" YEAR="1973">
<REFERENCE MODIFIED="2009-07-04 19:34:32 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McKenney JM, Slining JM, Henderson HR, Devins D, Barr M</AU>
<TI>The effect of clinical pharmacy services on patients with essential hypertension</TI>
<SO>Circulation</SO>
<YR>1973</YR>
<VL>48</VL>
<NO>5</NO>
<PG>1104-11</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="74028680"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Murray-2004" MODIFIED="2009-01-26 23:21:50 -0500" MODIFIED_BY="Olga Mostovetsky" NAME="Murray 2004" YEAR="2004">
<REFERENCE MODIFIED="2009-01-26 23:21:50 -0500" MODIFIED_BY="Olga Mostovetsky" NOTES="0277-0008 (Print)" NOTES_MODIFIED="2009-01-26 23:21:50 -0500" NOTES_MODIFIED_BY="Olga Mostovetsky" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Murray MD, Harris LE, Overhage JM, Zhou XH, Eckert GJ, Smith FE, et al</AU>
<TI>Failure of computerized treatment suggestions to improve health outcomes of outpatients with uncomplicated hypertension: Results of a randomized controlled trial</TI>
<SO>Pharmacotherapy</SO>
<YR>2004</YR>
<VL>24</VL>
<NO>3</NO>
<PG>324-37</PG>
<IDENTIFIERS MODIFIED="2009-03-02 19:43:13 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Murray-2004a" MODIFIED="2010-06-07 10:45:16 -0400" MODIFIED_BY="[Empty name]" NAME="Murray 2004a" YEAR="2004">
<REFERENCE MODIFIED="2010-06-07 10:45:16 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Murray MD, Young JM, Morrow DG, Weiner M, Tu W, Hoke SC, et al</AU>
<TI>Methodology of an ongoing, randomized, controlled trial to improve drug use for elderly patients with chronic heart failure</TI>
<SO>American Journal of Geriatric Pharmacotherapy</SO>
<YR>2004</YR>
<VL>2</VL>
<PG>53-65</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Peterson-1995" MODIFIED="2009-01-26 19:23:35 -0500" MODIFIED_BY="Olga Mostovetsky" NAME="Peterson 1995" YEAR="1995">
<REFERENCE MODIFIED="2009-01-26 19:23:35 -0500" MODIFIED_BY="Olga Mostovetsky" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Peterson GM, Sugden JE</AU>
<TI>Educational program to improve the dosage prescribing of allopurinol</TI>
<SO>Medical Journal of Australia</SO>
<YR>1995</YR>
<VL>162</VL>
<NO>2</NO>
<PG>74-7</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="95139868"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Peterson-1996" MODIFIED="2010-06-07 10:45:38 -0400" MODIFIED_BY="[Empty name]" NAME="Peterson 1996" YEAR="1996">
<REFERENCE MODIFIED="2010-06-07 10:45:38 -0400" MODIFIED_BY="[Empty name]" NOTES="0269-4727 (Print)" NOTES_MODIFIED="2010-06-07 10:45:38 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Peterson GM, Bergin JK, Nelson BJ, Stanton LA</AU>
<TI>Improving drug use in rheumatic disorders</TI>
<SO>Journal of Clinical Pharmacy and Therapeutics</SO>
<YR>1996</YR>
<VL>21</VL>
<NO>4</NO>
<PG>215-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Peterson-1997" MODIFIED="2010-06-07 10:46:39 -0400" MODIFIED_BY="[Empty name]" NAME="Peterson 1997" YEAR="1997">
<REFERENCE MODIFIED="2010-06-07 10:46:39 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Peterson GM, Stanton LA, Bergin JK, Chapman GA</AU>
<TI>Improving the prescribing of antibiotics for urinary tract infection</TI>
<SO>Journal of Clinical Pharmacy and Therapeutics</SO>
<YR>1997</YR>
<VL>22</VL>
<NO>2</NO>
<PG>147-53</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="98041148"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Powers-1983" MODIFIED="2010-06-07 10:47:33 -0400" MODIFIED_BY="[Empty name]" NAME="Powers 1983" YEAR="1983">
<REFERENCE MODIFIED="2010-06-07 10:47:33 -0400" MODIFIED_BY="[Empty name]" NOTES="0002-9289 (Print)" NOTES_MODIFIED="2010-06-07 10:47:33 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Powers DA, Hamilton CW, Roberts KB</AU>
<TI>Pharmacist intervention in methadone administration to cancer patients with chronic pain</TI>
<SO>American Journal of Hospital Pharmacy</SO>
<YR>1983</YR>
<VL>40</VL>
<NO>9</NO>
<PG>1520-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Raisch-1990" NAME="Raisch 1990" YEAR="1990">
<REFERENCE NOTES="&lt;p&gt;Raisch DW, Bootman JL, Larson LN, McGhan WF.  Improving antiulcer agent prescribing in a health maintenance organization.  Am J Hosp Pharm 1990;47:1766-73.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Raisch DW, Bootman JL, Larson LN, McGhan WF</AU>
<TI>Improving antiulcer agent prescribing in a health maintenance organization</TI>
<SO>American Journal of Hospital Pharmacy</SO>
<YR>1990</YR>
<VL>47</VL>
<NO>8</NO>
<PG>1766-73</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="90358226"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rathbun-2005" MODIFIED="2010-06-07 10:48:22 -0400" MODIFIED_BY="[Empty name]" NAME="Rathbun 2005" YEAR="2005">
<REFERENCE MODIFIED="2010-06-07 10:48:22 -0400" MODIFIED_BY="[Empty name]" NOTES="0149-2918 (Print)" NOTES_MODIFIED="2010-06-07 10:48:22 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rathbun RC, Farmer KC, Stephens JR, Lockhart SM</AU>
<TI>Impact of an adherence clinic on behavioral outcomes and virologic response in treatment of HIV infection: A prospective, randomized, controlled pilot study</TI>
<SO>Clinical Therapeutics</SO>
<YR>2005</YR>
<VL>27</VL>
<NO>2</NO>
<PG>199-209</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rodgers-1999" MODIFIED="2010-06-07 10:48:46 -0400" MODIFIED_BY="[Empty name]" NAME="Rodgers 1999" YEAR="1999">
<REFERENCE MODIFIED="2010-06-07 10:48:46 -0400" MODIFIED_BY="[Empty name]" NOTES="0960-1643 (Print)" NOTES_MODIFIED="2010-06-07 10:48:46 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rodgers S, Avery AJ, Meechan D, Briant S, Geraghty M, Doran K, et al</AU>
<TI>Controlled trial of pharmacist intervention in general practice: The effect on prescribing costs</TI>
<SO>British Journal of General Practice</SO>
<YR>1999</YR>
<VL>49</VL>
<NO>446</NO>
<PG>717-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rogers-1998" MODIFIED="2009-01-26 23:21:50 -0500" MODIFIED_BY="Olga Mostovetsky" NAME="Rogers 1998" YEAR="1998">
<REFERENCE MODIFIED="2009-01-26 23:21:50 -0500" MODIFIED_BY="Olga Mostovetsky" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rogers KC, Johnson GL, White DM, Becker DM</AU>
<TI>Outcomes of clinical pharmacists' recommendations on prescribing of oral H2 antagonists</TI>
<SO>Hospital Pharmacy</SO>
<YR>1998</YR>
<VL>33</VL>
<PG>1102-1104 +1110</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schaffner-1983" MODIFIED="2009-01-26 19:22:55 -0500" MODIFIED_BY="Olga Mostovetsky" NAME="Schaffner 1983" YEAR="1983">
<REFERENCE MODIFIED="2009-01-26 19:22:55 -0500" MODIFIED_BY="Olga Mostovetsky" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schaffner W, Ray WA, Federspiel CF, Miller WO</AU>
<TI>Improving antibiotic prescribing in office practice. A controlled trial of three educational methods</TI>
<SO>Journal of the American Medical Association</SO>
<YR>1983</YR>
<VL>250</VL>
<NO>13</NO>
<PG>1728-32</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="83294912"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sczupak-1977" MODIFIED="2010-06-07 10:49:14 -0400" MODIFIED_BY="[Empty name]" NAME="Sczupak 1977" YEAR="1977">
<REFERENCE MODIFIED="2010-06-07 10:49:14 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sczupak CA, Conrad WF</AU>
<TI>Relationship between patient-oriented pharmaceutical services and therapeutic outcomes of ambulatory patients with diabetes mellitus</TI>
<SO>American Journal of Hospital Pharmacy</SO>
<YR>1977</YR>
<VL>34</VL>
<PG>1238-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sellors-2001" MODIFIED="2009-02-22 20:10:42 -0500" MODIFIED_BY="Olga Mostovetsky" NAME="Sellors 2001" YEAR="2001">
<REFERENCE MODIFIED="2009-02-22 20:10:42 -0500" MODIFIED_BY="Olga Mostovetsky" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sellors C, Dalby DM, Howard M, Kaczorowski J, Sellors J</AU>
<TI>A pharmacist consultation service in community-based family practices: A randomized, controlled trial in seniors</TI>
<SO>Journal of Pharmacy Technology</SO>
<YR>2001</YR>
<VL>17</VL>
<PG>264-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sellors-2003" MODIFIED="2010-06-07 10:49:45 -0400" MODIFIED_BY="[Empty name]" NAME="Sellors 2003" YEAR="2003">
<REFERENCE MODIFIED="2010-06-07 10:49:45 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sellors J, Kaczorowski J, Sellors C, Dolovich L, Woodward C, Willan A, et al</AU>
<TI>A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients</TI>
<SO>CMAJ</SO>
<YR>2003</YR>
<VL>169</VL>
<NO>1</NO>
<PG>17-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shaw-2000" MODIFIED="2009-01-26 23:21:50 -0500" MODIFIED_BY="Olga Mostovetsky" NAME="Shaw 2000" YEAR="2000">
<REFERENCE MODIFIED="2009-01-26 23:21:50 -0500" MODIFIED_BY="Olga Mostovetsky" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shaw H, Mackie CA, Sharkie I</AU>
<TI>Evaluation of effect of pharmacy discharge planning on medication problems experienced by discharged acute admission mental health patients</TI>
<SO>International Journal of Pharmacy Practice</SO>
<YR>2000</YR>
<VL>8</VL>
<PG>144-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shibley-1997" NAME="Shibley 1997" YEAR="1997">
<REFERENCE NOTES="&lt;p&gt;Shibley MC, Pugh CB. Implementation of pharmaceutical care services for patients with hyperlipidemias by independent community pharmacy practitioners. Ann Pharmacother. 1997;31:713-9.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shibley MC, Pugh CB</AU>
<TI>Implementation of pharmaceutical care services for patients with hyperlipidemias by independent community pharmacy practitioners</TI>
<SO>Annals of Pharmacotherapy</SO>
<YR>1997</YR>
<VL>31</VL>
<NO>6</NO>
<PG>713-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="97328164"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sidel-1990" MODIFIED="2010-06-07 11:43:47 -0400" MODIFIED_BY="[Empty name]" NAME="Sidel 1990" YEAR="1990">
<REFERENCE MODIFIED="2010-06-07 11:43:47 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sidel VW, Beizer JL, Lisi-Fazio D, Kleinmann K, Wenston J, Thomas C, et al</AU>
<TI>Controlled study of the impact of educational home visits by pharmacists to high-risk older patients</TI>
<SO>Journal of Community Health</SO>
<YR>1990</YR>
<VL>15</VL>
<NO>3</NO>
<PG>163-74</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="90308016"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Simpson-2001" MODIFIED="2009-01-26 23:21:50 -0500" MODIFIED_BY="Olga Mostovetsky" NAME="Simpson 2001" YEAR="2001">
<REFERENCE MODIFIED="2009-01-26 23:21:50 -0500" MODIFIED_BY="Olga Mostovetsky" NOTES="0277-0008 (Print)" NOTES_MODIFIED="2009-01-26 23:21:50 -0500" NOTES_MODIFIED_BY="Olga Mostovetsky" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Simpson SH, Johnson JA, Tsuyuki RT</AU>
<TI>Economic impact of community pharmacist intervention in cholesterol risk management: An evaluation of the study of cardiovascular risk intervention by pharmacists</TI>
<SO>Pharmacotherapy</SO>
<YR>2001</YR>
<VL>21</VL>
<NO>5</NO>
<PG>627-35</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Simpson-2004" MODIFIED="2009-01-26 23:21:50 -0500" MODIFIED_BY="Olga Mostovetsky" NAME="Simpson 2004" YEAR="2004">
<REFERENCE MODIFIED="2009-01-26 23:21:50 -0500" MODIFIED_BY="Olga Mostovetsky" NOTES="0277-0008 (Print)" NOTES_MODIFIED="2009-01-26 23:21:50 -0500" NOTES_MODIFIED_BY="Olga Mostovetsky" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Simpson SH, Johnson JA, Biggs RS, Tsuyuki RT</AU>
<TI>Greater effect of enhanced pharmacist care on cholesterol management in patients with diabetes mellitus: A planned subgroup analysis of the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP)</TI>
<SO>Pharmacotherapy</SO>
<YR>2004</YR>
<VL>24</VL>
<NO>3</NO>
<PG>389-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Smith-1999" MODIFIED="2010-06-07 10:50:09 -0400" MODIFIED_BY="[Empty name]" NAME="Smith 1999" YEAR="1999">
<REFERENCE MODIFIED="2010-06-07 10:50:09 -0400" MODIFIED_BY="[Empty name]" NOTES="1086-5802 (Print)" NOTES_MODIFIED="2010-06-07 10:50:09 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Smith DH, Fassett WE, Christensen DB</AU>
<TI>Washington State CARE Project: downstream cost changes associated with the provision of cognitive services by pharmacists</TI>
<SO>Journal of the American Pharmacists Association</SO>
<YR>1999</YR>
<VL>39</VL>
<NO>5</NO>
<PG>650-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Soumerai-1986" MODIFIED="2010-06-07 11:44:20 -0400" MODIFIED_BY="[Empty name]" NAME="Soumerai 1986" YEAR="1986">
<REFERENCE MODIFIED="2010-06-07 11:44:20 -0400" MODIFIED_BY="[Empty name]" NOTES="0025-7079 (Print)" NOTES_MODIFIED="2010-06-07 11:44:20 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Soumerai SB, Avorn J</AU>
<TI>Economic and policy analysis of university-based drug "detailing"</TI>
<SO>Medical Care</SO>
<YR>1986</YR>
<VL>24</VL>
<NO>4</NO>
<PG>313-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Steele-1989" MODIFIED="2009-07-04 19:30:20 -0400" MODIFIED_BY="[Empty name]" NAME="Steele 1989" YEAR="1989">
<REFERENCE MODIFIED="2009-07-04 19:30:19 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Steele MA, Bess DT, Franse VL, Graber SE</AU>
<TI>Cost effectiveness of two interventions for reducing outpatient prescribing costs</TI>
<SO>DICP</SO>
<YR>1989</YR>
<VL>23</VL>
<NO>6</NO>
<PG>497-500</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="89299726"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tamai-1987" MODIFIED="2010-06-07 10:51:04 -0400" MODIFIED_BY="[Empty name]" NAME="Tamai 1987" YEAR="1987">
<REFERENCE MODIFIED="2010-06-07 10:51:04 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tamai IY, Rubenstein LZ, Josephson KR, Yamauchi JA</AU>
<TI>Impact of computerized drug profiles and a consulting pharmacist on outpatient prescribing patterns: a clinical trial</TI>
<SO>Drug Intelligence and Clinical Pharmacy</SO>
<YR>1987</YR>
<VL>21</VL>
<NO>11</NO>
<PG>890-5</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="88054589"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Varma-1999" MODIFIED="2009-01-26 23:21:50 -0500" MODIFIED_BY="Olga Mostovetsky" NAME="Varma 1999" YEAR="1999">
<REFERENCE MODIFIED="2009-01-26 23:21:50 -0500" MODIFIED_BY="Olga Mostovetsky" NOTES="0277-0008 (Print)" NOTES_MODIFIED="2009-01-26 23:21:50 -0500" NOTES_MODIFIED_BY="Olga Mostovetsky" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Varma S, McElnay JC, Hughes CM, Passmore AP, Varma M</AU>
<TI>Pharmaceutical care of patients with congestive heart failure: Interventions and outcomes</TI>
<SO>Pharmacotherapy</SO>
<YR>1999</YR>
<VL>19</VL>
<NO>7</NO>
<PG>860-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vrijens-2006" MODIFIED="2010-06-07 10:51:27 -0400" MODIFIED_BY="[Empty name]" NAME="Vrijens 2006" YEAR="2006">
<REFERENCE MODIFIED="2010-06-07 10:51:27 -0400" MODIFIED_BY="[Empty name]" NOTES="1053-8569 (Print)" NOTES_MODIFIED="2010-06-07 10:51:27 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vrijens B, Belmans A, Matthys K, de Klerk E, Lesaffre E</AU>
<TI>Effect of intervention through a pharmaceutical care program on patient adherence with prescribed once-daily atorvastatin</TI>
<SO>Pharmacoepidemiology and Drug Safety</SO>
<YR>2006</YR>
<VL>15</VL>
<NO>2</NO>
<PG>115-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wandless-1981" MODIFIED="2010-06-07 10:51:48 -0400" MODIFIED_BY="[Empty name]" NAME="Wandless 1981" YEAR="1981">
<REFERENCE MODIFIED="2010-06-07 10:51:48 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wandless I, Whitmore J</AU>
<TI>The effect of counseling by a pharmacist on drug compliance in elderly patients</TI>
<SO>Journal of Clinical and Hospital Pharmacy</SO>
<YR>1981</YR>
<VL>6</VL>
<NO>1</NO>
<PG>51-6</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="82239828"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yamada-2005" MODIFIED="2009-01-26 23:21:50 -0500" MODIFIED_BY="Olga Mostovetsky" NAME="Yamada 2005" YEAR="2005">
<REFERENCE MODIFIED="2009-01-26 23:21:50 -0500" MODIFIED_BY="Olga Mostovetsky" NOTES="0277-0008 (Print)" NOTES_MODIFIED="2009-01-26 23:21:50 -0500" NOTES_MODIFIED_BY="Olga Mostovetsky" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yamada C, Johnson JA, Robertson P, Pearson G, Tsuyuki RT</AU>
<TI>Long-term impact of a community pharmacist intervention on cholesterol levels in patients at high risk for cardiovascular events: Extended follow-up of the second study of cardiovascular risk intervention by pharmacists (SCRIP-plus)</TI>
<SO>Pharmacotherapy</SO>
<YR>2005</YR>
<VL>25</VL>
<NO>1</NO>
<PG>110-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zermansky-2001" MODIFIED="2010-06-07 10:52:18 -0400" MODIFIED_BY="[Empty name]" NAME="Zermansky 2001" YEAR="2001">
<REFERENCE MODIFIED="2010-06-07 10:52:18 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zermansky AG, Petty DR, Raynor DK, Freemantle N, Vail A, Lowe CJ</AU>
<TI>Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice</TI>
<SO>BMJ</SO>
<YR>2001</YR>
<VL>323</VL>
<NO>7325</NO>
<PG>1340-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2010-12-01 08:35:01 -0500" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Bond-2007" MODIFIED="2010-05-19 22:24:31 -0400" MODIFIED_BY="[Empty name]" NAME="Bond 2007" YEAR="2007">
<REFERENCE MODIFIED="2010-05-19 22:24:31 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bond C</AU>
<TI>The MEDMAN study: A randomized controlled trial of community pharmacy-led medicines management for patients with coronary heart disease." Family Practice</TI>
<SO>Family Practice</SO>
<YR>2007</YR>
<VL>24</VL>
<PG>189-200</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bond-2007a" MODIFIED="2010-06-10 18:56:40 -0400" MODIFIED_BY="[Empty name]" NAME="Bond 2007a" YEAR="2007">
<REFERENCE MODIFIED="2010-06-10 18:56:40 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bond CMA, Fish A, Porteous T, Reid J, Scott A, and Antonazzo E.</AU>
<TI>A randomised controlled trial of the effects of note-based medication review by community pharmacists on prescribing of cardiovascular drugs in general practice</TI>
<SO>International Journal of Pharmacy Practice</SO>
<YR>2007</YR>
<VL>15</VL>
<PG>39-46</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cameron-2006" MODIFIED="2010-06-10 18:58:21 -0400" MODIFIED_BY="[Empty name]" NAME="Cameron 2006" YEAR="2006">
<REFERENCE MODIFIED="2010-06-10 18:58:21 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cameron IM, Matheson CI, Bond CM, McNamee P, Lawrie T, Robinson A, et al.</AU>
<TI>Pilot randomised controlled trial of community pharmacy administration of buprenorphine versus methadone</TI>
<SO>International Journal of Pharmacy Practice</SO>
<YR>2006</YR>
<VL>14</VL>
<PG>243-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Carter-2008" MODIFIED="2010-06-07 10:55:08 -0400" MODIFIED_BY="[Empty name]" NAME="Carter 2008" YEAR="2008">
<REFERENCE MODIFIED="2010-06-07 10:55:08 -0400" MODIFIED_BY="[Empty name]" NOTES="Carter, Barry L" NOTES_MODIFIED="2010-06-07 10:55:08 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Carter BL, Bergus GR, Dawson JD, Farris KB, Doucette WR, Chrischilles EA, et al</AU>
<TI>A cluster randomized trial to evaluate physician/pharmacist collaboration to improve blood pressure control</TI>
<SO>Journal of Clinical Hypertension</SO>
<YR>2008</YR>
<VL>10</VL>
<PG>260-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Carter-2009" MODIFIED="2010-06-07 10:56:40 -0400" MODIFIED_BY="[Empty name]" NAME="Carter 2009" YEAR="2009">
<REFERENCE MODIFIED="2010-06-07 10:56:40 -0400" MODIFIED_BY="[Empty name]" NOTES="Carter, Barry L" NOTES_MODIFIED="2010-06-07 10:56:40 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Carter BL, Ardery G, Dawson JD, James PA, Bergus GR, Doucette WR, et al</AU>
<TI>Physician and pharmacist collaboration to improve blood pressure control</TI>
<SO>Archives of Internal Medicine</SO>
<YR>2009</YR>
<VL>169</VL>
<PG>1996-2002</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chan-2006" MODIFIED="2010-06-07 10:57:34 -0400" MODIFIED_BY="[Empty name]" NAME="Chan 2006" YEAR="2006">
<REFERENCE MODIFIED="2010-06-07 10:57:33 -0400" MODIFIED_BY="[Empty name]" NOTES="0306-5251 (Print)" NOTES_MODIFIED="2010-06-07 10:57:33 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chan FW, Wong RS, Lau WH, Chan TY, Cheng G, You JH</AU>
<TI>Management of Chinese patients on warfarin therapy in two models of anticoagulation service - a prospective randomized trial</TI>
<SO>British Journal of Clinical Pharmacology</SO>
<YR>2006</YR>
<VL>62</VL>
<PG>601-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Charrois-2006" MODIFIED="2010-06-07 10:58:09 -0400" MODIFIED_BY="[Empty name]" NAME="Charrois 2006" YEAR="2006">
<REFERENCE MODIFIED="2010-06-07 10:58:09 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Charrois LT, Newman CS, Senthilselvan A, Tsuyuki TR</AU>
<TI>Improving asthma control in the rural setting: The BREATHE (Better Respiratory Education and Asthma Treatment in Hinton and Edson) study</TI>
<SO>Canadian Pharmacists Journal</SO>
<YR>2006</YR>
<VL>139</VL>
<NO>4</NO>
<PG>44-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chisholm-2002" MODIFIED="2010-06-07 10:58:56 -0400" MODIFIED_BY="[Empty name]" NAME="Chisholm 2002" YEAR="2002">
<REFERENCE MODIFIED="2010-06-07 10:58:56 -0400" MODIFIED_BY="[Empty name]" NOTES="1049-510X (Print)" NOTES_MODIFIED="2010-06-07 10:58:56 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chisholm MA, Mulloy LL, Jagadeesan M, Martin BC, DiPiro JT</AU>
<TI>Effect of clinical pharmacy services on the blood pressure of African-American renal transplant patients</TI>
<SO>Ethnicity and Disease</SO>
<YR>2002</YR>
<VL>12</VL>
<PG>392-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cordina-2001" MODIFIED="2010-06-07 11:00:32 -0400" MODIFIED_BY="[Empty name]" NAME="Cordina 2001" YEAR="2001">
<REFERENCE MODIFIED="2010-06-07 11:00:31 -0400" MODIFIED_BY="[Empty name]" NOTES="0277-0008 (Print)" NOTES_MODIFIED="2010-06-07 11:00:31 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cordina M, McElnay JC, Hughes CM</AU>
<TI>Assessment of a community pharmacy-based program for patients with asthma</TI>
<SO>Pharmacotherapy</SO>
<YR>2001</YR>
<VL>21</VL>
<PG>1196-203</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Faulkner-2000" MODIFIED="2010-06-07 11:00:52 -0400" MODIFIED_BY="[Empty name]" NAME="Faulkner 2000" YEAR="2000">
<REFERENCE MODIFIED="2010-06-07 11:00:52 -0400" MODIFIED_BY="[Empty name]" NOTES="0277-0008 (Print)" NOTES_MODIFIED="2010-06-07 11:00:52 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Faulkner MA, Wadibia EC, Lucas BD, Hilleman DE</AU>
<TI>Impact of pharmacy counseling on compliance and effectiveness of combination lipid-lowering therapy in patients undergoing coronary artery revascularization: a randomized, controlled trial</TI>
<SO>Pharmacotherapy</SO>
<YR>2000</YR>
<VL>20</VL>
<PG>410-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Feldstein-2006" MODIFIED="2010-06-07 11:05:52 -0400" MODIFIED_BY="[Empty name]" NAME="Feldstein 2006" YEAR="2006">
<REFERENCE MODIFIED="2010-06-07 11:05:52 -0400" MODIFIED_BY="[Empty name]" NOTES="0003-9926 (Print)" NOTES_MODIFIED="2010-06-07 11:05:52 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Feldstein AC, Smith DH, Perrin N, Yang X, Rix M, Raebel MA, et al</AU>
<TI>Improved therapeutic monitoring with several interventions: a randomized trial</TI>
<SO>Archives of Internal Medicine</SO>
<YR>2006</YR>
<VL>166</VL>
<PG>1848-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fornos-2006" MODIFIED="2010-06-07 11:07:20 -0400" MODIFIED_BY="[Empty name]" NAME="Fornos 2006" YEAR="2006">
<REFERENCE MODIFIED="2010-06-07 11:07:20 -0400" MODIFIED_BY="[Empty name]" NOTES="0928-1231 (Print)" NOTES_MODIFIED="2010-06-07 11:07:20 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fornos JA, Andres NF, Andres JC, Guerra MM, Egea B</AU>
<TI>A pharmacotherapy follow-up program in patients with type-2 diabetes in community pharmacies in Spain</TI>
<SO>Pharmacy World and Science</SO>
<YR>2006</YR>
<VL>28</VL>
<PG>65-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hay-2006" MODIFIED="2010-06-07 11:07:53 -0400" MODIFIED_BY="[Empty name]" NAME="Hay 2006" YEAR="2006">
<REFERENCE MODIFIED="2010-06-07 11:07:53 -0400" MODIFIED_BY="[Empty name]" NOTES="1468-5833 (Electronic)" NOTES_MODIFIED="2010-06-07 11:07:53 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hay EM, Foster NE, Thomas E, Peat G, Phelan M, Yates HE, et al</AU>
<TI>Effectiveness of community physiotherapy and enhanced pharmacy review for knee pain in people aged over 55 presenting to primary care: pragmatic randomised trial</TI>
<SO>BMJ</SO>
<YR>2006</YR>
<VL>333</VL>
<PG>995</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hennessy-2006" MODIFIED="2010-06-07 11:08:18 -0400" MODIFIED_BY="[Empty name]" NAME="Hennessy 2006" YEAR="2006">
<REFERENCE MODIFIED="2010-06-07 11:08:17 -0400" MODIFIED_BY="[Empty name]" NOTES="0277-0008 (Print)" NOTES_MODIFIED="2010-06-07 11:08:17 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hennessy S, Leonard CE, Yang W, Kimmel SE, Townsend RR, Wasserstein AG, et al</AU>
<TI>Effectiveness of a two-part educational intervention to improve hypertension control: a cluster-randomized trial</TI>
<SO>Pharmacotherapy</SO>
<YR>2006</YR>
<VL>26</VL>
<PG>1342-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kritikos-2007" MODIFIED="2010-06-07 11:08:33 -0400" MODIFIED_BY="[Empty name]" NAME="Kritikos 2007" YEAR="2007">
<REFERENCE MODIFIED="2010-06-07 11:08:33 -0400" MODIFIED_BY="[Empty name]" NOTES="0277-0903 (Print)" NOTES_MODIFIED="2010-06-07 11:08:33 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kritikos V, Armour CL, Bosnic-Anticevich SZ</AU>
<TI>Interactive small-group asthma education in the community pharmacy setting: a pilot study</TI>
<SO>Journal of Asthma</SO>
<YR>2007</YR>
<VL>44</VL>
<PG>57-64</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kwan-2007" MODIFIED="2010-06-07 11:09:06 -0400" MODIFIED_BY="[Empty name]" NAME="Kwan 2007" YEAR="2007">
<REFERENCE MODIFIED="2010-06-07 11:09:06 -0400" MODIFIED_BY="[Empty name]" NOTES="0003-9926 (Print)" NOTES_MODIFIED="2010-06-07 11:09:06 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kwan Y, Fernandes OA, Nagge JJ, Wong GG, Huh JH, Hurn DA, et al</AU>
<TI>Pharmacist medication assessments in a surgical preadmission clinic</TI>
<SO>Archives of Internal Medicine</SO>
<YR>2007</YR>
<VL>167</VL>
<PG>1034-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lopez-2006" MODIFIED="2010-06-07 11:09:14 -0400" MODIFIED_BY="[Empty name]" NAME="Lopez 2006" YEAR="2006">
<REFERENCE MODIFIED="2010-06-07 11:09:14 -0400" MODIFIED_BY="[Empty name]" NOTES="1130-6343 (Print)" NOTES_MODIFIED="2010-06-07 11:09:14 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lopez Cabezas C, Falces Salvador C, Cubi Quadrada D, Arnau Bartes A, Ylla Bore M, Muro Perea N, et al</AU>
<TI>Randomized clinical trial of a postdischarge pharmaceutical care program vs regular follow-up in patients with heart failure</TI>
<SO>Farmacia Hospitalaria</SO>
<YR>2006</YR>
<VL>30</VL>
<PG>328-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Maguire-2001" MODIFIED="2010-06-07 11:09:48 -0400" MODIFIED_BY="[Empty name]" NAME="Maguire 2001" YEAR="2001">
<REFERENCE MODIFIED="2010-06-07 11:09:48 -0400" MODIFIED_BY="[Empty name]" NOTES="0965-2140 (Print)" NOTES_MODIFIED="2010-06-07 11:09:48 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maguire TA, McElnay JC, Drummond A</AU>
<TI>A randomized controlled trial of a smoking cessation intervention based in community pharmacies</TI>
<SO>Addiction</SO>
<YR>2001</YR>
<VL>96</VL>
<PG>325-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Murray-2007" MODIFIED="2010-06-07 11:09:34 -0400" MODIFIED_BY="[Empty name]" NAME="Murray 2007" YEAR="2007">
<REFERENCE MODIFIED="2010-06-07 11:09:34 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Murray DM, Young J, Hoke S, Wanzhu T, Weiner M, Morrow D, et al</AU>
<TI>Pharmacist intervention to improve medication adherence in heart failure</TI>
<SO>Annals of Internal Medicine</SO>
<YR>2007</YR>
<VL>146</VL>
<PG>714-25</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Raebel-2005" MODIFIED="2010-06-07 11:45:01 -0400" MODIFIED_BY="[Empty name]" NAME="Raebel 2005" YEAR="2005">
<REFERENCE MODIFIED="2010-06-07 11:45:01 -0400" MODIFIED_BY="[Empty name]" NOTES="0003-9926 (Print)" NOTES_MODIFIED="2010-06-07 11:45:01 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Raebel MA, Lyons EE, Chester EA, Bodily MA, Kelleher JA, Long CL, et al</AU>
<TI>Improving laboratory monitoring at initiation of drug therapy in ambulatory care: a randomized trial</TI>
<SO>Archives of Internal Medicine</SO>
<YR>2005</YR>
<VL>165</VL>
<PG>2395-401</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Raebel-2006" MODIFIED="2010-06-07 11:11:02 -0400" MODIFIED_BY="[Empty name]" NAME="Raebel 2006" YEAR="2006">
<REFERENCE MODIFIED="2010-06-07 11:11:02 -0400" MODIFIED_BY="[Empty name]" NOTES="0277-0008 (Print)" NOTES_MODIFIED="2010-06-07 11:11:02 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Raebel MA, Chester EA, Newsom EE, Lyons EE, Kelleher JA, Long C, et al</AU>
<TI>Randomized trial to improve laboratory safety monitoring of ongoing drug therapy in ambulatory patients</TI>
<SO>Pharmacotherapy</SO>
<YR>2006</YR>
<VL>26</VL>
<PG>619-26</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Raebel-2007" MODIFIED="2010-06-07 11:11:31 -0400" MODIFIED_BY="[Empty name]" NAME="Raebel 2007" YEAR="2007">
<REFERENCE MODIFIED="2010-06-07 11:11:31 -0400" MODIFIED_BY="[Empty name]" NOTES="0002-8614 (Print)" NOTES_MODIFIED="2010-06-07 11:11:31 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Raebel MA, Charles J, Dugan J, Carroll NM, Korner EJ, Brand DW, et al</AU>
<TI>Randomized trial to improve prescribing safety in ambulatory elderly patients</TI>
<SO>Journal of the American Geriatrics Society</SO>
<YR>2007</YR>
<VL>55</VL>
<PG>977-85</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rehring-2006" MODIFIED="2010-06-07 11:12:25 -0400" MODIFIED_BY="[Empty name]" NAME="Rehring 2006" YEAR="2006">
<REFERENCE MODIFIED="2010-06-07 11:12:25 -0400" MODIFIED_BY="[Empty name]" NOTES="0741-5214 (Print)" NOTES_MODIFIED="2010-06-07 11:12:25 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rehring TF, Stolcpart RS, Sandhoff BG, Merenich JA, Hollis HW Jr</AU>
<TI>Effect of a clinical pharmacy service on lipid control in patients with peripheral arterial disease</TI>
<SO>Journal of Vascular Surgery</SO>
<YR>2006</YR>
<VL>43</VL>
<PG>1205-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Reid-2005" MODIFIED="2010-06-07 11:12:47 -0400" MODIFIED_BY="[Empty name]" NAME="Reid 2005" YEAR="2005">
<REFERENCE MODIFIED="2010-06-07 11:12:47 -0400" MODIFIED_BY="[Empty name]" NOTES="0928-1231 (Print)" NOTES_MODIFIED="2010-06-07 11:12:47 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Reid F, Murray P, Storrie M</AU>
<TI>Implementation of a pharmacist-led clinic for hypertensive patients in primary care--a pilot study</TI>
<SO>Pharmacy World and Science</SO>
<YR>2005</YR>
<VL>27</VL>
<PG>202-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rothman-2005" MODIFIED="2010-06-07 11:13:14 -0400" MODIFIED_BY="[Empty name]" NAME="Rothman 2005" YEAR="2005">
<REFERENCE MODIFIED="2010-06-07 11:13:14 -0400" MODIFIED_BY="[Empty name]" NOTES="0002-9343 (Print)" NOTES_MODIFIED="2010-06-07 11:13:14 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rothman RL, Malone R, Bryant B, Shintani AK, Crigler B, Dewalt DA, et al</AU>
<TI>A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes</TI>
<SO>American Journal of Medicine</SO>
<YR>2005</YR>
<VL>118</VL>
<PG>276-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Simon-2000" MODIFIED="2010-06-07 11:13:29 -0400" MODIFIED_BY="[Empty name]" NAME="Simon 2000" YEAR="2000">
<REFERENCE MODIFIED="2010-06-07 11:13:28 -0400" MODIFIED_BY="[Empty name]" NOTES="0959-8138 (Print)" NOTES_MODIFIED="2010-06-07 11:13:28 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Simon GE, VonKorff M, Rutter C, Wagner E</AU>
<TI>Randomised trial of monitoring, feedback, and management of care by telephone to improve treatment of depression in primary care</TI>
<SO>BMJ</SO>
<YR>2000</YR>
<VL>320</VL>
<PG>550-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stergachis-2002" MODIFIED="2010-06-07 11:42:59 -0400" MODIFIED_BY="[Empty name]" NAME="Stergachis 2002" YEAR="2002">
<REFERENCE MODIFIED="2010-06-07 11:42:59 -0400" MODIFIED_BY="[Empty name]" NOTES="1086-5802 (Print)" NOTES_MODIFIED="2010-06-07 11:42:59 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stergachis A, Gardner JS, Anderson MT, Sullivan SD</AU>
<TI>Improving pediatric asthma outcomes in the community setting: does pharmaceutical care make a difference?</TI>
<SO>Journal of the American Pharmacists Association</SO>
<YR>2002</YR>
<VL>42</VL>
<PG>743-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sturgess-2003" MODIFIED="2010-06-07 11:14:14 -0400" MODIFIED_BY="[Empty name]" NAME="Sturgess 2003" YEAR="2003">
<REFERENCE MODIFIED="2010-06-07 11:14:14 -0400" MODIFIED_BY="[Empty name]" NOTES="0928-1231 (Print)" NOTES_MODIFIED="2010-06-07 11:14:14 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sturgess IK, McElnay JC, Hughes CM, Crealey G</AU>
<TI>Community pharmacy based provision of pharmaceutical care to older patients</TI>
<SO>Pharmacy World and Science</SO>
<YR>2003</YR>
<VL>25</VL>
<PG>218-26</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vivian-2002" MODIFIED="2010-06-07 11:14:23 -0400" MODIFIED_BY="[Empty name]" NAME="Vivian 2002" YEAR="2002">
<REFERENCE MODIFIED="2010-06-07 11:14:23 -0400" MODIFIED_BY="[Empty name]" NOTES="0277-0008 (Print)" NOTES_MODIFIED="2010-06-07 11:14:23 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vivian EM</AU>
<TI>Improving blood pressure control in a pharmacist-managed hypertension clinic</TI>
<SO>Pharmacotherapy</SO>
<YR>2002</YR>
<VL>22</VL>
<PG>1533-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Volume-2001" MODIFIED="2010-06-07 11:14:51 -0400" MODIFIED_BY="[Empty name]" NAME="Volume 2001" YEAR="2001">
<REFERENCE MODIFIED="2010-06-07 11:14:51 -0400" MODIFIED_BY="[Empty name]" NOTES="1086-5802 (Print)" NOTES_MODIFIED="2010-06-07 11:14:51 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Volume CI, Farris KB, Kassam R, Cox CE, Cave A</AU>
<TI>Pharmaceutical care research and education project: patient outcomes</TI>
<SO>Journal of the American Pharmacists Association</SO>
<YR>2001</YR>
<VL>41</VL>
<PG>411-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Welschen-2004" MODIFIED="2010-06-07 11:15:13 -0400" MODIFIED_BY="[Empty name]" NAME="Welschen 2004" YEAR="2004">
<REFERENCE MODIFIED="2010-06-07 11:15:13 -0400" MODIFIED_BY="[Empty name]" NOTES="1468-5833 (Electronic)" NOTES_MODIFIED="2010-06-07 11:15:13 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Welschen I, Kuyvenhoven MM, Hoes AW, Verheij TJ</AU>
<TI>Effectiveness of a multiple intervention to reduce antibiotic prescribing for respiratory tract symptoms in primary care: randomised controlled trial</TI>
<SO>BMJ</SO>
<YR>2004</YR>
<VL>329</VL>
<PG>431</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wiedemer-2007" MODIFIED="2010-06-07 11:16:32 -0400" MODIFIED_BY="[Empty name]" NAME="Wiedemer 2007" YEAR="2007">
<REFERENCE MODIFIED="2010-06-07 11:16:32 -0400" MODIFIED_BY="[Empty name]" NOTES="1526-2375 (Print)" NOTES_MODIFIED="2010-06-07 11:16:32 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wiedemer NL, Harden PS, Arndt IO, Gallagher RM</AU>
<TI>The opioid renewal clinic: a primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse</TI>
<SO>Pain Medicine</SO>
<YR>2007</YR>
<VL>8</VL>
<PG>573-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wu-2006" MODIFIED="2010-06-07 11:17:12 -0400" MODIFIED_BY="[Empty name]" NAME="Wu 2006" YEAR="2006">
<REFERENCE MODIFIED="2010-06-07 11:17:12 -0400" MODIFIED_BY="[Empty name]" NOTES="1468-5833 (Electronic)" NOTES_MODIFIED="2010-06-07 11:17:12 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wu JY, Leung WY, Chang S, Lee B, Zee B, Tong PC, et al</AU>
<TI>Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trial</TI>
<SO>BMJ</SO>
<YR>2006</YR>
<VL>333</VL>
<PG>522</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yuan-2003" MODIFIED="2010-06-07 11:17:47 -0400" MODIFIED_BY="[Empty name]" NAME="Yuan 2003" YEAR="2003">
<REFERENCE MODIFIED="2010-06-07 11:17:47 -0400" MODIFIED_BY="[Empty name]" NOTES="1088-0224 (Print)" NOTES_MODIFIED="2010-06-07 11:17:47 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yuan Y, Hay JW, McCombs JS</AU>
<TI>Effects of ambulatory-care pharmacist consultation on mortality and hospitalization</TI>
<SO>American Journal of Managed Care</SO>
<YR>2003</YR>
<VL>9</VL>
<PG>45-56</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zillich-2005" MODIFIED="2010-12-01 08:35:01 -0500" MODIFIED_BY="[Empty name]" NAME="Zillich 2005" YEAR="2005">
<REFERENCE MODIFIED="2010-12-01 08:35:01 -0500" MODIFIED_BY="[Empty name]" NOTES="1525-1497 (Electronic)" NOTES_MODIFIED="2010-12-01 08:35:01 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zillich AJ, Sutherland JM, Kumbera PA, Carter BL</AU>
<TI>Hypertension outcomes through blood pressure monitoring and evaluation by pharmacists (HOME study)</TI>
<SO>Journal of General Internal Medicine</SO>
<YR>2005</YR>
<VL>20</VL>
<PG>1091-6</PG>
<IDENTIFIERS MODIFIED="2010-12-01 08:32:58 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES MODIFIED="2009-07-04 19:22:36 -0400" MODIFIED_BY="[Empty name]"/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2010-06-07 13:36:29 -0400" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2010-06-07 13:36:29 -0400" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Beney-2000" MODIFIED="2010-05-21 12:27:39 -0400" MODIFIED_BY="[Empty name]" NAME="Beney 2000" TYPE="COCHRANE_REVIEW">
<AU>Beney J, Bero L, Bond CM</AU>
<TI>Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2000</YR>
<NO>2. Art. No.: CD000336. DOI: 10.1002/14651858.CD000336</NO>
<IDENTIFIERS MODIFIED="2010-04-28 12:12:08 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-04-28 12:12:08 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="&lt;html&gt;&lt;body id=&quot;body&quot;&gt;&lt;span class=&quot;inserted&quot; modified=&quot;2010-04-28 12:04:26 -0400&quot; modified_by=&quot;[Empty name]&quot;&gt;Art. No.: CD000336. DOI: 10.1002/14651858.CD000336&lt;/span&gt;&lt;/body&gt;&lt;/html&gt;"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Blenkinsopp-2003" MODIFIED="2010-06-07 11:19:44 -0400" MODIFIED_BY="[Empty name]" NAME="Blenkinsopp 2003" TYPE="JOURNAL_ARTICLE">
<AU>Blenkinsopp A, Anderson C, Armstrong M</AU>
<TI>Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease</TI>
<SO>Journal of Public Health Medicine</SO>
<YR>2003</YR>
<VL>25</VL>
<NO>2</NO>
<PG>144-53</PG>
<IDENTIFIERS MODIFIED="2009-02-19 22:57:25 -0500" MODIFIED_BY="Olga Mostovetsky">
<IDENTIFIER TYPE="PUBMED" VALUE="12848404"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Christensen-2006" MODIFIED="2010-06-07 11:20:20 -0400" MODIFIED_BY="[Empty name]" NAME="Christensen 2006" TYPE="JOURNAL_ARTICLE">
<AU>Christensen DB, Farris KB</AU>
<TI>Pharmaceutical care in community pharmacies: practice and research in the US</TI>
<SO>The Annals of Pharmacotherapy</SO>
<YR>2006</YR>
<VL>40</VL>
<NO>7-8</NO>
<PG>1400-6</PG>
<IDENTIFIERS MODIFIED="2009-02-19 22:57:25 -0500" MODIFIED_BY="Olga Mostovetsky">
<IDENTIFIER TYPE="PUBMED" VALUE="16868221"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Dent-2007" MODIFIED="2009-02-19 22:57:48 -0500" MODIFIED_BY="Olga Mostovetsky" NAME="Dent 2007" TYPE="JOURNAL_ARTICLE">
<AU>Dent LA, Harris KJ, Noonan CW</AU>
<TI>Tobacco interventions delivered by pharmacists: a summary and systematic review</TI>
<SO>Pharmacotherapy</SO>
<YR>2007</YR>
<VL>27</VL>
<NO>7</NO>
<PG>1040-51</PG>
<IDENTIFIERS MODIFIED="2009-02-19 22:57:25 -0500" MODIFIED_BY="Olga Mostovetsky">
<IDENTIFIER TYPE="PUBMED" VALUE="17594210"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Donovan-2006" MODIFIED="2010-06-07 11:20:51 -0400" MODIFIED_BY="[Empty name]" NAME="Donovan 2006" TYPE="JOURNAL_ARTICLE">
<AU>Donovan JL, Drake JA, Whittaker P, Tran MT</AU>
<TI>Pharmacy-managed anticoagulation: assessment of in-hospital efficacy and evaluation of financial impact and community acceptance</TI>
<SO>Journal of Thrombosis and Thrombolysis</SO>
<YR>2006</YR>
<VL>22</VL>
<NO>1</NO>
<PG>23-30</PG>
<IDENTIFIERS MODIFIED="2009-02-19 22:57:25 -0500" MODIFIED_BY="Olga Mostovetsky">
<IDENTIFIER TYPE="PUBMED" VALUE="16786229"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Finley-2003" MODIFIED="2009-02-19 22:57:48 -0500" MODIFIED_BY="Olga Mostovetsky" NAME="Finley 2003" TYPE="JOURNAL_ARTICLE">
<AU>Finley PR, Crismon ML, Rush AJ</AU>
<TI>Evaluating the impact of pharmacists in mental health: a systematic review</TI>
<SO>Pharmacotherapy</SO>
<YR>2003</YR>
<VL>23</VL>
<NO>12</NO>
<PG>1634-44</PG>
<IDENTIFIERS MODIFIED="2009-02-19 22:57:25 -0500" MODIFIED_BY="Olga Mostovetsky">
<IDENTIFIER TYPE="PUBMED" VALUE="14695043"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hanlon-2004" MODIFIED="2010-06-07 11:21:30 -0400" MODIFIED_BY="[Empty name]" NAME="Hanlon 2004" TYPE="JOURNAL_ARTICLE">
<AU>Hanlon JT, Lindblad CI, Gray SL</AU>
<TI>Can clinical pharmacy services have a positive impact on drug-related problems and health outcomes in community-based older adults?</TI>
<SO>The American Journal of Geriatric Pharmacotherapy</SO>
<YR>2004</YR>
<VL>2</VL>
<NO>1</NO>
<PG>3-13</PG>
<IDENTIFIERS MODIFIED="2009-02-19 22:57:25 -0500" MODIFIED_BY="Olga Mostovetsky">
<IDENTIFIER TYPE="PUBMED" VALUE="15555474"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Haynes-2008" MODIFIED="2010-06-07 11:21:45 -0400" MODIFIED_BY="[Empty name]" NAME="Haynes 2008" TYPE="COCHRANE_REVIEW">
<AU>Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X</AU>
<TI>Interventions for enhancing medication adherence</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2008</YR>
<NO>2. Art. No.: CD000011. DOI: 10.1002/14651858.CD000011.pub3</NO>
<PG>n/a</PG>
<IDENTIFIERS MODIFIED="2010-04-28 12:12:34 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-04-28 12:12:34 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="&lt;html&gt;&lt;body id=&quot;body&quot;&gt;&lt;span class=&quot;inserted&quot; modified=&quot;2010-04-28 12:06:26 -0400&quot; modified_by=&quot;[Empty name]&quot;&gt;Art. No.: CD000011. DOI: 10.1002/14651858.CD000011.pub3.&lt;/span&gt;&lt;/body&gt;&lt;/html&gt;"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hogue-2006" MODIFIED="2009-02-19 22:57:48 -0500" MODIFIED_BY="Olga Mostovetsky" NAME="Hogue 2006" TYPE="JOURNAL_ARTICLE">
<AU>Hogue MD, Grabenstein JD, Foster SL, Rothholz MC</AU>
<TI>Pharmacist involvement with immunizations: a decade of professional advancement</TI>
<SO>Journal of the American Pharmacists Association : JAPhA</SO>
<YR>2006</YR>
<VL>46</VL>
<NO>2</NO>
<PG>168-79; quiz 179-82</PG>
<IDENTIFIERS MODIFIED="2009-02-19 22:57:25 -0500" MODIFIED_BY="Olga Mostovetsky">
<IDENTIFIER TYPE="PUBMED" VALUE="16602227"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Holland-2008" MODIFIED="2010-06-07 11:22:18 -0400" MODIFIED_BY="[Empty name]" NAME="Holland 2008" TYPE="JOURNAL_ARTICLE">
<AU>Holland R, Desborough J, Goodyer L, Hall S, Wright D, Loke YK</AU>
<TI>Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis</TI>
<SO>British Journal of Clinical Pharmacology</SO>
<YR>2008</YR>
<VL>65</VL>
<NO>3</NO>
<PG>303-16</PG>
<IDENTIFIERS MODIFIED="2009-02-19 22:57:25 -0500" MODIFIED_BY="Olga Mostovetsky">
<IDENTIFIER TYPE="PUBMED" VALUE="18093253"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Horn-2006" MODIFIED="2010-06-07 11:23:27 -0400" MODIFIED_BY="[Empty name]" NAME="Horn 2006" TYPE="JOURNAL_ARTICLE">
<AU>Horn E, Jacobi J</AU>
<TI>The critical care clinical pharmacist: evolution of an essential team member</TI>
<SO>Critical Care Medicine</SO>
<YR>2006</YR>
<VL>34</VL>
<NO>3 Suppl</NO>
<PG>S46-S51</PG>
<IDENTIFIERS MODIFIED="2009-02-19 22:57:25 -0500" MODIFIED_BY="Olga Mostovetsky">
<IDENTIFIER TYPE="PUBMED" VALUE="16477202"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Jenkins-1996" MODIFIED="2009-02-19 22:57:48 -0500" MODIFIED_BY="Olga Mostovetsky" NAME="Jenkins 1996" TYPE="JOURNAL_ARTICLE">
<AU>Jenkins MH, Bond CA</AU>
<TI>The impact of clinical pharmacists on psychiatric patients</TI>
<SO>Pharmacotherapy</SO>
<YR>1996</YR>
<VL>16</VL>
<NO>4</NO>
<PG>708-14</PG>
<IDENTIFIERS MODIFIED="2009-02-19 22:57:25 -0500" MODIFIED_BY="Olga Mostovetsky">
<IDENTIFIER TYPE="PUBMED" VALUE="8840383"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kaboli-2006" MODIFIED="2009-02-19 22:57:48 -0500" MODIFIED_BY="Olga Mostovetsky" NAME="Kaboli 2006" TYPE="JOURNAL_ARTICLE">
<AU>Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL</AU>
<TI>Clinical pharmacists and inpatient medical care: a systematic review</TI>
<SO>Archives of internal medicine</SO>
<YR>2006</YR>
<VL>166</VL>
<NO>9</NO>
<PG>955-64</PG>
<IDENTIFIERS MODIFIED="2009-02-19 22:57:25 -0500" MODIFIED_BY="Olga Mostovetsky">
<IDENTIFIER TYPE="PUBMED" VALUE="16682568"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kane-2003" MODIFIED="2009-02-19 22:57:48 -0500" MODIFIED_BY="Olga Mostovetsky" NAME="Kane 2003" TYPE="JOURNAL_ARTICLE">
<AU>Kane SL, Weber RJ, Dasta JF</AU>
<TI>The impact of critical care pharmacists on enhancing patient outcomes</TI>
<SO>Intensive care medicine</SO>
<YR>2003</YR>
<VL>29</VL>
<NO>5</NO>
<PG>691-8</PG>
<IDENTIFIERS MODIFIED="2009-02-19 22:57:25 -0500" MODIFIED_BY="Olga Mostovetsky">
<IDENTIFIER TYPE="PUBMED" VALUE="12665997"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Lindenmeyer-2006" MODIFIED="2010-06-07 11:24:15 -0400" MODIFIED_BY="[Empty name]" NAME="Lindenmeyer 2006" TYPE="JOURNAL_ARTICLE">
<AU>Lindenmeyer A, Hearnshaw H, Vermeire E, Van Royen P, Wens J, Biot Y</AU>
<TI>Interventions to improve adherence to medication in people with type 2 diabetes mellitus: a review of the literature on the role of pharmacists</TI>
<SO>Journal of Clinical Pharmacy and Therapeutics</SO>
<YR>2006</YR>
<VL>31</VL>
<NO>5</NO>
<PG>409-19</PG>
<IDENTIFIERS MODIFIED="2009-02-19 22:57:25 -0500" MODIFIED_BY="Olga Mostovetsky">
<IDENTIFIER TYPE="PUBMED" VALUE="16958818"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Machado-2007a" MODIFIED="2010-06-07 11:25:10 -0400" MODIFIED_BY="[Empty name]" NAME="Machado 2007a" TYPE="JOURNAL_ARTICLE">
<AU>Machado M, Bajcar J, Guzzo GC, Einarson TR</AU>
<TI>Sensitivity of patient outcomes to pharmacist interventions. Part II: Systematic review and meta-analysis in hypertension management</TI>
<SO>The Annals of Pharmacotherapy</SO>
<YR>2007</YR>
<VL>41</VL>
<NO>11</NO>
<PG>1770-81</PG>
<IDENTIFIERS MODIFIED="2009-02-19 22:57:25 -0500" MODIFIED_BY="Olga Mostovetsky">
<IDENTIFIER TYPE="PUBMED" VALUE="17925496"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Machado-2007b" MODIFIED="2010-06-07 11:25:35 -0400" MODIFIED_BY="[Empty name]" NAME="Machado 2007b" TYPE="JOURNAL_ARTICLE">
<AU>Machado M, Bajcar J, Guzzo GC, Einarson TR</AU>
<TI>Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management</TI>
<SO>The Annals of Pharmacotherapy</SO>
<YR>2007</YR>
<VL>41</VL>
<NO>10</NO>
<PG>1569-82</PG>
<IDENTIFIERS MODIFIED="2009-02-19 22:57:25 -0500" MODIFIED_BY="Olga Mostovetsky">
<IDENTIFIER TYPE="PUBMED" VALUE="17712043"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Manley-2002" MODIFIED="2010-06-07 11:25:48 -0400" MODIFIED_BY="[Empty name]" NAME="Manley 2002" TYPE="JOURNAL_ARTICLE">
<AU>Manley HJ, Carroll CA</AU>
<TI>The clinical and economic impact of pharmaceutical care in end-stage renal disease patients</TI>
<SO>Seminars in Dialysis</SO>
<YR>2002</YR>
<VL>15</VL>
<NO>1</NO>
<PG>45-9</PG>
<IDENTIFIERS MODIFIED="2009-02-19 22:57:25 -0500" MODIFIED_BY="Olga Mostovetsky">
<IDENTIFIER TYPE="PUBMED" VALUE="11874593"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-McLean-2005" MODIFIED="2010-06-07 11:26:05 -0400" MODIFIED_BY="[Empty name]" NAME="McLean 2005" TYPE="JOURNAL_ARTICLE">
<AU>McLean WM, MacKeigan LD</AU>
<TI>When does pharmaceutical care impact health outcomes? A comparison of community pharmacy-based studies of pharmaceutical care for patients with asthma</TI>
<SO>The Annals of Pharmacotherapy</SO>
<YR>2005</YR>
<VL>39</VL>
<NO>4</NO>
<PG>625-31</PG>
<IDENTIFIERS MODIFIED="2009-02-19 22:57:25 -0500" MODIFIED_BY="Olga Mostovetsky">
<IDENTIFIER TYPE="PUBMED" VALUE="15741416"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-O_x0027_Brien-2007" MODIFIED="2010-06-07 13:36:29 -0400" MODIFIED_BY="[Empty name]" NAME="O'Brien 2007" TYPE="COCHRANE_REVIEW">
<AU>O'Brien MA, Rogers S, Jamtvedt G, Oxman AD, Odgaard-Jensen J, Kristoffersen DT, et al</AU>
<TI>Educational outreach visits: effects on professional practice and health care outcomes</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2007</YR>
<NO>4. Art. No.: CD000409. DOI: 10.1002/14651858.CD000409.pub2.</NO>
<PG>N/A</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Perez-2009" MODIFIED="2010-05-21 12:25:43 -0400" MODIFIED_BY="[Empty name]" NAME="Perez 2009" TYPE="JOURNAL_ARTICLE">
<AU>Perez A, Doloresco F, Hoffman JM, Meek PD, Touchette DR, Vermeulen LC, et al; American College of Clinical Pharmacy</AU>
<TI>ACCP: economic evaluations of clinical pharmacy services: 2001-2005</TI>
<SO>Pharmacotherapy</SO>
<YR>2009</YR>
<VL>29</VL>
<NO>1</NO>
<PG>128</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Pickard-1999" MODIFIED="2010-06-07 11:26:16 -0400" MODIFIED_BY="[Empty name]" NAME="Pickard 1999" TYPE="JOURNAL_ARTICLE">
<AU>Pickard AS, Johnson JA, Farris KB</AU>
<TI>The impact of pharmacist interventions on health-related quality of life</TI>
<SO>The Annals of Pharmacotherapy</SO>
<YR>1999</YR>
<VL>33</VL>
<NO>11</NO>
<PG>1167-72</PG>
<IDENTIFIERS MODIFIED="2009-02-19 22:57:25 -0500" MODIFIED_BY="Olga Mostovetsky">
<IDENTIFIER TYPE="PUBMED" VALUE="10573313"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Pickard-2006" MODIFIED="2010-06-07 11:26:31 -0400" MODIFIED_BY="[Empty name]" NAME="Pickard 2006" TYPE="JOURNAL_ARTICLE">
<AU>Pickard AS, Hung SY</AU>
<TI>An update on evidence of clinical pharmacy services' impact on health-related quality of life</TI>
<SO>The Annals of Pharmacotherapy</SO>
<YR>2006</YR>
<VL>40</VL>
<NO>9</NO>
<PG>1623-34</PG>
<IDENTIFIERS MODIFIED="2009-02-19 22:57:25 -0500" MODIFIED_BY="Olga Mostovetsky">
<IDENTIFIER TYPE="PUBMED" VALUE="16912249"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Ponniah-2007" MODIFIED="2010-06-07 11:27:11 -0400" MODIFIED_BY="[Empty name]" NAME="Ponniah 2007" TYPE="JOURNAL_ARTICLE">
<AU>Ponniah A, Anderson B, Shakib S, Doecke CJ, Angley M</AU>
<TI>Pharmacists' role in the post-discharge management of patients with heart failure: a literature review</TI>
<SO>Journal of Clinical Pharmacy and Therapeutics</SO>
<YR>2007</YR>
<VL>32</VL>
<NO>4</NO>
<PG>343-52</PG>
<IDENTIFIERS MODIFIED="2009-02-19 22:57:25 -0500" MODIFIED_BY="Olga Mostovetsky">
<IDENTIFIER TYPE="PUBMED" VALUE="17635336"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Rollason-2003" MODIFIED="2010-06-07 11:27:27 -0400" MODIFIED_BY="[Empty name]" NAME="Rollason 2003" TYPE="JOURNAL_ARTICLE">
<AU>Rollason V, Vogt N</AU>
<TI>Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist</TI>
<SO>Drugs and Aging</SO>
<YR>2003</YR>
<VL>20</VL>
<NO>11</NO>
<PG>817-32</PG>
<IDENTIFIERS MODIFIED="2009-02-19 22:57:25 -0500" MODIFIED_BY="Olga Mostovetsky">
<IDENTIFIER TYPE="PUBMED" VALUE="12964888"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Royal-2006" MODIFIED="2010-06-07 11:27:55 -0400" MODIFIED_BY="[Empty name]" NAME="Royal 2006" TYPE="JOURNAL_ARTICLE">
<AU>Royal S, Smeaton L, Avery AJ, Hurwitz B, Sheikh A</AU>
<TI>Interventions in primary care to reduce medication related adverse events and hospital admissions: systematic review and meta-analysis</TI>
<SO>Quality and Safety in Health Care</SO>
<YR>2006</YR>
<VL>15</VL>
<NO>1</NO>
<PG>23-31</PG>
<IDENTIFIERS MODIFIED="2009-02-19 22:57:25 -0500" MODIFIED_BY="Olga Mostovetsky">
<IDENTIFIER TYPE="PUBMED" VALUE="16456206"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Sanghera-2006" MODIFIED="2009-02-19 22:57:48 -0500" MODIFIED_BY="Olga Mostovetsky" NAME="Sanghera 2006" TYPE="JOURNAL_ARTICLE">
<AU>Sanghera N, Chan PY, Khaki ZF, Planner C, Lee KK, Cranswick NE, et al</AU>
<TI>Interventions of hospital pharmacists in improving drug therapy in children: a systematic literature review</TI>
<SO>Drug safety : an international journal of medical toxicology and drug experience</SO>
<YR>2006</YR>
<VL>29</VL>
<NO>11</NO>
<PG>1031-47</PG>
<IDENTIFIERS MODIFIED="2009-02-19 22:57:25 -0500" MODIFIED_BY="Olga Mostovetsky">
<IDENTIFIER TYPE="PUBMED" VALUE="17061909"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Schumock-1996" MODIFIED="2010-04-25 02:18:05 -0400" MODIFIED_BY="[Empty name]" NAME="Schumock 1996" TYPE="JOURNAL_ARTICLE">
<AU>Schumock GT, Meek PD, Ploetz PA, Vermeulen LC</AU>
<TI>Economic evaluations of clinical pharmacy services--1988-1995. The Publications Committee of the American College of Clinical Pharmacy</TI>
<SO>Pharmacotherapy</SO>
<YR>1996</YR>
<VL>16</VL>
<NO>6</NO>
<PG>1188-208</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="97103623"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Schumock-2003" MODIFIED="2009-02-19 22:57:48 -0500" MODIFIED_BY="Olga Mostovetsky" NAME="Schumock 2003" TYPE="JOURNAL_ARTICLE">
<AU>Schumock GT, Butler MG, Meek PD, Vermeulen LC, Arondekar BV, Bauman JL</AU>
<TI>Evidence of the economic benefit of clinical pharmacy services: 1996-2000</TI>
<SO>Pharmacotherapy</SO>
<YR>2003</YR>
<VL>23</VL>
<NO>1</NO>
<PG>113-32</PG>
<IDENTIFIERS MODIFIED="2009-02-19 22:57:25 -0500" MODIFIED_BY="Olga Mostovetsky">
<IDENTIFIER TYPE="PUBMED" VALUE="12523470"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Simonson-2007" MODIFIED="2010-06-07 11:28:23 -0400" MODIFIED_BY="[Empty name]" NAME="Simonson 2007" TYPE="JOURNAL_ARTICLE">
<AU>Simonson W, Hauser RA, Schapira AH</AU>
<TI>Role of the pharmacist in the effective management of wearing-off in Parkinson's disease</TI>
<SO>The Annals of Pharmacotherapy</SO>
<YR>2007</YR>
<VL>41</VL>
<NO>11</NO>
<PG>1842-9</PG>
<IDENTIFIERS MODIFIED="2009-02-19 22:57:25 -0500" MODIFIED_BY="Olga Mostovetsky">
<IDENTIFIER TYPE="PUBMED" VALUE="17878397"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Singhal-1999" MODIFIED="2010-06-07 11:28:35 -0400" MODIFIED_BY="[Empty name]" NAME="Singhal 1999" TYPE="JOURNAL_ARTICLE">
<AU>Singhal PK, Raisch DW, Gupchup GV</AU>
<TI>The impact of pharmaceutical services in community and ambulatory care settings: evidence and recommendations for future research</TI>
<SO>The Annals of Pharmacotherapy</SO>
<YR>1999</YR>
<VL>33</VL>
<NO>12</NO>
<PG>1336-55</PG>
<IDENTIFIERS MODIFIED="2009-02-19 22:57:25 -0500" MODIFIED_BY="Olga Mostovetsky">
<IDENTIFIER TYPE="PUBMED" VALUE="10630834"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Tully-2000" MODIFIED="2010-06-07 11:28:46 -0400" MODIFIED_BY="[Empty name]" NAME="Tully 2000" TYPE="JOURNAL_ARTICLE">
<AU>Tully MP, Seston EM</AU>
<TI>Impact of pharmacists providing a prescription review and monitoring service in ambulatory care or community practice</TI>
<SO>The Annals of Pharmacotherapy</SO>
<YR>2000</YR>
<VL>34</VL>
<NO>11</NO>
<PG>1320-31</PG>
<IDENTIFIERS MODIFIED="2009-02-19 22:57:25 -0500" MODIFIED_BY="Olga Mostovetsky">
<IDENTIFIER TYPE="PUBMED" VALUE="11098348"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-van-Eijken-2003" MODIFIED="2010-06-07 11:29:03 -0400" MODIFIED_BY="[Empty name]" NAME="van Eijken 2003" TYPE="JOURNAL_ARTICLE">
<AU>van Eijken M, Tsang S, Wensing M, de Smet PA, Grol RP</AU>
<TI>Interventions to improve medication compliance in older patients living in the community: a systematic review of the literature</TI>
<SO>Drugs and Aging</SO>
<YR>2003</YR>
<VL>20</VL>
<NO>3</NO>
<PG>229-40</PG>
<IDENTIFIERS MODIFIED="2009-02-19 22:57:25 -0500" MODIFIED_BY="Olga Mostovetsky">
<IDENTIFIER TYPE="PUBMED" VALUE="12578402"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Van-Wijk-2005" MODIFIED="2009-02-19 22:57:48 -0500" MODIFIED_BY="Olga Mostovetsky" NAME="Van Wijk 2005" TYPE="JOURNAL_ARTICLE">
<AU>Van Wijk BL, Klungel OH, Heerdink ER, de Boer A</AU>
<TI>Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medication: a systematic review</TI>
<SO>The Annals of pharmacotherapy</SO>
<YR>2005</YR>
<VL>39</VL>
<NO>2</NO>
<PG>319-28</PG>
<IDENTIFIERS MODIFIED="2009-02-19 22:57:25 -0500" MODIFIED_BY="Olga Mostovetsky">
<IDENTIFIER TYPE="PUBMED" VALUE="15632223"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-von-Gunten-2007" MODIFIED="2010-06-07 11:29:30 -0400" MODIFIED_BY="[Empty name]" NAME="von Gunten 2007" TYPE="JOURNAL_ARTICLE">
<AU>von Gunten V, Reymond JP, Beney J</AU>
<TI>Clinical and economic outcomes of pharmaceutical services related to antibiotic use: a literature review</TI>
<SO>Pharmacy World and Science</SO>
<YR>2007</YR>
<VL>29</VL>
<NO>3</NO>
<PG>146-63</PG>
<IDENTIFIERS MODIFIED="2009-02-19 22:57:25 -0500" MODIFIED_BY="Olga Mostovetsky">
<IDENTIFIER TYPE="PUBMED" VALUE="17273907"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Westerlund-2006" MODIFIED="2010-06-07 11:29:39 -0400" MODIFIED_BY="[Empty name]" NAME="Westerlund 2006" TYPE="JOURNAL_ARTICLE">
<AU>Westerlund LT, Bjork HT</AU>
<TI>Pharmaceutical care in community pharmacies: practice and research in Sweden</TI>
<SO>The Annals of Pharmacotherapy</SO>
<YR>2006</YR>
<VL>40</VL>
<NO>6</NO>
<PG>1162-9</PG>
<IDENTIFIERS MODIFIED="2009-02-19 22:57:25 -0500" MODIFIED_BY="Olga Mostovetsky">
<IDENTIFIER TYPE="PUBMED" VALUE="16735653"/>
</IDENTIFIERS>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2010-05-20 17:24:47 -0400" MODIFIED_BY="[Empty name]"/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2010-06-11 13:57:50 -0400" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2010-06-11 13:57:50 -0400" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2010-06-10 16:51:38 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Barbanel-2003">
<CHAR_METHODS MODIFIED="2010-06-03 13:49:27 -0400" MODIFIED_BY="[Empty name]">
<P>RCT (randomized by patient)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 16:51:38 -0400" MODIFIED_BY="[Empty name]">
<P>community pharmacy in Tower Hamlets, east London (United Kingdom)<BR/>patients with asthma<BR/>patients - 24 (12 intervention group, 12 control group)<BR/>health professional (delivering intervention) - 1<BR/>practice - 1<BR/>no unit of analysis error<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-05-21 00:20:06 -0400" MODIFIED_BY="[Empty name]">
<P>targeted towards PATIENTS<BR/>pharmacists reviewed inhaler technique, provided personal education on a variety of asthma-related topics and followed up with patients with weekly telephone calls vs usual care<BR/>length of intervention - 45 to 60 min initial education session and weekly telephone calls<BR/>number of interventions - 12 during 3 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-05-21 00:20:06 -0400" MODIFIED_BY="[Empty name]">
<P>PROCESS</P>
<P>not measured<BR/>PATIENT</P>
<P>improvement in asthma symptoms based on North of England asthma symptom scale</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 16:51:43 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bogden-1997">
<CHAR_METHODS MODIFIED="2010-06-03 13:49:32 -0400" MODIFIED_BY="[Empty name]">
<P>RCT (randomized by patient)<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 16:51:43 -0400" MODIFIED_BY="[Empty name]">
<P>university affiliated teaching clinic<BR/>outpatient clinic in Hawaii (United States)<BR/>patients with hypercholesterolemia<BR/>patients - 100<BR/>health professional (delivering intervention) - 1<BR/>practice -1<BR/>no unit of analysis error</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-07-04 14:34:06 -0400" MODIFIED_BY="[Empty name]">
<P>targeted towards PATIENTS<BR/>pharmacist advising and interacting with patients and physicians on the best course of pharmacologic therapy vs usual care<BR/>length of the intervention - 30 min<BR/>number of interventions - 1 or more during 6 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-04-28 10:25:21 -0400" MODIFIED_BY="[Empty name]">
<P>PROCESS </P>
<P>not measured<BR/>PATIENT </P>
<P>Total Cholesterol (men and women)<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-07-04 14:34:06 -0400" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 17:40:19 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bond-2000">
<CHAR_METHODS MODIFIED="2009-02-14 21:26:50 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>RCT (by medical practice)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 17:40:19 -0400" MODIFIED_BY="[Empty name]">
<P>university affiliated setting<BR/>medical practices in Grampian, United Kingdom<BR/>patients on repeat medications<BR/>patients - 3074 (1614 intervention, 1460 control)<BR/>health professional (delivering intervention) - 62<BR/>practice - 19<BR/>unit of analysis mismatch corrected (randomized by practice, analyzed by patient---analysis accounted for clustering effect)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-02-14 21:39:44 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>targeted towards PATIENTS<BR/>pharmacist dispensed repeat prescriptions following a protocol to check whether items were required, or patients were experiencing side-effects or drug interactions vs usual care<BR/>length of the intervention - not clear<BR/>number of interventions - 12 during 12 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-05-18 15:24:24 -0400" MODIFIED_BY="[Empty name]">
<P>PROCESS<BR/>prescribing<BR/>costs (excluded)<BR/>PATIENT<BR/>death rate<BR/>adverse drug reactions</P>
<P>hospital admissions<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 16:51:53 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Borenstein-2003">
<CHAR_METHODS MODIFIED="2010-06-03 13:50:18 -0400" MODIFIED_BY="[Empty name]">
<P>RCT (randomized by patient)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 16:51:53 -0400" MODIFIED_BY="[Empty name]">
<P>outpatient hypertension clinic run by clinical pharmacists (patients recruited from two main offices of a group medical practice of general internists and internal medicine subspecialists affiliated with a large community hospital)<BR/>patients with uncontrolled hypertension<BR/>patients - 1272 (635 intervention, 637 control)<BR/>health professional (delivering intervention) - not clear<BR/>practice - 2<BR/>no unit of analysis error</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-06-04 14:04:33 -0400" MODIFIED_BY="[Empty name]">
<P>targeted towards PATIENTS<BR/>pharmacist assessed patients' blood pressure, medication regimen, medication adherence, adverse drug effects and lifestyle habits and provided individualized patient education regarding dietary and life-style modifications during initial and follow-up visits vs usual care<BR/>targeted towards HEALTH PROFESSIONALS<BR/>pharmacist reported findings and treatment recommendations to patients' physicians vs usual care<BR/>length of the intervention - not clear<BR/>number of interventions - not clear; follow-up visits scheduled every 2 to 4 weeks at the discretion of the pharmacist over 12 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-03-19 17:13:29 -0400" MODIFIED_BY="Olga Mostovetsky">
<P>PATIENT <BR/>achievement of blood pressure control based on Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-06-10 16:51:08 -0400" MODIFIED_BY="[Empty name]">
<P>Total professional visits (pharmacist and physician) in the intervention vs control (8.0 vs 6.6, P = 0.06)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 16:51:59 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Brook-2003a">
<CHAR_METHODS MODIFIED="2010-06-03 13:50:41 -0400" MODIFIED_BY="[Empty name]">
<P>RCT (randomized by patient)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 16:51:59 -0400" MODIFIED_BY="[Empty name]">
<P>community pharmacy in the Netherlands<BR/>patients with depression<BR/>patients - 135 (intervention 64, control 71)<BR/>health professional (delivering intervention) - 19<BR/>practice - not clear<BR/>no unit of analysis error</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-02-14 22:25:35 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>targeted towards PATIENTS<BR/>pharmacist coaching patients and take-home video vs usual care<BR/>length of the intervention - not clear<BR/>number of interventions - 3 during 6 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-05-21 00:20:06 -0400" MODIFIED_BY="[Empty name]">
<P>PROCESS</P>
<P>not measured<BR/>PATIENT</P>
<P>disease control assessed by self-rating 90-item (Hopkins) Symptom Checklist (SCL-90)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-03-21 19:41:24 -0400" MODIFIED_BY="Olga Mostovetsky">
<P>required 75 patients per arm to detect 13% difference in depression at significance level of 0.05</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 16:52:08 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Capoccia-2004">
<CHAR_METHODS MODIFIED="2010-06-03 13:50:59 -0400" MODIFIED_BY="[Empty name]">
<P>RCT (randomized by patient)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 16:52:08 -0400" MODIFIED_BY="[Empty name]">
<P>university affiliated teaching clinic<BR/>outpatient clinic in United States<BR/>patients with depression<BR/>patients - 74 (41 intervention, 33 control)<BR/>health professional (delivering intervention) - 2<BR/>practice - 1<BR/>no unit of analysis error</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-05-21 00:20:06 -0400" MODIFIED_BY="[Empty name]">
<P>targeted towards PATIENTS<BR/>pharmacist collaborating with primary care physicians (PCPs) to provide patient education, antidepressant therapy adjustment, monitoring of adherence and adverse drug reactions and prevention of relapse vs usual care<BR/>length of the intervention - 15 min<BR/>number of interventions - 13 during 12 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-05-21 00:20:06 -0400" MODIFIED_BY="[Empty name]">
<P>PATIENT</P>
<P>disease control using 20-item Hopkins Symptom Checklist (SCL-20)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-05-20 17:32:29 -0400" MODIFIED_BY="[Empty name]">
<P>-not all patients completed 13 sessions<BR/>-required 55 patients per arm to detect a difference of 28% in clinical improvement rates at 0.05 significance level</P>
<P>-Boudreau is the design paper for this study; no results reported in Boudreau</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 16:51:16 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Choe-2005">
<CHAR_METHODS MODIFIED="2010-06-03 13:51:01 -0400" MODIFIED_BY="[Empty name]">
<P>RCT (randomized by patient)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 16:51:16 -0400" MODIFIED_BY="[Empty name]">
<P>university affiliated internal medicine clinic<BR/>patients - 80 (41 intervention, 39 control)<BR/>professional (delivering intervention) - unclear<BR/>practices -1<BR/>no unit of analysis error</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-06-04 14:17:18 -0400" MODIFIED_BY="[Empty name]">
<P>targeted towards PATIENTS<BR/>pharmacist evaluated/modified therapy, educated on diabetes management and complications, performed screening processes and telephone follow-ups vs usual care<BR/>targeted towards HEALTH PROFESSIONALS<BR/>pharmacist discussed therapeutic recommendations with the primary care physicians vs usual care<BR/>length of intervention - 1 hour<BR/>number of interventions - unclear number in 12 months with another 12 months of follow-up</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-03-13 17:49:39 -0400" MODIFIED_BY="Olga Mostovetsky">
<P>PATIENT<BR/>HbA1c </P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-03-13 17:48:08 -0400" MODIFIED_BY="Olga Mostovetsky">
<P>Follow-up for HbA1c measurement was 13.6 months for intervention group and 14.9 months for control group</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 18:44:06 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Clifford-2005">
<CHAR_METHODS MODIFIED="2010-06-04 14:18:56 -0400" MODIFIED_BY="[Empty name]">
<P>RCT (randomized by patient)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 18:44:06 -0400" MODIFIED_BY="[Empty name]">
<P>university affiliated internal medicine clinic<BR/>patients - 180 (92 intervention, 88 control)<BR/>professional (delivering intervention) - unclear<BR/>practices -1<BR/>no unit of analysis error</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-05-21 00:20:06 -0400" MODIFIED_BY="[Empty name]">
<P>targeted towards PATIENTS<BR/>pharmacist assessed patients' drug regimen and clinical parameters, developed therapeutic plan, provided patient education regarding diet, exercise, compliance and home-glucose monitoring and forwarded patient information (medication lists, labs results, goals) to PCPs vs usual care<BR/>length of intervention - 5 to 30 minutes (average 15 minutes)<BR/>number of interventions - 8 in 12 months (face-to-face meetings at baseline, 6, and 12 months; 6-weekly intervals by phone)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-04-25 02:17:09 -0400" MODIFIED_BY="[Empty name]">
<P>PATIENT<BR/>HbA1c (primary)</P>
<P>Fasting plasma glucose, blood pressure, serum lipids, urinary albumin-to-creatinine ratio</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-03-09 00:45:52 -0400" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-05-21 00:20:06 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cody-1998">
<CHAR_METHODS MODIFIED="2009-02-13 17:22:30 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>RCT (by patient) + CBA (by geographic area)<BR/>Similar control site: NOT CLEAR</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>community pharmacies of the Kaiser Permanente<BR/> patients - 6000 in the RCT / 4600 in the CBA<BR/> pharmacies - 9 in the RCT / 101 in the CBA<BR/>no unit of analysis error for the RCT<BR/>unit of analysis error for the CBA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-02-20 11:56:15 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>targeted toward PATIENTS<BR/>comparison of three models<BR/>Control model: usual care before 1992 in California<BR/>California state model (1992) which requires outpatient pharmacist to counsel all patients who receive new or changed prescription about direction for use, the importance of compliance, proper storage, and relevant precautions and warnings.<BR/>Kaiser Permanente (KP) model that focuses on a more comprehensive pharmacist consultation and other elements of pharmaceutical care on selected high-risk patients.<BR/>length of study - 23 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-04-28 10:24:42 -0400" MODIFIED_BY="[Empty name]">
<P>PROCESS </P>
<P>not measured<BR/>PATIENT </P>
<P>Quality of life (SF 36)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-05-21 00:20:06 -0400" MODIFIED_BY="[Empty name]">
<P>see McCombs 1998 for design</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 18:44:07 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Diwan-1995">
<CHAR_METHODS MODIFIED="2010-06-04 14:37:19 -0400" MODIFIED_BY="[Empty name]">
<P>RCT (randomized by health center)<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 18:44:07 -0400" MODIFIED_BY="[Empty name]">
<P>primary care health centers in Sweden, excluding health centers in counties with a university hospital, department of general medicine, or extensive activities for the prevention of cardiovascular disease or both.<BR/>education provided by pharmacists focused on treating patients with cardiovascular disease.<BR/>patients - 1308<BR/>practices - 134 health centers<BR/>professional - 1<BR/>no unit of analysis error (the unit of analysis was the health center)<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-06-04 14:38:58 -0400" MODIFIED_BY="[Empty name]">
<P>targeted towards HEALTH PROFESSIONALS<BR/>pharmacist vs. no intervention<BR/>pharmacist conducted academic group detailing sessions at health centers<BR/>length of intervention - four 30 minute detailing sessions over a 5 month period<BR/>product related</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-07-03 18:02:43 -0400" MODIFIED_BY="[Empty name]">
<P>PROCESS<BR/>number of prescriptions of lipid-lowering drugs/month<BR/>PATIENT<BR/>not measured</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 18:44:08 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Finley-2003">
<CHAR_METHODS MODIFIED="2010-06-03 13:51:32 -0400" MODIFIED_BY="[Empty name]">
<P>RCT (randomized by patient)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 18:44:08 -0400" MODIFIED_BY="[Empty name]">
<P>outpatient clinic in Kaiser Permanente Medical Center, San Rafael, United States<BR/>patients with depression<BR/>patients - 125 (75 intervention, 50 control)<BR/>professional (delivering intervention) - 2<BR/>practice - 1<BR/>no unit of analysis error</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-05-21 00:20:07 -0400" MODIFIED_BY="[Empty name]">
<P>targeted towards PATIENTS<BR/>pharmacist managed medication regimens, conducted in-clinic and telephone follow-ups and educated patients regarding medications and disease state vs usual care<BR/>length of the intervention - 30 min initial clinic visit, "brief" second and third clinic visits, 5 to 10 min telephone calls<BR/>number of interventions - 3 clinic visits + 5 telephone follow-ups during 6 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-06-07 11:39:40 -0400" MODIFIED_BY="[Empty name]">
<P>Brief Inventory for Depressive Symptoms (BIDS) score<BR/>% patients with &#8805; 50% reduction in BIDS score<BR/>% patient achieving remission (BIDS score &lt; 9)<BR/>% patients with reduction in Work and Social Disability Scale (WSDS) score</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-03-21 19:36:36 -0400" MODIFIED_BY="Olga Mostovetsky">
<P>-pharmacists met weekly with a psychiatrist ("psychiatric mentor") to present new patients and provide updates on other patients; the psychiatrist was also available for consultations as needed<BR/>-study was powered to detect compliance outcomes only</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 18:44:09 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Freemantle-2002">
<CHAR_METHODS MODIFIED="2010-06-04 14:41:38 -0400" MODIFIED_BY="[Empty name]">
<P>RCT (randomized by health authority)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 18:44:09 -0400" MODIFIED_BY="[Empty name]">
<P>outpatient general practices in United Kingdom National Health Service health authorities<BR/>professional (delivering intervention) - 12<BR/>practice - 75<BR/>unit of analysis error (randomized by health authority, analyzed by practice)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-06-04 14:41:42 -0400" MODIFIED_BY="[Empty name]">
<P>targeted towards HEALTH PROFESSIONALS<BR/>pharmacist performed educational outreach visits on two of four practice guideline topics ((1) use of aspirin as antiplatelet therapy, (2) use of ACEIs in heart failure, (3) use of NSAIDs in pain due to osteoarthritis, (4) choice of antidepressant for depression) vs non-targeted guideline control<BR/>length of the intervention - not clear<BR/>number of interventions - 2; 12 months pre-intervention and 12 months post-intervention periods</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-02-27 20:14:01 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>PROCESS<BR/># of patients treated in accordance with guideline recommendations</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 18:44:09 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gattis-1999">
<CHAR_METHODS MODIFIED="2010-06-04 14:46:23 -0400" MODIFIED_BY="[Empty name]">
<P>RCT (randomized by patient)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 18:44:09 -0400" MODIFIED_BY="[Empty name]">
<P>university affiliated teaching clinic<BR/>outpatient cardiology clinic in United States<BR/>patients with heart failure<BR/>patients - 181 (90 intervention, 91 control)<BR/>professional (delivering intervention) - not clear<BR/>practice - 1<BR/>no unit of analysis error</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-06-04 14:46:55 -0400" MODIFIED_BY="[Empty name]">
<P>targeted towards PATIENTS<BR/>pharmacist educated patients regarding therapy modification and provided telephone follow-up vs usual care with telephone follow-up<BR/>targeted towards HEALTH PROFESSIONALS<BR/>pharmacist made recommendation to physicians regarding therapy optimization<BR/>length of the intervention - not clear<BR/>number of interventions - 4 during 6 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-05-21 00:20:07 -0400" MODIFIED_BY="[Empty name]">
<P>PATIENT</P>
<P>all-cause mortality and heart failure events at 6 months</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 18:44:10 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gonzalez_x002d_Martin-2003">
<CHAR_METHODS MODIFIED="2010-06-03 14:01:39 -0400" MODIFIED_BY="[Empty name]">
<P>RCT (randomized by patient)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 18:44:10 -0400" MODIFIED_BY="[Empty name]">
<P>outpatient pediatric clinic affiliated with Catholic University, Chile<BR/>patients with asthma<BR/>patients - 21 (11 intervention, 10 control)<BR/>professional (delivering intervention) - not clear<BR/>practice - 1<BR/>no unit of analysis error</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-03-17 16:16:36 -0400" MODIFIED_BY="[Empty name]">
<P>targeted towards PATIENTS<BR/>pharmacist educated patients on medication therapy and inhaler use using asthma explanatory booklet and prescribed medications brochure vs usual care<BR/>length of the intervention - 30 min<BR/>number of interventions - 3 during 9 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-02-27 21:13:59 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>PATIENT<BR/>Pediatric asthma quality of life questionnaire (PAQLQ) score: emotions, activities, symptoms domains<BR/>Spirometry testing: FVC, FEV1</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-04 14:48:40 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Goodyer-1995">
<CHAR_METHODS MODIFIED="2010-06-03 13:52:51 -0400" MODIFIED_BY="[Empty name]">
<P>RCT (randomized by patient)<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-04 14:48:40 -0400" MODIFIED_BY="[Empty name]">
<P>outpatient clinics of the Medicine for Elderly Department at Charing Cross Hospital (United Kingdom)<BR/>patients over the age of 70 years - 100<BR/>no unit of analysis error</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-06-03 14:01:45 -0400" MODIFIED_BY="[Empty name]">
<P>targeted towards PATIENTS</P>
<P>verbal counseling on the correct use of medication + medication calendar and information leaflets<BR/>length of intervention - 3 domiciliary visits over a 6 to 12 week period</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-04-27 15:46:00 -0400" MODIFIED_BY="[Empty name]">
<P>PROCESS </P>
<P>not measured<BR/>PATIENT<BR/>compliance (pill count) defined as the percentage of the number that should have been consumed<BR/>patient knowledge<BR/>exercise test (distance in 6 min and distance till breathless)<BR/>clinical assessment<BR/>Nottingham Health Profile<BR/>breathlessness when performing different activities.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 18:44:10 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hall-2001">
<CHAR_METHODS MODIFIED="2010-06-03 13:53:07 -0400" MODIFIED_BY="[Empty name]">
<P>RCT (randomized by practice) - before and after pragmatic randomized controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 18:44:10 -0400" MODIFIED_BY="[Empty name]">
<P>outpatient general practice clinics in a single health authority district, Enlgand<BR/>professional (delivering intervention) - 1<BR/>practice -79 (38 intervention, 38 control)<BR/>no unit of analysis error (general practices the unit of analysis)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-06-04 14:50:45 -0400" MODIFIED_BY="[Empty name]">
<P>targeted towards HEALTH PROFESSIONALS<BR/>pharmacist conducted educational outreach visits to promote undertaking of <I>H. pylori</I> eradication using mailed consensus guidelines vs mailed consensus guidelines alone<BR/>length of the intervention - not clear<BR/>number of interventions - 1 between 12 months pre-intervention and 12 months post-intervention periods</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-02-27 19:48:07 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>PROCESS<BR/>increase in omeprazole prescribing in accordance with consensus guidelines<BR/>increase in metronidazole prescribing in accordance with consensus guidelines</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-06-03 13:53:08 -0400" MODIFIED_BY="[Empty name]">
<P>21 practices from randomized 38 received intervention</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 18:44:11 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hanlon-1996">
<CHAR_METHODS MODIFIED="2010-06-03 14:01:48 -0400" MODIFIED_BY="[Empty name]">
<P>RCT (randomized by patient)<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 18:44:11 -0400" MODIFIED_BY="[Empty name]">
<P>general medicine clinic at the Durham Veteran Affairs Medical Center North Carolina (United States)<BR/>patients over 64 years with 5 or more regularly scheduled medications - 208<BR/>professional (delivering intervention) - 1<BR/>practices -1<BR/>no unit of analysis error<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-06-04 14:52:26 -0400" MODIFIED_BY="[Empty name]">
<P>targeted towards PATIENTS<BR/>education regarding any drug related problem + reinforcement of physician instructions<BR/>targeted towards HEALTH PROFESSIONALS</P>
<P>thorough medication history review; recommendation and their rationale presented orally and in writing to the patients' physicians<BR/>length of intervention - not clear<BR/>number of interventions - multiple during 12 months<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-04-27 15:46:56 -0400" MODIFIED_BY="[Empty name]">
<P>PROCESS </P>
<P>Medication Appropriateness Index (MAI)<BR/>PATIENT<BR/>SF 36 (Health Related Quality of Life)<BR/>Adverse Drug Events (ADE)<BR/>Compliance<BR/>Satisfaction</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>ADE and Compliance were self reported by the patients and are therefore not reported in this review</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 18:44:11 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hawkins-1979">
<CHAR_METHODS MODIFIED="2010-06-03 13:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>RCT (randomized by patient)<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 18:44:11 -0400" MODIFIED_BY="[Empty name]">
<P>outpatient primary care clinic in United States (Texas)<BR/>diabetic or hypertensive patients or both<BR/>episodes of care - 12,918<BR/>patients - 1148<BR/>professionals (delivering intervention) - 2<BR/>practices - 1<BR/>no unit of analysis error</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-05-21 00:20:07 -0400" MODIFIED_BY="[Empty name]">
<P>targeted towards PATIENTS<BR/>pharmacist management of drug therapy (physician not involved) vs usual care (physician only)<BR/>pharmacists prescribed drugs and modified drug therapy as needed<BR/>length of intervention - 29 months<BR/>product related</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-05-21 00:20:07 -0400" MODIFIED_BY="[Empty name]">
<P>PROCESS<BR/>kept appointment rate<BR/>follow-up clinic visits<BR/>hospital admissions<BR/>emergency department visits<BR/>PATIENT<BR/>compliance<BR/>mean blood pressure<BR/>blood sugar level<BR/>percent of patients with decreased blood pressure<BR/>percent of patients with decreased blood sugar levels</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-06-07 11:39:39 -0400" MODIFIED_BY="[Empty name]">
<P>Intervention was delivered by pharmacists who were assisted by trainees</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 18:51:56 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ilett-2000">
<CHAR_METHODS MODIFIED="2010-06-10 18:51:45 -0400" MODIFIED_BY="[Empty name]">
<P>RCT (randomized by health professional)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 18:51:56 -0400" MODIFIED_BY="[Empty name]">
<P>outpatient clinics in Australia<BR/>patients with antibiotic prescriptions<BR/>physicians (receiving intervention) - 112 (56 intervention, 56 control)<BR/>health professional (delivering intervention) - not clear<BR/>practice - unclear (multiple practices in Osborne Division of General Practice in the Perth Western Australia)<BR/>no unit of analysis error</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-06-04 14:56:14 -0400" MODIFIED_BY="[Empty name]">
<P>targeted towards HEALTH PROFESSIONALS<BR/>pharmacist provided academic detailing, consisting of in-person visit and paper chart, to physicians on best practice guidelines for antibiotic use vs no intervention<BR/>length of the intervention - 10 to 15 min<BR/>number of interventions - 1 during 3 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-06-04 14:56:35 -0400" MODIFIED_BY="[Empty name]">
<P>PROCESS</P>
<P>Number of prescriptions for all antibiotics<BR/>PATIENT</P>
<P>none measured</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-05-21 00:20:08 -0400" MODIFIED_BY="[Empty name]">
<P>Guidelines for antibiotic prescribing were developed by an expert panel and were in line with published Australian therapeutic guidelines for antibiotics</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 18:52:00 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jaber-1996">
<CHAR_METHODS MODIFIED="2010-06-03 13:53:20 -0400" MODIFIED_BY="[Empty name]">
<P>RCT (randomized by patient)<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 18:52:00 -0400" MODIFIED_BY="[Empty name]">
<P>university-affiliated general medicine outpatient clinic in United States (Michigan)<BR/>urban African-American patients with diabetes<BR/>patients - 45<BR/>health professionals - 1<BR/>practices - 1<BR/>no unit of analysis error</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-06-03 13:53:24 -0400" MODIFIED_BY="[Empty name]">
<P>targeted towards PATIENTS<BR/>
<BR/>pharmacist provided diabetes education, medication counseling, instructions on dietary regulation, exercise and home glucose monitoring, and evaluation and adjustment of drug regimen vs usual care<BR/>length of intervention - 4 months<BR/>non-product related</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>PROCESS<BR/>not measured<BR/>PATIENT<BR/>glucose levels<BR/>quality of life</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 18:52:01 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jackson-2004">
<CHAR_METHODS MODIFIED="2010-06-03 13:53:28 -0400" MODIFIED_BY="[Empty name]">
<P>open-label RCT (randomized by patient)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 18:52:01 -0400" MODIFIED_BY="[Empty name]">
<P>home-based follow-up of patients discharged from Royal Hobart acute care teaching hospital in southern Tasmania, Australia<BR/>patients - 128 (60 intervention, 68 control)<BR/>health professional (delivering intervention) - 1<BR/>practice - 1<BR/>no unit of analysis error</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-06-04 14:59:09 -0400" MODIFIED_BY="[Empty name]">
<P>targeted towards PATIENTS<BR/>pharmacist conducted home-visit to test INR and educate patients regarding anticoagulant therapy using printed educational materials<BR/>targeted towards HEALTH PROFESSIONALS<BR/>pharmacist informed physicians regarding patients' INR, recommended dosage adjustments and implemented therapy changes vs usual care<BR/>length of the intervention - 24 min<BR/>number of interventions - 4 during 90 days</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-05-21 00:20:08 -0400" MODIFIED_BY="[Empty name]">
<P>PATIENT<BR/>therapeutic INR as defined by ACCP on day 8 after-discharge<BR/>total, major, and minor bleeding complications within 90 days of discharge<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 18:52:02 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jameson-1995">
<CHAR_METHODS MODIFIED="2010-06-03 13:53:31 -0400" MODIFIED_BY="[Empty name]">
<P>RCT (randomized by patient)<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 18:52:02 -0400" MODIFIED_BY="[Empty name]">
<P>primary care practice in United States (Michigan)<BR/>patients at high risk for adverse consequences of drug therapy<BR/>patients - 64<BR/>health professionals - 1<BR/>practices - 1<BR/>no unit of analysis error</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-05-21 00:20:08 -0400" MODIFIED_BY="[Empty name]">
<P>targeted towards PATIENTS<BR/>
<BR/>pharmacist conducted a single pharmacotherapy consultation with patient, met with physician to discuss findings, conducted educational session with patient vs usual care<BR/>length of intervention - brief (a few hours total)<BR/>product related</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>PROCESS<BR/>number of drugs<BR/>doses of drugs <BR/>costs of drugs<BR/>PATIENT<BR/>compliance<BR/>side effects</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 18:52:04 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Malone-2001">
<CHAR_METHODS MODIFIED="2010-06-03 13:53:32 -0400" MODIFIED_BY="[Empty name]">
<P>RCT (randomized by patient)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 18:52:04 -0400" MODIFIED_BY="[Empty name]">
<P>ambulatory care clinics in Veterans Affairs Medical Centers across continental United States<BR/>patients with high risk for medication related problems (&#8805; 3 of following criteria: (1) more than 5 medications, (2) more than 12 doses per day, (3) more than 3 chronic medical conditions, (4) more than 4 changes to medication regimen over past year, (5) taking &lt; 80% of medications based on pharmacy refill records, (6) taking medication requiring therapeutic monitoring<BR/>patients - 1054 (intervention 523, control 531)<BR/>health professional (delivering intervention) - 78<BR/>practice - 9<BR/>no unit of analysis error</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-06-10 17:39:10 -0400" MODIFIED_BY="[Empty name]">
<P>targeted towards PATIENTS<BR/>pharmacist reviewed medical records, performed physical assessment and laboratory tests to assess appropriateness of medication therapy, modified therapy as necessary, educated patients, and made referrals to other health professionals vs usual care<BR/>length of the intervention - &gt; 15 minutes for &gt; 73% of patient contacts<BR/>number of interventions - mean of 3.5 during 12 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-05-21 00:20:08 -0400" MODIFIED_BY="[Empty name]">
<P>PATIENT </P>
<P>health-related quality of life using SF-36 questionnaire</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-05-20 17:41:12 -0400" MODIFIED_BY="[Empty name]">
<P>*Ellis 2000 is a subgroup analysis of Improve Study (<LINK REF="STD-Malone-2001" TYPE="STUDY">Malone 2001</LINK>)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 18:52:07 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mehos-2000">
<CHAR_METHODS MODIFIED="2010-06-03 13:53:55 -0400" MODIFIED_BY="[Empty name]">
<P>RCT (randomized by patient)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 18:52:04 -0400" MODIFIED_BY="[Empty name]">
<P>family medicine residency training clinic in Colorado, United States<BR/>patients with stage 1 or 2 hypertension<BR/>patients - 41 (intervention 20, control 21)<BR/>health professionals (delivering intervention) - not clear<BR/>practices - 1<BR/>no unit of analysis error</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-06-10 18:52:07 -0400" MODIFIED_BY="[Empty name]">
<P>targeted towards PATIENTS<BR/>patients received blood pressure monitors, blood pressure diaries and telephone contacts by pharmacist to evaluate blood pressure and response to therapy vs usual care without blood pressure self-monitoring<BR/>targeted towards HEALTH PROFESSIONALS<BR/>pharmacist informed primary care health professionals of patients' blood pressure results and provided therapy recommendations vs usual care<BR/>length of intervention - 30 minutes (initial visit)<BR/>number of interventions - initial visits and phone call follow-ups during 6 months<BR/>product and non-product related</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-05-21 00:20:09 -0400" MODIFIED_BY="[Empty name]">
<P>PATIENT<BR/>systolic, diastolic, and mean arterial blood pressure</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-03-13 18:57:25 -0400" MODIFIED_BY="Olga Mostovetsky"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 18:52:08 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Meredith-2002">
<CHAR_METHODS MODIFIED="2010-06-04 15:18:08 -0400" MODIFIED_BY="[Empty name]">
<P>RCT (randomized by patient)<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 18:52:08 -0400" MODIFIED_BY="[Empty name]">
<P>home care agencies in United States (New York City and Los Angeles)<BR/>patients with home care services<BR/>patients - 317 (160 intervention group, 157 control group)<BR/>health professional (delivering intervention) - 2<BR/>practice -2<BR/>no unit of analysis error</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-06-04 15:18:36 -0400" MODIFIED_BY="[Empty name]">
<P>targeted towards PATIENTS<BR/>pharmacist, assisted by a patient's nurse, reviewed patient profiles, identified medication problems (related to inappropriate use of H2 blockers, cardiovascular medication, psychotropic medication and NSAIDs); the nurse assisted the patient with the medication changes and monitored the effect. Clinical pharmacists provided nurses with educational materials that explained the background of each of the problems and suggested ways to resolve them.<BR/>targeted towards HEALTH PROFESSIONALS<BR/>pharmacist developed a plan to address therapeutic problems to the patient's physician vs usual care<BR/>length of the intervention - 30 min<BR/>number of interventions - 1 during 6 weeks to 90 days</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-05-21 00:20:09 -0400" MODIFIED_BY="[Empty name]">
<P>PROCESS </P>
<P>improvement in prescribing for any medication use</P>
<P>therapeutic duplication</P>
<P>cardiovascular medication use</P>
<P>psychotropic medication use</P>
<P>NSAIDs use as % of patients</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-03-19 18:10:57 -0400" MODIFIED_BY="Olga Mostovetsky">
<P>nurse presented the plan to physicians for uncomplicated cases and assisted patients with medication changes and monitored their effect</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 18:52:09 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Odegard-2005">
<CHAR_METHODS MODIFIED="2010-06-03 13:54:31 -0400" MODIFIED_BY="[Empty name]">
<P>RCT (randomized by patient)<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 18:52:09 -0400" MODIFIED_BY="[Empty name]">
<P>university affiliated teaching clinic<BR/>outpatient clinic in University of Washington Medicine Neighborhood Clinics, United States<BR/>patients with Type II diabetes<BR/>patients - 77 (43 intervention group, 34 control group)<BR/>health professional (delivering intervention) - not clear<BR/>practice - 8<BR/>no unit of analysis error</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-03-01 15:29:10 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>targeted towards PATIENTS<BR/>pharmacist developed a diabetes care plan and communicated with patients and physicians regarding diabetes care progress vs usual care<BR/>length of the intervention - 10 min per telephone call and 30 min per in-person visit<BR/>number of interventions - average of 4.5 telephone contacts and 2.1 in-person visits during 6 months followed by 6 month usual care follow-up</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-05-21 00:20:09 -0400" MODIFIED_BY="[Empty name]">
<P>PROCESS</P>
<P>not measured<BR/>PATIENT</P>
<P>HbA1C at 6 months (end of intervention) and 12 months (6 months of usual care follow-up)<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 18:52:10 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Okamoto-2001">
<CHAR_METHODS MODIFIED="2010-06-03 13:54:32 -0400" MODIFIED_BY="[Empty name]">
<P>RCT (randomized by patient)<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 18:52:10 -0400" MODIFIED_BY="[Empty name]">
<P>hypertension and general medicine clinics within a managed care facility in United States<BR/>patients with hypertension<BR/>patients - 330 (164 intervention group, 166 control group)<BR/>health professional (delivering intervention) - 1<BR/>practice - not clear<BR/>no unit of analysis error</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-01-28 17:37:59 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>targeted towards PATIENTS<BR/>pharmacist managed treatment of patients with hypertension and obtained consent from physicians for therapy changes vs usual care<BR/>length of the intervention - not clear<BR/>number of interventions - 5 during 6 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-03-02 15:19:30 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>PATIENT<BR/>Blood pressure<BR/>Health-related quality of life using short-form health survey (SF-36)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 18:52:11 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Park-1996">
<CHAR_METHODS MODIFIED="2010-06-03 13:54:34 -0400" MODIFIED_BY="[Empty name]">
<P>RCT (randomized by patient)<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 18:52:11 -0400" MODIFIED_BY="[Empty name]">
<P>two sites of a chain pharmacy in Chicago Ill, United States<BR/>patients with hypertension - 64<BR/>health professionals (delivering intervention) - 2 pharmacy residents<BR/>practices -2 (not studied at the same time)<BR/>no unit of analysis error<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-05-21 00:20:09 -0400" MODIFIED_BY="[Empty name]">
<P>targeted towards PATIENTS<BR/>oral and written education about hypertension, its treatments and risk factors to the patients<BR/>+ recommendation to the physician if necessary<BR/>length of the intervention - 15 to 30 min approximately<BR/>frequency of the intervention - 4 in 4 months<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-04-27 15:57:38 -0400" MODIFIED_BY="[Empty name]">
<P>PROCESS </P>
<P>not measured<BR/>PATIENT<BR/>blood pressure<BR/>compliance (pill count)<BR/>Health Status Questionnaire (HSQ)<BR/>Hypertension/Lipid Form (HTN)<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>the intervention group and control group were different at baseline (for their systolic blood pressure) but the authors did not provide the significance level of this difference</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 18:52:12 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Paulos-2005">
<CHAR_METHODS MODIFIED="2010-06-03 13:54:35 -0400" MODIFIED_BY="[Empty name]">
<P>RCT (randomized by patient)<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 18:52:12 -0400" MODIFIED_BY="[Empty name]">
<P>community pharmacy in Chile<BR/>patients with hyperlipidemia<BR/>patients - 42 (23 in intervention group, 19 in control group)<BR/>health professional (delivering intervention) - 1<BR/>practice - 1<BR/>no unit of analysis error</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-05-21 00:20:09 -0400" MODIFIED_BY="[Empty name]">
<P>targeted towards PATIENTS<BR/>pharmacist measured total blood cholesterol and triglyceride levels and educated patients on cardiovascular disease and risk factors and appropriate medication use vs usual care<BR/>length of the intervention - 20 to 25 min<BR/>number of interventions - 5 during 4 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-05-21 00:20:09 -0400" MODIFIED_BY="[Empty name]">
<P>PROCESS </P>
<P>not measured<BR/>PATIENT<BR/>Total cholesterol levels<BR/>Triglyceride levels<BR/>% of patients with decrease in total cholesterol levels<BR/>% of patients with decrease in triglyceride levels</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-02-27 16:14:58 -0500" MODIFIED_BY="Olga Mostovetsky"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 18:52:12 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Peterson-2004">
<CHAR_METHODS MODIFIED="2010-06-03 13:54:43 -0400" MODIFIED_BY="[Empty name]">
<P>RCT (randomized by patient)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 18:52:12 -0400" MODIFIED_BY="[Empty name]">
<P>acute care teaching hospital (Royal Hobart Hospital) in southern Tasmania, Australia<BR/>patients with cardiovascular disease discharged from the hospital on statin therapy<BR/>patients - 94 (46 intervention, 48 control)<BR/>health professional (delivering intervention) - 1<BR/>practice - 1<BR/>no unit of analysis error</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-02-27 15:39:18 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>targeted towards PATIENTS<BR/>pharmacist conducted home-visits to perform cholesterol measurements, assess medication regimen and educate patients regarding lipid-lowering drug therapy and dietary and life-style modifications vs usual care<BR/>length of the intervention - not clear<BR/>number of interventions - 6 during 6 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-02-27 15:41:40 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>PATIENT<BR/>cholesterol level at follow-up (6 months)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 18:52:14 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rickles-2005">
<CHAR_METHODS MODIFIED="2010-06-04 15:25:09 -0400" MODIFIED_BY="[Empty name]">
<P>RCT (randomized by patient) - randomized, controlled, unblinded, mixed experimental design</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 18:52:14 -0400" MODIFIED_BY="[Empty name]">
<P>community pharmacies within a large managed care organization in Wisconsin, United States<BR/>patients presenting with new antidepressant prescriptions<BR/>patients - 63 (31 intervention, 32 control)<BR/>health professional (delivering intervention) - 14<BR/>practice - 8<BR/>no unit of analysis error</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-05-21 00:20:09 -0400" MODIFIED_BY="[Empty name]">
<P>targeted towards PATIENTS<BR/>pharmacist provided monthly telephone-based education on antidepressant use and goal of therapy and monitoring of adverse effects and adherence vs usual care<BR/>length of the intervention - 19, 12, and 11 min for first, second, and third phone call, respectively<BR/>number of interventions - 3 during 3 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-02-26 18:43:27 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>PATIENT<BR/>greater than 50% improvement in depression symptoms measured with Beck Depression Inventory-II (BDI-II) instrument</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-03-21 19:36:45 -0400" MODIFIED_BY="Olga Mostovetsky">
<P>-past use of psychiatric medications was different between groups at baseline<BR/>-study was powered to detect compliance outcomes only</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 18:52:15 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sadik-2005">
<CHAR_METHODS MODIFIED="2010-06-03 13:55:09 -0400" MODIFIED_BY="[Empty name]">
<P>RCT (randomized by patient)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 18:52:15 -0400" MODIFIED_BY="[Empty name]">
<P>outpatient clinic in Al-Ain Hospital, Al-Ain, UAE<BR/>patients with heart failure (HF)<BR/>patients - 221 (intervention 109, control 112)<BR/>health professional (delivering intervention) - 1<BR/>practice - 1<BR/>no unit of analysis error</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-06-04 15:27:07 -0400" MODIFIED_BY="[Empty name]">
<P>targeted towards PATIENTS<BR/>pharmacist providing patient education regarding HF medications and disease management during clinic follow-up visits, printed booklet on HF, symptom monitoring diary card<BR/>targeted towards HEALTH PROFESSIONALS<BR/>pharmacist discussed drug therapy with patients' physicians vs usual care<BR/>length of the intervention - not clear<BR/>number of interventions - 5 during 12 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-06-04 15:27:15 -0400" MODIFIED_BY="[Empty name]">
<P>PATIENT<BR/>mean distance walked in 2 min test<BR/>QOL (quality of life) using SF-36 questionnaire<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-06-07 11:36:36 -0400" MODIFIED_BY="[Empty name]">
<P>Patients were recruited from the hospital ward and hospital outpatient clinic; intervention took place in hospital outpatient clinic</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 18:52:15 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sarkadi-2004">
<CHAR_METHODS MODIFIED="2010-06-04 15:28:26 -0400" MODIFIED_BY="[Empty name]">
<P>RCT (randomized by patient)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 18:52:15 -0400" MODIFIED_BY="[Empty name]">
<P>community pharmacies in Sweden<BR/>patients with diabetes mellitus Type II<BR/>patients - 64 (intervention 33, control 31)<BR/>health professional (delivering intervention) - unclear<BR/>practice - unclear<BR/>no unit of analysis error</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-06-10 17:39:18 -0400" MODIFIED_BY="[Empty name]">
<P>targeted towards PATIENTS<BR/>pharmacist led an educational program using a video, a dice game and a booklet on diabetes management to promote dietary modifications, exercise and blood glucose control and referred patients to health professionals in cases of unsatisfactory glucose control vs no intervention<BR/>length of the intervention - unclear<BR/>number of interventions - 3 during 1 year; 1 year follow-up after intervention completion</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-03-13 18:20:19 -0400" MODIFIED_BY="Olga Mostovetsky">
<P>PATIENT<BR/>HbA1c at 12 months (end of study)<BR/>HbA1c at 24 months (follow-up)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-03-13 18:20:51 -0400" MODIFIED_BY="Olga Mostovetsky">
<P>Pharmacist led educational group had assistance from a diabetes nurse specialist on the first two occasions; patients were self-referred to the program</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 18:52:16 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schneider-1982">
<CHAR_METHODS MODIFIED="2010-06-03 14:02:19 -0400" MODIFIED_BY="[Empty name]">
<P>RCT (randomized by patient)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 18:52:16 -0400" MODIFIED_BY="[Empty name]">
<P>outpatient medicine clinic at the University Hospital Clinic, University Hospital, Ohio State University<BR/>patients with essential hypertension and congestive heart failure<BR/>patients - 40 (intervention 20, control 20)<BR/>health professional (delivering intervention) - 1<BR/>practice - 1<BR/>no unit of analysis error</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-06-07 08:15:26 -0400" MODIFIED_BY="[Empty name]">
<P>targeted towards PATIENTS<BR/>pharmacist examined and evaluated patients during a clinic visit<BR/>targeted towards HEALTH PROFESSIONALS<BR/>pharmacist communicated findings and suggestions to physician vs usual care<BR/>length of intervention - 12 months<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-03-13 18:22:36 -0400" MODIFIED_BY="Olga Mostovetsky">
<P>PATIENT<BR/>systolic and diastolic blood pressure</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-03-04 14:31:15 -0500" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 18:52:18 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Solomon-1998">
<CHAR_METHODS MODIFIED="2010-06-03 14:02:22 -0400" MODIFIED_BY="[Empty name]">
<P>RCT (randomized by patient)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 18:52:18 -0400" MODIFIED_BY="[Empty name]">
<P>outpatient clinics at 10 Veterans Administration Medical Centers and 1 university hospital in United States<BR/>patients with hypertension and/or COPD<BR/>patients - hypertension arm 133 (intervention 63, control 70); COPD arm 98 (intervention 43, control 55)<BR/>health professionals - not clear<BR/>practices - 11<BR/>no unit of analysis error</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-05-21 00:20:10 -0400" MODIFIED_BY="[Empty name]">
<P>targeted towards PATIENTS<BR/>pharmacist provided clinical pharmaceutical care services vs usual care<BR/>length of intervention - approximately 60 minutes for initial visits, 30 minutes for follow-up visits<BR/>number of interventions - monthly visits over 6 months<BR/>no unit of analysis error<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-03-13 18:27:43 -0400" MODIFIED_BY="Olga Mostovetsky">
<P>PATIENT<BR/>blood pressure (hypertension arm)<BR/>Borg Scale (COPD arm)<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-06-07 08:16:03 -0400" MODIFIED_BY="[Empty name]">
<P>-pharmaceutical care services included clinical management of hypertension and COPD via standardized patient assessment activities, pharmacists' involvement with the health care team, collaboration with physicians to develop patient-specific plan, patient education on hypertension and COPD, counseling to address patients' questions or concerns, and regular patient assessments and care<BR/>-intention-to-treat analysis not done (number of patients reported is number of patients analyzed; number of patients randomized not clear)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 18:52:20 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sookaneknun-2004">
<CHAR_METHODS MODIFIED="2010-06-03 14:02:25 -0400" MODIFIED_BY="[Empty name]">
<P>RCT (randomized by patient)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 18:52:20 -0400" MODIFIED_BY="[Empty name]">
<P>university-affiliated community pharmacy and 2 primary care units in Thailand (Mahasarakham, Takonyarng village, Kharmrieng village)<BR/>patients with hypertension<BR/>patients -235 (intervention 118, control 117)<BR/>health professionals - not clear<BR/>practices - 3<BR/>no unit of analysis error</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-06-07 08:17:18 -0400" MODIFIED_BY="[Empty name]">
<P>targeted towards PATIENTS<BR/>pharmacist provided monthly consultation and blood pressure monitoring vs usual care<BR/>targeted towards HEALTH PROFESSIONALS<BR/>pharmacist made medication regimen change recommendations to physicians after identifying drug-related problems<BR/>length of the intervention - 30 to 50 minutes<BR/>number of interventions - 6 (monthly) during 6 months<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-03-13 18:59:18 -0400" MODIFIED_BY="Olga Mostovetsky">
<P>PATIENT<BR/>blood pressure</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-03-13 19:04:44 -0400" MODIFIED_BY="Olga Mostovetsky"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 18:52:21 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Stergachis-1987">
<CHAR_METHODS MODIFIED="2010-06-03 14:02:28 -0400" MODIFIED_BY="[Empty name]">
<P>RCT (randomized by clinic)<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 18:52:21 -0400" MODIFIED_BY="[Empty name]">
<P>outpatient primary care clinic that is part of a managed care organization in the United States (Washington)<BR/>patients receiving NSAIDS and salicylates<BR/>patients - not clear<BR/>health professionals - 2 pharmacists, 17 physicians<BR/>practices - 2<BR/>no unit of analysis error</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-06-07 08:20:40 -0400" MODIFIED_BY="[Empty name]">
<P>targeted towards PATIENTS (minimal) AND HEALTH PROFESSIONALS (primary intervention)<BR/>
<BR/>pharmacist in family practice clinic provided educational/drug monitoring services to physicians and counseling to patients vs usual care<BR/>length of intervention - 6 months<BR/>product related</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-06-03 13:56:15 -0400" MODIFIED_BY="[Empty name]">
<P>PROCESS<BR/>number of prescriptions<BR/>drug ingredient costs<BR/>operating cost of clinical pharmacy program<BR/>PATIENT<BR/>not measured</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-06-07 11:36:40 -0400" MODIFIED_BY="[Empty name]">
<P>This was one of few studies that included an assessment of the cost of the intervention</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 18:52:22 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Taylor-2003">
<CHAR_METHODS MODIFIED="2010-06-03 13:56:20 -0400" MODIFIED_BY="[Empty name]">
<P>RCT (randomized by patient)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 18:52:22 -0400" MODIFIED_BY="[Empty name]">
<P>University of Alabama School of Medicine affiliated outpatient clinics in Alabama, United States<BR/>patients with high risk for medication-related adverse effects (&#8805; 3 of the following: 5 or more medications, 12 or more doses/day, 4 or more medication changes in previous year, 3 or more concurrent diseases, history of medication noncompliance, drugs requiring therapeutic monitoring)<BR/>patients - 81 patients enrolled (12 lost to follow-up); Study analyses based on 69 (33 intervention, 36 control)<BR/>health professional (delivering intervention) - 4<BR/>practice - 3<BR/>no unit of analysis error</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-02-26 20:30:37 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>targeted towards PATIENTS<BR/>pharmacist performed pharmaceutical care including chart and medication review, patient education and therapeutic monitoring vs usual care<BR/>length of the intervention - 20 min<BR/>number of interventions - multiple during 12 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-06-07 08:23:59 -0400" MODIFIED_BY="[Empty name]">
<P>PROCESS<BR/>Number of prescribed medications at 12 months<BR/>Number of inappropriate prescriptions for various MAI domains<BR/>PATIENT<BR/>patients at goal for hypertension<BR/>patients at goal for diabetes<BR/>patients at goal for dyslipidemia<BR/>patients at goal for anticoagulation<BR/>QOL using SF-36 questionnaire</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-06-07 11:38:43 -0400" MODIFIED_BY="[Empty name]">
<P>Number of patients randomized not explicitly mentioned (appears to be 81) - not intention-to-treat analysis. Analysis based on number of patients who completed the study</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 18:52:23 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tsuyuki-2002">
<CHAR_METHODS MODIFIED="2010-06-03 14:02:32 -0400" MODIFIED_BY="[Empty name]">
<P>RCT (randomized by patient)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 18:52:23 -0400" MODIFIED_BY="[Empty name]">
<P>community pharmacies in 2 provinces of Canada: Alberta and Saskatchewan<BR/>patients at high risk for cardiovascular disease: previous acute myocardial infarction, stable or unstable angina, coronary revascularization, cerebral or peripheral vascular disease, diabetes mellitus with at least 1 other cardiovascular risk factor (cigarette smoking, hypertension, positive family history of premature cardiovascular disease, obesity, sedentary lifestyle, hypercholesterolemia, male &gt; 45 years old, female &gt; 55 years old)<BR/>patients - 675 (344 intervention, 331 control)<BR/>health professional (delivering intervention) - unclear<BR/>practice - 54<BR/>no unit of analysis error</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-06-07 08:27:35 -0400" MODIFIED_BY="[Empty name]">
<P>targeted towards PATIENTS<BR/>pharmacist provided regular follow-ups to perform point-of-care cholesterol testing and educate patients regarding cardiovascular risk factors using patient brochure developed by Alberta Medical Association and the Clinical Quality Improvement Network<BR/>targeted towards HEALTH PROFESSIONALS<BR/>pharmacists faxed recommendations to patients' primary physician regarding disease management and testing<BR/>length of intervention - not clear<BR/>number of interventions - 5 episodes during 12 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-06-03 13:56:45 -0400" MODIFIED_BY="[Empty name]">
<P>PROCESS<BR/># of new prescribed cholesterol-lowering medications<BR/># of modified pre-existing cholesterol-lowering medications<BR/>PATIENT<BR/>patients at goal for hyperlipidemia</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-06-07 11:36:44 -0400" MODIFIED_BY="[Empty name]">
<P>-Tsuyuki 1999 is a companion paper for this study; <LINK REF="STD-Simpson-2001" TYPE="STUDY">Simpson 2001</LINK>; <LINK REF="STD-Simpson-2004" TYPE="STUDY">Simpson 2004</LINK> are planned subgroup analyses of this paper.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 18:52:24 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Turner-2000">
<CHAR_METHODS MODIFIED="2010-06-03 13:57:00 -0400" MODIFIED_BY="[Empty name]">
<P>RCT (randomized by practice)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 18:52:24 -0400" MODIFIED_BY="[Empty name]">
<P>outpatient practices in Avalon Peninsula, Newfoundland, Canada<BR/>all physicians in the region were invited to participate in the study; intervention focused on physicians treating CHF (congestive heart failure) patients<BR/>patients - not clear<BR/>health professional (delivering intervention) - not clear<BR/>practice - 72<BR/>unit of analysis error (no correction)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-06-07 08:30:08 -0400" MODIFIED_BY="[Empty name]">
<P>targeted towards HEALTH PROFESSIONALS<BR/>pharmacist provided academic detailing to physicians on use and dosage of ACEIs and ARBs for prevention and management of CHF using Canadian consensus guidelines on management of CHF vs no intervention<BR/>length of the intervention - not clear<BR/>number of interventions - 1 during 3 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-02-26 19:08:54 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>PROCESS<BR/>utilization of ACEIs in patient receiving digoxin and furosemide for CHF<BR/>targeted daily dose of ACEIs</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-02-26 19:17:38 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>Number of patients allocated to each group not reported <BR/>Statistical analysis of results did not account for clustering and unit of analysis error</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 18:52:25 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Van-Veldhuizen-1995">
<CHAR_METHODS MODIFIED="2009-02-13 17:47:17 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>RCT (by patient)<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 18:52:25 -0400" MODIFIED_BY="[Empty name]">
<P>outpatient diabetes center in United States (Indiana)<BR/>diabetic patients<BR/>patients - 41<BR/>health professionals - 1<BR/>practices - 1<BR/>no unit of analysis error</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-05-21 00:20:10 -0400" MODIFIED_BY="[Empty name]">
<P>targeted towards PATIENTS<BR/>1-on-1 interaction with pharmacist plus follow-up vs group education from pharmacist vs standard education.<BR/>
<BR/>length of intervention - 2 months<BR/>product related<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>PROCESS<BR/>not measured<BR/>PATIENT<BR/>knowledge of diabetes<BR/>perception/attitudes towards diabetes, therapy, pharmacists<BR/>blood glucose levels</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-10 18:52:25 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Watson-2001">
<CHAR_METHODS MODIFIED="2010-06-03 13:57:15 -0400" MODIFIED_BY="[Empty name]">
<P>cluster RCT (randomized by practice)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 18:52:25 -0400" MODIFIED_BY="[Empty name]">
<P>university affiliated teaching clinic<BR/>outpatient general practices in Avon, United Kingdom<BR/>health professional (delivering intervention) - 3<BR/>practice - 20<BR/>no unit of analysis error</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-06-07 08:34:43 -0400" MODIFIED_BY="[Empty name]">
<P>targeted towards HEALTH PROFESSIONALS<BR/>pharmacist performed educational outreach visits to promote mailed practice guideline on NSAID use vs mailed practice guideline alone vs no intervention<BR/>length of the intervention - less than 10 minutes<BR/>number of interventions - 2 during 12 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-02-26 19:56:47 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>PROCESS<BR/>change in volume of prescribing for ibuprofen, diclofenac and naproxen as % of total NSAID prescribing</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-06-11 13:57:50 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Weinberger-2002">
<CHAR_METHODS MODIFIED="2009-02-23 16:33:39 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>RCT (by practice - 36 drugstores divided into 12 clusters of 3 geographically proximal drugstores)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-10 18:52:26 -0400" MODIFIED_BY="[Empty name]">
<P>CVS community pharmacies in Indianapolis, United States<BR/>patients with COPD and asthma<BR/>patients - 1113<BR/>asthma - 660 (pharmaceutical care program 262, peak flow monitoring control 233, usual care control 165)<BR/>COPD - 453 (pharmaceutical care program 185, peak flow monitoring control 130, usual care control 138)<BR/>health professional (delivering intervention) - not clear<BR/>practice - 36<BR/>unit of analysis error (randomized by practice, analyzed by patient)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-06-07 08:38:21 -0400" MODIFIED_BY="[Empty name]">
<P>targeted towards PATIENTS<BR/>pharmaceutical care (patients received peak flow monitor + instructions for use, written educational materials, and monthly telephone calls from research personnel to collect PEFR results; pharmacist assessed PEFR results and other relevant medical information (medications, refill history, emergency department visits and hospitalizations) and implemented pharmaceutical care activities) vs peak flow monitoring (patients received peak flow monitors and instructions for use and monthly telephone calls from research personnel to collect peak flow PEFR results (results were not seen by the pharmacist)) vs usual care (patients did not receive peak flow monitors but received monthly follow-up phone calls from research personnel)<BR/>length of the intervention - not clear<BR/>number of interventions - mean 19.4 in asthma, 22.4 in COPD patients during 12 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-06-07 08:39:24 -0400" MODIFIED_BY="[Empty name]">
<P>PATIENT<BR/>peak flow rate (PEFR) (combined for asthma and COPD patients) at 12 months<BR/>HRQOL (health-related quality of life) for asthma patients at 12 months<BR/>HRQOL for COPD patients at 12 months</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-06-11 13:57:50 -0400" MODIFIED_BY="[Empty name]">
<P>No statistical analysis done to adjust for unit of analysis error</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2010-06-07 11:38:42 -0400" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2009-02-04 18:41:40 -0500" MODIFIED_BY="Olga Mostovetsky" STUDY_ID="STD-Abramowitz-1982">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-04 18:41:40 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>Hospital-based intervention</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-13 17:51:29 -0500" MODIFIED_BY="Olga Mostovetsky" STUDY_ID="STD-Bogden-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-13 17:51:29 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-04 18:42:41 -0500" MODIFIED_BY="Olga Mostovetsky" STUDY_ID="STD-Bolas-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-04 18:42:41 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>Hospital-based intervention</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-04 18:44:06 -0500" MODIFIED_BY="Olga Mostovetsky" STUDY_ID="STD-Bouvy-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-04 18:44:06 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>Subjective primary outcome</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-13 17:51:32 -0500" MODIFIED_BY="Olga Mostovetsky" STUDY_ID="STD-Bozovich-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-13 17:51:32 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-04 18:44:03 -0500" MODIFIED_BY="Olga Mostovetsky" STUDY_ID="STD-Brook-2003b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-04 18:44:03 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>Subjective primary outcomes</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-04 18:43:56 -0500" MODIFIED_BY="Olga Mostovetsky" STUDY_ID="STD-Brook-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-04 18:43:56 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>Subjective primary outcome</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-22 19:53:32 -0500" MODIFIED_BY="Olga Mostovetsky" STUDY_ID="STD-Bucci-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-22 19:53:32 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>Intervention not performed solely by pharmacist - patients followed by a multidisciplinary team including a pharmacist</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-05-20 18:27:27 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Charrois-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-05-20 18:27:27 -0400" MODIFIED_BY="[Empty name]">
<P>Design paper - no results reported. A search was performed for the completed manuscript. The completed manuscript was found by searching for studies that referenced the original design paper. The completed manuscript is not indexed in PubMed; it is in the <LINK TAG="AWAITING_STUDIES" TYPE="SECTION">Studies awaiting classification</LINK> section and will be coded in Phase II.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-04 18:47:15 -0500" MODIFIED_BY="Olga Mostovetsky" STUDY_ID="STD-Chisholm-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-04 18:47:15 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>Relevant and interpretable data are not presented</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-15 20:48:31 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cowper-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-15 20:48:31 -0400" MODIFIED_BY="[Empty name]">
<P>Economic data only reported as primary outcomes</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-05-19 13:36:43 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Davidson-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-05-19 13:36:43 -0400" MODIFIED_BY="[Empty name]">
<P>Not RCT (experimental gp-not prospectively assigned)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-15 20:48:31 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-de-Maat-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-15 20:48:31 -0400" MODIFIED_BY="[Empty name]">
<P>Sequential study design</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-04 19:33:13 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-De-Tullio-1987a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-04 19:33:13 -0400" MODIFIED_BY="[Empty name]">
<P>Subjective primary outcome</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-13 17:51:40 -0500" MODIFIED_BY="Olga Mostovetsky" STUDY_ID="STD-De-Tullio-1987b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-13 17:51:40 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>Not RCT </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-13 17:51:44 -0500" MODIFIED_BY="Olga Mostovetsky" STUDY_ID="STD-Erickson-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-13 17:51:44 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>Not RCT </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-15 20:48:32 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fischer-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-15 20:48:32 -0400" MODIFIED_BY="[Empty name]">
<P>Resource utilization and costs only reported as primary outcomes</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-06-07 11:36:50 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fornos-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-06-07 11:36:50 -0400" MODIFIED_BY="[Empty name]">
<P>Design paper - no results reported. Manuscript for completed study is in <LINK TAG="AWAITING_STUDIES" TYPE="SECTION">Studies awaiting classification</LINK> section</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-15 20:48:32 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Forstrom-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-15 20:48:32 -0400" MODIFIED_BY="[Empty name]">
<P>Costs only reported as primary outcomes</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Garnett-1981">
<CHAR_REASON_FOR_EXCLUSION>
<P>Patient self-reported data</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-06-07 11:38:42 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gourley-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-06-07 11:38:42 -0400" MODIFIED_BY="[Empty name]">
<P>Subgroup analysis of <LINK REF="STD-Solomon-1998" TYPE="STUDY">Solomon 1998</LINK>; focused on humanistic outcomes only</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Helling-1979">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT<BR/>Subjective outcome measure - patient satisfaction only was measured</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-04 18:57:45 -0500" MODIFIED_BY="Olga Mostovetsky" STUDY_ID="STD-Holland-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-04 18:57:45 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>Subjective primary outcomes</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Ibrahim-1990">
<CHAR_REASON_FOR_EXCLUSION>
<P>No control group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-24 16:53:33 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jameson-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-24 16:53:33 -0500" MODIFIED_BY="[Empty name]">
<P>Subjective primary outcome - adverse effect and symptom score self reported by patients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Johnson-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Patient self-reported data</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-15 20:48:32 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jones-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-15 20:48:32 -0400" MODIFIED_BY="[Empty name]">
<P>Costs only reported as primary outcomes</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-04 18:58:28 -0500" MODIFIED_BY="Olga Mostovetsky" STUDY_ID="STD-Karki-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-04 18:58:28 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>Hospital-based intervention</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-14 21:14:15 -0500" MODIFIED_BY="Olga Mostovetsky" STUDY_ID="STD-Knoell-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-14 21:14:15 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-24 16:53:38 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Krska-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-24 16:53:38 -0500" MODIFIED_BY="[Empty name]">
<P>Subjective primary outcome - pharmaceutical care issues identified by pharmacist</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-13 17:50:08 -0500" MODIFIED_BY="Olga Mostovetsky" STUDY_ID="STD-Lai-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-13 17:50:08 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>Not RCT </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-15 20:48:32 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Law-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-15 20:48:32 -0400" MODIFIED_BY="[Empty name]">
<P>Cost-savings only reported as primary outcome</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-03-02 18:15:32 -0500" MODIFIED_BY="Olga Mostovetsky" STUDY_ID="STD-Lim-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-03-02 18:15:32 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>Relevant and interpretable data not reported for primary outcome</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-15 20:48:32 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Malone-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-15 20:48:32 -0400" MODIFIED_BY="[Empty name]">
<P>Economic analysis only reported as primary outcome</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-13 17:50:21 -0500" MODIFIED_BY="Olga Mostovetsky" STUDY_ID="STD-Malone-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-13 17:50:21 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-04 19:35:11 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-McKenney-1973">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-04 19:35:11 -0400" MODIFIED_BY="[Empty name]">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-05-20 18:51:54 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Murray-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-05-20 18:51:54 -0400" MODIFIED_BY="[Empty name]">
<P>Intervention not primarily performed by a pharmacist</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-05-20 23:01:14 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Murray-2004a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-05-20 23:01:14 -0400" MODIFIED_BY="[Empty name]">
<P>Design paper - no results presented; Manuscript for completed study is in <LINK TAG="AWAITING_STUDIES" TYPE="SECTION">Studies awaiting classification</LINK> section.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-13 17:50:37 -0500" MODIFIED_BY="Olga Mostovetsky" STUDY_ID="STD-Peterson-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-13 17:50:37 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>Not RCT </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-13 17:50:46 -0500" MODIFIED_BY="Olga Mostovetsky" STUDY_ID="STD-Peterson-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-13 17:50:46 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-13 17:50:53 -0500" MODIFIED_BY="Olga Mostovetsky" STUDY_ID="STD-Peterson-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-13 17:50:53 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>Not RCT </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-13 17:50:57 -0500" MODIFIED_BY="Olga Mostovetsky" STUDY_ID="STD-Powers-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-13 17:50:57 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>Not RCT </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Raisch-1990">
<CHAR_REASON_FOR_EXCLUSION>
<P>All three comparison groups included a pharmacist intervention, therefore there was no relevant control group for this review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-04 20:30:23 -0500" MODIFIED_BY="Olga Mostovetsky" STUDY_ID="STD-Rathbun-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-04 20:30:23 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>Subjective primary outcome (medication compliance)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-13 17:51:04 -0500" MODIFIED_BY="Olga Mostovetsky" STUDY_ID="STD-Rodgers-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-13 17:51:04 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-15 20:48:33 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rogers-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-15 20:48:33 -0400" MODIFIED_BY="[Empty name]">
<P>Cost-savings only reported as primary outcomes</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-13 17:51:09 -0500" MODIFIED_BY="Olga Mostovetsky" STUDY_ID="STD-Schaffner-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-13 17:51:09 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>Not RCT </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-22 20:03:26 -0500" MODIFIED_BY="Olga Mostovetsky" STUDY_ID="STD-Sczupak-1977">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-22 20:03:26 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>Results not interpretable </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-22 20:11:02 -0500" MODIFIED_BY="Olga Mostovetsky" STUDY_ID="STD-Sellors-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-22 20:11:02 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>Results not interpretable - no baseline data</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-22 20:11:37 -0500" MODIFIED_BY="Olga Mostovetsky" STUDY_ID="STD-Sellors-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-22 20:11:37 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>Results not interpretable - no baseline data</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-04 20:31:40 -0500" MODIFIED_BY="Olga Mostovetsky" STUDY_ID="STD-Shaw-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-04 20:31:40 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>Hospital-based intervention</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-06-07 08:46:17 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shibley-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-06-07 08:46:17 -0400" MODIFIED_BY="[Empty name]">
<P>Patients served as their own control</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-04 19:38:13 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sidel-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-04 19:38:13 -0400" MODIFIED_BY="[Empty name]">
<P>Subjective primary outcome</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-04 20:32:42 -0500" MODIFIED_BY="Olga Mostovetsky" STUDY_ID="STD-Simpson-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-04 20:32:42 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>Subgroup analysis</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-04 20:32:48 -0500" MODIFIED_BY="Olga Mostovetsky" STUDY_ID="STD-Simpson-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-04 20:32:48 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>Subgroup analysis</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-15 20:48:33 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Smith-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-15 20:48:33 -0400" MODIFIED_BY="[Empty name]">
<P>Cost-savings only reported as primary outcome</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-15 20:48:33 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Soumerai-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-15 20:48:33 -0400" MODIFIED_BY="[Empty name]">
<P>Cost-savings only reported as primary outcome</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-15 20:48:33 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Steele-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-15 20:48:33 -0400" MODIFIED_BY="[Empty name]">
<P>Cost-savings only reported as primary outcome</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-13 17:51:16 -0500" MODIFIED_BY="Olga Mostovetsky" STUDY_ID="STD-Tamai-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-13 17:51:16 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>Not RCT </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-04 20:33:31 -0500" MODIFIED_BY="Olga Mostovetsky" STUDY_ID="STD-Varma-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-04 20:33:31 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>Hospital-based intervention</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-04 20:34:24 -0500" MODIFIED_BY="Olga Mostovetsky" STUDY_ID="STD-Vrijens-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-04 20:34:24 -0500" MODIFIED_BY="Olga Mostovetsky">
<P>Subjective primary outcome (medication compliance)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-04 19:39:09 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wandless-1981">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-04 19:39:09 -0400" MODIFIED_BY="[Empty name]">
<P>Subjective primary outcome (medication compliance)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-13 18:54:29 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yamada-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-13 18:54:29 -0400" MODIFIED_BY="[Empty name]">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-24 16:53:59 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zermansky-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-24 16:53:59 -0500" MODIFIED_BY="[Empty name]">
<P>Primary outcome not relevant - number of changes to prescriptions over one year</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2010-05-20 23:14:17 -0400" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR STUDY_ID="STD-Bond-2007">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Bond-2007a">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Cameron-2006">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Carter-2008">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Carter-2009">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Chan-2006">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Charrois-2006">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Chisholm-2002">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Cordina-2001">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Faulkner-2000">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Feldstein-2006">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Fornos-2006">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Hay-2006">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Hennessy-2006">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Kritikos-2007">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Kwan-2007">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Lopez-2006">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Maguire-2001">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Murray-2007">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Raebel-2005">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Raebel-2006">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Raebel-2007">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Rehring-2006">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Reid-2005">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Rothman-2005">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Simon-2000">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Stergachis-2002">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Sturgess-2003">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Vivian-2002">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Volume-2001">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Welschen-2004">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Wiedemer-2007">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Wu-2006">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Yuan-2003">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Zillich-2005">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2009-07-04 19:22:36 -0400" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2010-06-11 13:55:12 -0400" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2010-06-11 13:55:12 -0400" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-03 13:49:30 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Barbanel-2003">
<DESCRIPTION>
<P>Patients were randomized using sealed envelopes to intervention or control groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-03 13:49:51 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bogden-1997">
<DESCRIPTION>
<P>Authors report randomization by last digit of social security number (even vs odd)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-18 14:48:00 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bond-2000">
<DESCRIPTION>
<P>Random number tables were used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:17:32 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Borenstein-2003">
<DESCRIPTION>
<P>Not explicitly mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-04 14:07:29 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Brook-2003a">
<DESCRIPTION>
<P>Randomization used "block randomization"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-18 19:00:17 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Capoccia-2004">
<DESCRIPTION>
<P>Not explicitly mentioned in paper</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-03 13:51:04 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Choe-2005">
<DESCRIPTION>
<P>Unit of randomization by patient; drew numbers (0 or 1) from a container</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-04 14:20:19 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Clifford-2005">
<DESCRIPTION>
<P>"randomised...by consecutive allocation"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-03 13:51:22 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cody-1998">
<DESCRIPTION>
<P>Not explicitly described; appears to have been performed via a central randomized scheme/computer system</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 13:43:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Diwan-1995">
<DESCRIPTION>
<P>Coin toss</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-02-27 19:06:34 -0500" MODIFIED_BY="Olga Mostovetsky" RESULT="UNKNOWN" STUDY_ID="STD-Finley-2003">
<DESCRIPTION>
<P>used "sealed envelopes", no mention of whether envelopes were opaque</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-02-27 20:19:53 -0500" MODIFIED_BY="Olga Mostovetsky" RESULT="YES" STUDY_ID="STD-Freemantle-2002">
<DESCRIPTION>
<P>health authorities allocated in pairs through a central random process</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-04 14:47:24 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gattis-1999">
<DESCRIPTION>
<P>"computer generated randomization scheme"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-08-04 22:29:17 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gonzalez_x002d_Martin-2003">
<DESCRIPTION>
<P>Allocation procedure not described explicitly</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-08-04 22:28:11 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Goodyer-1995">
<DESCRIPTION>
<P>Allocation procedure not described explicitly</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-04 14:51:50 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hall-2001">
<DESCRIPTION>
<P>"computer generated random number list"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 14:51:44 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hanlon-1996">
<DESCRIPTION>
<P>Randomised using a computer generated scheme</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-08-04 22:22:49 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hawkins-1979">
<DESCRIPTION>
<P>Allocation procedure not described explicitly </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:26 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ilett-2000">
<DESCRIPTION>
<P>Not explicitly described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-08-04 22:51:16 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jaber-1996">
<DESCRIPTION>
<P>Allocation procedure not described explicitly</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-11 13:55:12 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jackson-2004">
<DESCRIPTION>
<P>Patients were home-based; allocation was likely adequately concealed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-04 15:13:45 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jameson-1995">
<DESCRIPTION>
<P>"Randomised by a simple coin toss"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-04 15:15:40 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Malone-2001">
<DESCRIPTION>
<P>"Were randomised by a central coordinating centre"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-04 15:17:12 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mehos-2000">
<DESCRIPTION>
<P>"randomized using a deck of cards". Unclear how this concealed allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-04 15:19:32 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meredith-2002">
<DESCRIPTION>
<P>"Coordinating centre randomised eligible patients using balanced block randomisation"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:26 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Odegard-2005">
<DESCRIPTION>
<P>Not explicitly described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:28 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Okamoto-2001">
<DESCRIPTION>
<P>Not explicitly described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-08-04 22:48:15 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Park-1996">
<DESCRIPTION>
<P>Allocation procedure not described explicitly</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-04 15:24:32 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Paulos-2005">
<DESCRIPTION>
<P>Randomization and allocation process was not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-04 15:24:55 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peterson-2004">
<DESCRIPTION>
<P>"Computer-generated list of random numbers"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-02-26 18:56:39 -0500" MODIFIED_BY="Olga Mostovetsky" RESULT="UNKNOWN" STUDY_ID="STD-Rickles-2005">
<DESCRIPTION>
<P>assignment sealed in an envelope; envelope not reported as "opaque"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-07 11:38:45 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sadik-2005">
<DESCRIPTION>
<P>Not explicitly described. Manuscript cited a reference from 1981 for randomization method (minimization methods)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-04 15:29:32 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sarkadi-2004">
<DESCRIPTION>
<P>"An assistant mixed envelopes in a box, took them out one at a time, and randomly placed them into 2 piles. A third person, acting as a witness, pointed out which pile should be allocated to the intervention group and which pile to the control group"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:29 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schneider-1982">
<DESCRIPTION>
<P>Not explicitly described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-07 08:16:27 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Solomon-1998">
<DESCRIPTION>
<P>"Table of random numbers"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-07 11:36:39 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sookaneknun-2004">
<DESCRIPTION>
<P>Not explicitly described (Per study - "Simple randomization technique was used")</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-08-04 22:47:22 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stergachis-1987">
<DESCRIPTION>
<P>Allocation procedure not described explicitly</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:31 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Taylor-2003">
<DESCRIPTION>
<P>Not explicitly described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-07 08:28:37 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tsuyuki-2002">
<DESCRIPTION>
<P>"Computer generated sequence using block randomization (block size of 4) with stratification by study centre (pharmacy)"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:31 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Turner-2000">
<DESCRIPTION>
<P>Not explicitly described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:31 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Van-Veldhuizen-1995">
<DESCRIPTION>
<P>Not explicitly described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:32 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Watson-2001">
<DESCRIPTION>
<P>Not explicitly described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-07 08:40:23 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weinberger-2002">
<DESCRIPTION>
<P>"Used a randomized number chart"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2010-06-07 11:39:42 -0400" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-02-20 12:01:48 -0500" MODIFIED_BY="Olga Mostovetsky" RESULT="YES" STUDY_ID="STD-Barbanel-2003">
<DESCRIPTION>
<P>Outcome variables are objective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-05-18 14:41:09 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bogden-1997">
<DESCRIPTION>
<P>Objective outcomes assessed-total cholesterol </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-05-18 15:33:28 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bond-2000">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-05-18 15:37:08 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Borenstein-2003">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-06-04 14:07:40 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Brook-2003a">
<DESCRIPTION>
<P>"Neither patients nor pharmacists were blinded for group assignment; could potentially impact patient self-rating.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-05-18 17:50:03 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Capoccia-2004">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-05-18 19:03:22 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Choe-2005">
<DESCRIPTION>
<P>Objective outcome measure</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-05-19 13:29:31 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Clifford-2005">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-06-07 11:39:42 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cody-1998">
<DESCRIPTION>
<P>Objective outcome assessed; nature of study design appears to have ensured blinding - patients were randomly assigned to separate pharmacies with a more comprehensive consultation model</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-05-19 13:43:55 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Diwan-1995">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-02-27 19:06:38 -0500" MODIFIED_BY="Olga Mostovetsky" RESULT="YES" STUDY_ID="STD-Finley-2003">
<DESCRIPTION>
<P>objective primary outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-02-27 20:20:13 -0500" MODIFIED_BY="Olga Mostovetsky" RESULT="YES" STUDY_ID="STD-Freemantle-2002">
<DESCRIPTION>
<P>objective measures</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-05-19 14:08:10 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gattis-1999">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-05-20 16:59:20 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gonzalez_x002d_Martin-2003">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-05-19 14:19:10 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Goodyer-1995">
<DESCRIPTION>
<P>Physician performing clinical assessment was blinded; outcome collected for the purpose of this review is objective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-05-19 14:30:40 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hall-2001">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-05-19 14:47:26 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hanlon-1996">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-05-19 14:55:08 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hawkins-1979">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-05-19 18:23:14 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ilett-2000">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-05-19 18:30:26 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jaber-1996">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-05-19 18:40:36 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jackson-2004">
<DESCRIPTION>
<P>Objective outcomes assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-05-20 13:03:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jameson-1995">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-05-19 19:03:30 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Malone-2001">
<DESCRIPTION>
<P>Objective outcomes assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-05-19 19:08:15 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mehos-2000">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-05-19 19:14:46 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meredith-2002">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-05-19 19:30:57 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Odegard-2005">
<DESCRIPTION>
<P>Objective outcome measure</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-05-19 19:40:06 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Okamoto-2001">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-05-19 19:51:48 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Park-1996">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-05-19 20:08:14 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Paulos-2005">
<DESCRIPTION>
<P>Objective outcome measure</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-05-20 17:03:55 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peterson-2004">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-05-19 20:21:00 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Rickles-2005">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-05-19 20:31:09 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sadik-2005">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-05-19 20:59:01 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sarkadi-2004">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-05-19 21:01:28 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schneider-1982">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-05-19 21:08:19 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Solomon-1998">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-05-19 21:09:43 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sookaneknun-2004">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-05-19 21:15:05 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stergachis-1987">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-05-19 21:21:44 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Taylor-2003">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-05-20 23:55:04 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tsuyuki-2002">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-05-19 21:43:08 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Turner-2000">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-05-19 21:50:52 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Van-Veldhuizen-1995">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-05-19 21:58:48 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Watson-2001">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-05-19 22:10:32 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weinberger-2002">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="STUDY" MODIFIED="2010-06-07 11:36:49 -0400" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Follow-up of professionals?</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:17:27 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barbanel-2003">
<DESCRIPTION>
<P>Not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:18:14 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bogden-1997">
<DESCRIPTION>
<P>Not applicable </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:17:30 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bond-2000">
<DESCRIPTION>
<P>Not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:17:42 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Borenstein-2003">
<DESCRIPTION>
<P>Not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:17:49 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Brook-2003a">
<DESCRIPTION>
<P>Not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:18:01 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Capoccia-2004">
<DESCRIPTION>
<P>Not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:23 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Choe-2005">
<DESCRIPTION>
<P>Not explicitly reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:23 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Clifford-2005">
<DESCRIPTION>
<P>Not explicitly reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:23 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cody-1998">
<DESCRIPTION>
<P>Not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-04 14:39:16 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Diwan-1995">
<DESCRIPTION>
<P>Data collected from 87% of health centers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:23 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Finley-2003">
<DESCRIPTION>
<P>Not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 14:06:27 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Freemantle-2002">
<DESCRIPTION>
<P>6 out of 69 practices refused follow-up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:24 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gattis-1999">
<DESCRIPTION>
<P>Not applicable </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-20 17:53:58 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gonzalez_x002d_Martin-2003">
<DESCRIPTION>
<P>not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:24 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Goodyer-1995">
<DESCRIPTION>
<P>Not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 14:37:05 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hall-2001">
<DESCRIPTION>
<P>3 of 19 intervention practices (that allowed a visit) allowed an audit</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:26 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hanlon-1996">
<DESCRIPTION>
<P>Not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:26 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hawkins-1979">
<DESCRIPTION>
<P>Not applicable </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 18:26:15 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ilett-2000">
<DESCRIPTION>
<P>Outcome data were available for all 112 physicians included in the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:26 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jaber-1996">
<DESCRIPTION>
<P>Not applicable </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 18:51:39 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jackson-2004">
<DESCRIPTION>
<P>Not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:26 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jameson-1995">
<DESCRIPTION>
<P>Not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-20 17:55:36 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Malone-2001">
<DESCRIPTION>
<P>not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:26 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mehos-2000">
<DESCRIPTION>
<P>Not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:26 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meredith-2002">
<DESCRIPTION>
<P>Not applicable </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:27 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Odegard-2005">
<DESCRIPTION>
<P>Not applicable </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:28 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Okamoto-2001">
<DESCRIPTION>
<P>Not applicable </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-20 17:56:15 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Park-1996">
<DESCRIPTION>
<P>not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:28 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Paulos-2005">
<DESCRIPTION>
<P>Not applicable </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-20 17:03:58 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peterson-2004">
<DESCRIPTION>
<P>Not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-20 17:56:38 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Rickles-2005">
<DESCRIPTION>
<P>not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-20 17:56:48 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sadik-2005">
<DESCRIPTION>
<P>not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:29 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sarkadi-2004">
<DESCRIPTION>
<P>Not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 21:01:38 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schneider-1982">
<DESCRIPTION>
<P>Not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:29 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Solomon-1998">
<DESCRIPTION>
<P>Not applicable </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:29 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sookaneknun-2004">
<DESCRIPTION>
<P> Not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-07 08:21:27 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stergachis-1987">
<DESCRIPTION>
<P>Data were included for all 17 physicians</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:31 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Taylor-2003">
<DESCRIPTION>
<P>Not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-20 23:55:16 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tsuyuki-2002">
<DESCRIPTION>
<P>Not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-07 08:31:24 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Turner-2000">
<DESCRIPTION>
<P>"First and second interviews were successfully completed with 25 and 23 physicians, respectively, in the control group and 32 and 31 physicians in the intervention group"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:32 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Van-Veldhuizen-1995">
<DESCRIPTION>
<P>Not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 22:09:22 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Watson-2001">
<DESCRIPTION>
<P>Data are presented for all practices included in the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-07 11:36:49 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weinberger-2002">
<DESCRIPTION>
<P>Not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="STUDY" MODIFIED="2010-06-07 11:39:43 -0400" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Follow-up of patients?</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-04 14:09:05 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barbanel-2003">
<DESCRIPTION>
<P>There were follow-up data on all 12 in the intervention group and 11 in the control group (1 person moved away).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-04 14:01:49 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bogden-1997">
<DESCRIPTION>
<P>50 patients were randomized; at time of study completion "there were 47 patients able to be evaluated in the intervention and control groups"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-07 11:39:43 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bond-2000">
<DESCRIPTION>
<P>Of 1614 patients recruited to intervention group, complete data were available for 905 patients</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-07 11:36:01 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Borenstein-2003">
<DESCRIPTION>
<P>Based on reported data-of the 197 patients included in the study, data was reported on all 197 patients</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-07 11:36:03 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Brook-2003a">
<DESCRIPTION>
<P>"the attrition rate at 3- and 6-month follow-up was 21% and 27%."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-18 18:37:39 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Capoccia-2004">
<DESCRIPTION>
<P>93% of patients completed the 12-month follow-up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-18 19:17:58 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Choe-2005">
<DESCRIPTION>
<P>Outcome measures were obtained for 81% of subjects </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 13:31:12 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Clifford-2005">
<DESCRIPTION>
<P>91% of recruited subjects completed the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:23 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cody-1998">
<DESCRIPTION>
<P>Not explicitly described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-04 14:39:22 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Diwan-1995">
<DESCRIPTION>
<P>Data were missing on 17 of 1308 patients</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-04 14:41:19 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Finley-2003">
<DESCRIPTION>
<P>data analyzed for &lt; 80% of randomized patients</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-20 17:53:35 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Freemantle-2002">
<DESCRIPTION>
<P>not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:24 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gattis-1999">
<DESCRIPTION>
<P>Not explicitly described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-04 14:48:29 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gonzalez_x002d_Martin-2003">
<DESCRIPTION>
<P>"All 21 recruited children completed the study"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 14:23:08 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Goodyer-1995">
<DESCRIPTION>
<P>18 out of 100 patients dropped out by the end of the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:25 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hall-2001">
<DESCRIPTION>
<P>Not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 14:49:53 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hanlon-1996">
<DESCRIPTION>
<P>169 out of 208 patients followed up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 15:40:32 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hawkins-1979">
<DESCRIPTION>
<P>Total attrition was 39.2% and 51.2% in experimental and control group, respectively</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:26 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ilett-2000">
<DESCRIPTION>
<P>Not applicable </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 18:29:39 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jaber-1996">
<DESCRIPTION>
<P>39 out of 45 patients completed the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 18:51:34 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jackson-2004">
<DESCRIPTION>
<P>127 of the 131 patients completed the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 18:57:59 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Jameson-1995">
<DESCRIPTION>
<P>268 of 340 patients completed the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 19:05:57 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Malone-2001">
<DESCRIPTION>
<P>931 of 1054 patients completed the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 19:09:54 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mehos-2000">
<DESCRIPTION>
<P>36 out of 41 patients completed the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 19:22:41 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meredith-2002">
<DESCRIPTION>
<P>259 of 317 patients completed the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 19:33:09 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Odegard-2005">
<DESCRIPTION>
<P>66 out of 77 subjects completed the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:28 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Okamoto-2001">
<DESCRIPTION>
<P>Specific data not provided on number of patients lost to follow-up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 19:50:47 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Park-1996">
<DESCRIPTION>
<P>53 out of 64 patients completed the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:29 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Paulos-2005">
<DESCRIPTION>
<P>Specific data not provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-20 17:06:41 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peterson-2004">
<DESCRIPTION>
<P>81 out of 94 subjects completed the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 20:20:51 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Rickles-2005">
<DESCRIPTION>
<P>60 out of 63 patients completed the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 20:32:48 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sadik-2005">
<DESCRIPTION>
<P>208 of 221 patients completed the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:29 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sarkadi-2004">
<DESCRIPTION>
<P>Not explicitly described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:29 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schneider-1982">
<DESCRIPTION>
<P>Not explicitly described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:29 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Solomon-1998">
<DESCRIPTION>
<P>Not explicitly described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 21:13:42 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sookaneknun-2004">
<DESCRIPTION>
<P>227 of 235 patients completed the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 21:16:53 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stergachis-1987">
<DESCRIPTION>
<P>Not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 21:25:32 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Taylor-2003">
<DESCRIPTION>
<P>69 out of 81 patients completed the intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-20 23:57:00 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tsuyuki-2002">
<DESCRIPTION>
<P>657 out of 675 patients completed the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:31 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Turner-2000">
<DESCRIPTION>
<P>Not Applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 21:57:21 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Van-Veldhuizen-1995">
<DESCRIPTION>
<P>Based on figures, 32 out of 41 patients completed the study (for blood glucose values)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-20 18:00:38 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Watson-2001">
<DESCRIPTION>
<P>not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-07 08:41:36 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weinberger-2002">
<DESCRIPTION>
<P>"Completed interviews with 947 patients (85.1%) at 6 months and 898 patients (80.7%) at 12 months. Completion rates did not differ significantly by disease or study group."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-09" LEVEL="STUDY" MODIFIED="2010-06-07 11:36:38 -0400" MODIFIED_BY="[Empty name]" NO="9">
<NAME>Baseline measurement?</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-04 14:10:01 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barbanel-2003">
<DESCRIPTION>
<P>"baseline scores were similar in the intervention and control groups"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-04 14:02:33 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bogden-1997">
<DESCRIPTION>
<P>Primary outcome based on absolute change "from the baseline enrolment value"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:17:41 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bond-2000">
<DESCRIPTION>
<P>Baseline measures not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:41:21 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Borenstein-2003">
<DESCRIPTION>
<P>Collected, but statistically significant difference in systolic blood pressure and number of African-American patients between groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-04 14:11:59 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Brook-2003a">
<DESCRIPTION>
<P>"At baseline there were no significant differences" between groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-04 14:15:17 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Capoccia-2004">
<DESCRIPTION>
<P>"no significant differences on any demographic or clinical variables between the two groups"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-18 19:05:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Choe-2005">
<DESCRIPTION>
<P>no statistically significant differences in demographic variables between groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-03-09 00:53:42 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Clifford-2005">
<DESCRIPTION>
<P>Intervention patients had a longer duration of diabetes, higher HbA1c, and were taking a greater number of medications</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:23 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cody-1998">
<DESCRIPTION>
<P>Not explicitly described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 13:55:44 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Diwan-1995">
<DESCRIPTION>
<P>Not explicitly described; some differences existed in the number of baseline prescriptions between control and intervention groups. May not affect outcome</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 13:57:43 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Finley-2003">
<DESCRIPTION>
<P>objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-02-27 20:23:25 -0500" MODIFIED_BY="Olga Mostovetsky" RESULT="UNKNOWN" STUDY_ID="STD-Freemantle-2002">
<DESCRIPTION>
<P>baseline adherence to recommendations not reported for intervention vs control groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 14:08:34 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gattis-1999">
<DESCRIPTION>
<P>Baseline characteristics were similar between groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-20 17:00:04 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gonzalez_x002d_Martin-2003">
<DESCRIPTION>
<P>There were no statistically significant differences between groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 14:23:14 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Goodyer-1995">
<DESCRIPTION>
<P>There were no significant differences between groups. The only concern was a non-significant difference between groups in baseline edema</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:26 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hall-2001">
<DESCRIPTION>
<P>Not explicitly described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 14:51:39 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hanlon-1996">
<DESCRIPTION>
<P>Control patients were more likely to have been married, to take more medications, and to have more medications for which the clinical pharmacist developed recommendations. Analyses controlled for these baseline differences. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 15:11:11 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hawkins-1979">
<DESCRIPTION>
<P>Control group contained a higher percentage of patients with hypertension as an only diagnosis; a higher percentage of experimental patients had both hypertension and diabetes </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-04 14:57:17 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ilett-2000">
<DESCRIPTION>
<P>"had similar demographic profile"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 18:30:14 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jaber-1996">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-04 15:13:02 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Jackson-2004">
<DESCRIPTION>
<P>"The two groups were well matched with regard to baseline demographics. There was a significantly higher incidence of previous myocardial infarction in the intervention group compared to the control group"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-04 15:14:01 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jameson-1995">
<DESCRIPTION>
<P>"There were no differences in demographics between patients"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-07 11:36:33 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Malone-2001">
<DESCRIPTION>
<P>"The two groups were similar in demographics and medical conditions at study enrolment. The scores for intervention group were lower for all domains compared with the control group, but differences were not statistically significant at the P = 0.01 level"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-04 15:17:47 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mehos-2000">
<DESCRIPTION>
<P>"No statistically significant differences in baseline characteristics between" groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 19:25:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meredith-2002">
<DESCRIPTION>
<P>There were no demographic differences between the intervention and control groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 19:34:15 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Odegard-2005">
<DESCRIPTION>
<P>Groups were similar, with the exception of the intervention group being less likely to have a high school education. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 19:41:03 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Okamoto-2001">
<DESCRIPTION>
<P>330 of 381 patients completed the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 20:02:05 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Park-1996">
<DESCRIPTION>
<P>The intervention group and control group were different at baseline (for their systolic blood pressure) but the authors did not provide the significance level of this difference</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-02-27 16:14:49 -0500" MODIFIED_BY="Olga Mostovetsky" RESULT="UNKNOWN" STUDY_ID="STD-Paulos-2005">
<DESCRIPTION>
<P>Significance for differences in baseline measurements for primary outcomes was not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-20 17:05:54 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peterson-2004">
<DESCRIPTION>
<P>There were no statistically significant differences between groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 20:23:52 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Rickles-2005">
<DESCRIPTION>
<P>Intervention group was more likely to have a history of psychotropic medication use</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 20:33:07 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sadik-2005">
<DESCRIPTION>
<P>No difference was mentioned between the groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-07 11:36:38 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Sarkadi-2004">
<DESCRIPTION>
<P>Intervention group had longer diabetes duration compare with control group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:29 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schneider-1982">
<DESCRIPTION>
<P>Not explicitly described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-07 08:16:48 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Solomon-1998">
<DESCRIPTION>
<P>"No significant differences in group characteristics were found"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-07 08:19:14 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sookaneknun-2004">
<DESCRIPTION>
<P>"The two groups were equal in all variables"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-07 08:21:53 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stergachis-1987">
<DESCRIPTION>
<P>"There were no significant differences among" demographic characteristics</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-07 08:25:32 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Taylor-2003">
<DESCRIPTION>
<P>"The intervention and control groups were not significantly different with respect to demographic characteristics and medication use, compliance, and knowledge"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-07 08:29:12 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tsuyuki-2002">
<DESCRIPTION>
<P>"Randomisation resulted in a balance of patient demographics"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:31 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Turner-2000">
<DESCRIPTION>
<P>Not explicitly described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 21:55:40 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Van-Veldhuizen-1995">
<DESCRIPTION>
<P>Not explicitly described, but there appears to be differences in the numbers presented (statistical significance not reported); data not reflected in a table or figure. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-07 08:35:44 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Watson-2001">
<DESCRIPTION>
<P>"There were only slight differences in NSAID prescribing between the three groups at baseline"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-07 08:42:54 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Weinberger-2002">
<DESCRIPTION>
<P>DONE for asthma patients, NOT DONE for COPD patients; "study groups were comparable at baseline, except for race (asthma/COPD) and PEFR (COPD only)...we controlled for race in all analyses and for baseline PEFR among COPD patients only."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-10" LEVEL="STUDY" MODIFIED="2010-06-07 11:39:21 -0400" MODIFIED_BY="[Empty name]" NO="10">
<NAME>Reliable outcome measures?</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-07 11:35:41 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barbanel-2003">
<DESCRIPTION>
<P>objective validated instrument - North of England asthma symptom scale</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-07 11:35:47 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bogden-1997">
<DESCRIPTION>
<P>Objective outcomes assessed - total cholesterol</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-18 15:33:30 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bond-2000">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-18 15:42:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Borenstein-2003">
<DESCRIPTION>
<P>Objective outcomes assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-18 16:29:06 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Brook-2003a">
<DESCRIPTION>
<P>Validated objective tool used-90-item Hopkins Symptom checklist</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-18 18:48:44 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Capoccia-2004">
<DESCRIPTION>
<P>Objective validated instrument used to assess outcome</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-18 19:18:05 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Choe-2005">
<DESCRIPTION>
<P>Objective outcome measure</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 13:31:33 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Clifford-2005">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-21 00:20:06 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cody-1998">
<DESCRIPTION>
<P>Patients self-completed and mailed in quality of life surveys</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 13:51:14 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Diwan-1995">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-02-27 19:06:48 -0500" MODIFIED_BY="Olga Mostovetsky" RESULT="YES" STUDY_ID="STD-Finley-2003">
<DESCRIPTION>
<P>objective primary outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 14:06:52 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Freemantle-2002">
<DESCRIPTION>
<P>objective outcome measure</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 14:08:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gattis-1999">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-20 17:00:10 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gonzalez_x002d_Martin-2003">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 14:20:15 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Goodyer-1995">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 14:31:00 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hall-2001">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 14:50:12 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hanlon-1996">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 15:40:24 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hawkins-1979">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 18:26:21 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ilett-2000">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 18:31:26 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jaber-1996">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 18:40:41 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jackson-2004">
<DESCRIPTION>
<P>Objective outcomes assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 18:57:21 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jameson-1995">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 19:03:36 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Malone-2001">
<DESCRIPTION>
<P>Objective outcomes assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 19:08:21 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mehos-2000">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 19:14:52 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meredith-2002">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 19:31:02 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Odegard-2005">
<DESCRIPTION>
<P>Objective outcome measure</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 19:40:11 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Okamoto-2001">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-07 11:39:21 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Park-1996">
<DESCRIPTION>
<P>Resident performed blood pressure measurement, which were not blinded from patients; these are objective outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 20:08:26 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Paulos-2005">
<DESCRIPTION>
<P>Objective outcome measure</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-20 17:04:10 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peterson-2004">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 20:20:58 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Rickles-2005">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 20:31:17 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sadik-2005">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-03 13:55:25 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sarkadi-2004">
<DESCRIPTION>
<P>Reliability of measurements unclear (patients brought in glycosylated hemoglobin measures)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 21:01:33 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schneider-1982">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 21:08:24 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Solomon-1998">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 21:09:49 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sookaneknun-2004">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 21:15:10 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stergachis-1987">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 21:21:51 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Taylor-2003">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-20 23:55:09 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tsuyuki-2002">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 21:43:20 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Turner-2000">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 21:51:49 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Van-Veldhuizen-1995">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 21:58:55 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Watson-2001">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 22:14:43 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weinberger-2002">
<DESCRIPTION>
<P>Objective outcome assessed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-11" LEVEL="STUDY" MODIFIED="2010-06-10 16:51:15 -0400" MODIFIED_BY="[Empty name]" NO="11">
<NAME>Protection against contamination?</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-07-31 16:31:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Barbanel-2003">
<DESCRIPTION>
<P>Did not explicitly mention </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:40:56 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bogden-1997">
<DESCRIPTION>
<P>Not explicitly described; subjects recruited from same clinic</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-18 15:34:15 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bond-2000">
<DESCRIPTION>
<P>Allocation was by practice</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-18 15:42:07 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Borenstein-2003">
<DESCRIPTION>
<P>Patients recruited from same medical group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-04 14:13:03 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Brook-2003a">
<DESCRIPTION>
<P>All participants received care from same pharmacy. To minimize "all pharmacists attended a pre-trial meeting at which they were instructed how to approach eligible patients, how to randomise them, and how to use different protocols for patients"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-10 16:51:15 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Capoccia-2004">
<DESCRIPTION>
<P>Patients received care from same medical center and potentially same group of professionals. "We cannot rule out the possibility of spillover effect" between groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-07 11:39:43 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Choe-2005">
<DESCRIPTION>
<P>Patients received care from same medical center</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:23 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Clifford-2005">
<DESCRIPTION>
<P>All participants received care from same clinic entity. Did not explicitly mention method to protect against contamination. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-02-13 17:22:18 -0500" MODIFIED_BY="Olga Mostovetsky" RESULT="NO" STUDY_ID="STD-Cody-1998">
<DESCRIPTION>
<P>NOT DONE for the RCT / DONE FOR the CBA</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-04 14:39:34 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Diwan-1995">
<DESCRIPTION>
<P>Detailing occurred in specific health center</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-03 13:51:53 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Finley-2003">
<DESCRIPTION>
<P>patients randomized within 1 practice</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-03 13:52:19 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Freemantle-2002">
<DESCRIPTION>
<P>randomized by health authority</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 14:09:59 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Gattis-1999">
<DESCRIPTION>
<P>Patients received care from same medical center</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-03 13:52:49 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Gonzalez_x002d_Martin-2003">
<DESCRIPTION>
<P>randomized by patient within 1 practice</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-08-04 22:28:52 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Goodyer-1995">
<DESCRIPTION>
<P>Two people from same family could have been assigned to different groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-03 13:53:12 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hall-2001">
<DESCRIPTION>
<P>General practices unit of randomization</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 14:52:12 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hanlon-1996">
<DESCRIPTION>
<P>Patients received care in the same clinic</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-08-04 22:25:31 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hawkins-1979">
<DESCRIPTION>
<P>Possible physician influence on intervention group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 20:29:58 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ilett-2000">
<DESCRIPTION>
<P>Communication between physicians was possible</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 18:39:23 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jaber-1996">
<DESCRIPTION>
<P>Unlikely that the control group received the intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 18:43:00 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jackson-2004">
<DESCRIPTION>
<P>Patients were home-based, contamination unlikely</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-07 11:36:13 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Jameson-1995">
<DESCRIPTION>
<P>Patients received care in the same clinic; communication between the pharmacist and physician could have influenced usual care</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 19:04:21 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Malone-2001">
<DESCRIPTION>
<P>Multi-site study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-07 11:36:34 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Mehos-2000">
<DESCRIPTION>
<P>Patients received care in the same clinic; communication between the pharmacist and physician could have influenced usual care</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 19:30:11 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meredith-2002">
<DESCRIPTION>
<P>Intervention took place in patients' home</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 19:39:08 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Odegard-2005">
<DESCRIPTION>
<P>Patients received care within the same clinic system (unit of allocation by the patient). Communication between the pharmacist and physician could have influenced usual care.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 19:43:05 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Okamoto-2001">
<DESCRIPTION>
<P>Patients received care within the same facility. Communication between the pharmacist and physician could have influenced usual care.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 20:28:57 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Park-1996">
<DESCRIPTION>
<P>All subjects were recruited from the same community pharmacy; there was the possibility of communication between subjects within the same household or family </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 20:28:32 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Paulos-2005">
<DESCRIPTION>
<P>All subjects were recruited from the same community pharmacy; there was the possibility of communication between subjects within the same household or family</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-03 13:54:45 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peterson-2004">
<DESCRIPTION>
<P>Patients randomized within 1 hospital but intervention performed at home</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-03 13:55:08 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Rickles-2005">
<DESCRIPTION>
<P>Patients were randomized. There was the possibility of communication between subjects within the same household or family</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-03 13:55:16 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Sadik-2005">
<DESCRIPTION>
<P>Patients were randomized. Communication between the pharmacist and physician could have influenced usual care.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:29 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sarkadi-2004">
<DESCRIPTION>
<P>Settings of intervention and control groups not explicitly described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-03 13:55:31 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schneider-1982">
<DESCRIPTION>
<P>Patients were randomized. Communication between the pharmacist and physician could have influenced usual care</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-07 08:17:13 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Solomon-1998">
<DESCRIPTION>
<P>Patients were randomized. Communication between the pharmacist and physician could have influenced usual care. "Seven sites participated in both study arms."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-03 13:56:00 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Sookaneknun-2004">
<DESCRIPTION>
<P>Patients were randomized. Communication between the pharmacist and physician could have influenced usual care.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-08-04 22:46:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stergachis-1987">
<DESCRIPTION>
<P>Intervention part of broader education campaign affecting cases and controls</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-03 13:56:34 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Taylor-2003">
<DESCRIPTION>
<P>Patients were randomized. Communication between the pharmacist and physician could have influenced usual care.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-07 08:29:23 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tsuyuki-2002">
<DESCRIPTION>
<P>Multi-center study could have minimized contamination. Patients were randomized. There was the possibility of communication between subjects within the same household or family</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-07 08:32:05 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Turner-2000">
<DESCRIPTION>
<P>"All members of a group practice were randomized to the same study group to minimize cross-contamination"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-24 16:42:32 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Van-Veldhuizen-1995">
<DESCRIPTION>
<P>Not explicitly described; subjects recruited from the same Regional Diabetes Center</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-19 21:59:36 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Watson-2001">
<DESCRIPTION>
<P>Randomised by practice</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-03 14:02:52 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weinberger-2002">
<DESCRIPTION>
<P>Sites were randomized in clusters.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2010-06-16 09:12:03 -0400" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2010-06-14 11:22:01 -0400" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Pharmacist services targeted at patients versus services delivered by other health professionals</NAME>
<OTHER_OUTCOME COLS="7" ID="CMP-001.01" MODIFIED="2010-06-14 11:22:01 -0400" MODIFIED_BY="[Empty name]" NO="1" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Outcomes Table: 2009 Review</NAME>
<TR>
<TH>
<P>Primary outcomes</P>
</TH>
<TH>
<P>Pre-intervention<BR/>(intervention vs control group)</P>
</TH>
<TH>
<P>Post-intervention<BR/>(intervention vs control group)</P>
</TH>
<TH>
<P>Change due<BR/>to intervention (intervention vs<BR/>control group)<BR/>
</P>
</TH>
<TH>
<P>Result interval<BR/>(&#916;I - &#916;C)</P>
</TH>
<TH>
<P>Significance</P>
</TH>
<TH>
<P>Notes</P>
</TH>
</TR>
<OTHER_DATA MODIFIED="2010-06-14 11:21:06 -0400" MODIFIED_BY="[Empty name]" ORDER="1" STUDY_ID="STD-Hawkins-1979">
<TR>
<TD>
<P>PATIENT OUTCOMES<BR/>1. Mean systolic blood pressure (mmHg)</P>
<P>2. Mean diastolic blood pressure (mmHg)</P>
<P>3. Mean fasting blood sugar (mg/dl)<BR/>
</P>
</TD>
<TD>
<P>1. 145 vs 143</P>
<P>2. 86 vs 86</P>
<P>3. 192 vs 182</P>
</TD>
<TD>
<P>1. 147 vs 141</P>
<P>2. 84 vs 84</P>
<P>3. 184 vs 189</P>
</TD>
<TD>
<P>1. 2 vs -2</P>
<P>2. -2 vs -2</P>
<P>3. -8 vs 7</P>
</TD>
<TD>
<P>1. 4</P>
<P>2. 0</P>
<P>3. 15</P>
</TD>
<TD>
<P>1. p&lt;/= 0.001</P>
<P>2. not sig</P>
<P>3. not sig</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2010-06-14 11:37:39 -0400" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Pharmacist services targeted at patients versus the delivery of no comparable service</NAME>
<OTHER_OUTCOME COLS="7" ID="CMP-002.01" MODIFIED="2010-06-14 11:37:39 -0400" MODIFIED_BY="[Empty name]" NO="1" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="35" SUBGROUPS="NO">
<NAME>Outcomes Table: 2009 Review</NAME>
<TR>
<TH>
<P>Primary outcomes</P>
</TH>
<TH>
<P>Pre-intervention<BR/>(intervention vs control group)</P>
</TH>
<TH>
<P>Post-intervention<BR/>(intervention vs control group)</P>
</TH>
<TH>
<P>Change due<BR/>to intervention (intervention vs<BR/>control group)<BR/>
</P>
</TH>
<TH>
<P>Result interval<BR/>(&#916;I - &#916;C)</P>
</TH>
<TH>
<P>Significance</P>
</TH>
<TH>
<P>Notes</P>
</TH>
</TR>
<OTHER_DATA MODIFIED="2010-05-20 23:45:14 -0400" MODIFIED_BY="[Empty name]" ORDER="2" STUDY_ID="STD-Barbanel-2003">
<TR>
<TD>
<P>PATIENT<BR/>Asthma symptom score - North of England asthma scale</P>
</TD>
<TD>
<P>
<BR/>26.3+/-4.8 vs 27.8+/-3.7</P>
</TD>
<TD>
<P>
<BR/>20.3+/-4.2 vs 28.1+/-3.6</P>
</TD>
<TD>
<P>
<BR/>-6.0 vs 0.3</P>
</TD>
<TD>
<P>
<BR/>7</P>
</TD>
<TD>
<P>p-value &lt; 0.001<BR/>95% CI 4.40-9.50</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2010-05-20 23:45:14 -0400" MODIFIED_BY="[Empty name]" ORDER="3" STUDY_ID="STD-Bogden-1997">
<TR>
<TD>
<P>PATIENT</P>
<P>1. Total cholesterol--Men (mg/dl)</P>
<P>2. Total cholesterol-Women (mg/dl)<BR/>
</P>
</TD>
<TD>
<P>n/a</P>
</TD>
<TD>
<P>n/a</P>
</TD>
<TD>
<P>1. -57 vs -26</P>
<P>2. -37 vs -9</P>
</TD>
<TD>
<P>1. 31</P>
<P>2. 28</P>
</TD>
<TD>
<P>1. not significant</P>
<P>2. p&lt;0.05</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2010-06-14 11:23:12 -0400" MODIFIED_BY="[Empty name]" ORDER="4" STUDY_ID="STD-Bond-2000">
<TR>
<TD>
<P>PROCESS<BR/># items prescribed (median quartile)</P>
<P>PATIENT<BR/>1. Death rate (% patients)<BR/>2. Adverse drug reactions (% patients)<BR/>
</P>
</TD>
<TD>
<P>PROCESS<BR/>not reported</P>
<P>PATIENT<BR/>1. n/a<BR/>2. n/a<BR/>
</P>
</TD>
<TD>
<P>PROCESS<BR/>2 vs 3</P>
<P>PATIENT<BR/>1. 3.6 vs 3.8<BR/>2. 8.3 vs 6.7<BR/>
</P>
</TD>
<TD>
<P>
<BR/>PROCESS<BR/>n/a</P>
<P>PATIENT<BR/>1. n/a<BR/>2. n/a<BR/>
<BR/>
</P>
</TD>
<TD>
<P>PROCESS<BR/>n/a</P>
<P>PATIENT<BR/>1. n/a<BR/>2. n/a</P>
</TD>
<TD>
<P>PROCESS<BR/>p-value 0.0001</P>
<P>PATIENT<BR/>1. p-value NS*<BR/>2. p-value 0.259</P>
</TD>
<TD>
<P>*exact value not reported</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2010-06-14 11:24:02 -0400" MODIFIED_BY="[Empty name]" ORDER="5" STUDY_ID="STD-Borenstein-2003">
<TR>
<TD>
<P>PATIENT<BR/>1. Systolic blood pressure (mmHg)<BR/>2. Diastolic blood pressure (mmHg)<BR/>3. % pts achieving blood pressure control</P>
</TD>
<TD>
<P/>
<P>1. 162 vs 156 <BR/>2. 92 vs 90 <BR/>3. n/a</P>
</TD>
<TD>
<P/>
<P>1. 140 vs 145 <BR/>2. 85 vs 82 <BR/>3. 60 vs 43 %</P>
</TD>
<TD>
<P/>
<P>1. -22 vs -11 <BR/>2. -7 vs -8 <BR/>3. n/a</P>
</TD>
<TD>
<P/>
<P>1. 11 &#8224;<BR/>2. 1 &#8224;<BR/>3. 17%&#8224;</P>
</TD>
<TD>
<P/>
<P>1. p-value &lt;0.01<BR/>2. p-value &lt;0.01<BR/>3. p-value 0.02</P>
</TD>
<TD>
<P>&#8224;calculated from reported data</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2010-06-14 11:37:39 -0400" MODIFIED_BY="[Empty name]" ORDER="6" STUDY_ID="STD-Brook-2003a">
<TR>
<TD>
<P>PATIENT<BR/>SCL - general anxiety subscale*</P>
</TD>
<TD>
<P>
<BR/>3.1 vs 2.8</P>
</TD>
<TD>
<P>
<BR/>1.8 vs 1.8</P>
</TD>
<TD>
<P>
<BR/>-1.3 vs -1.0&#8224;</P>
</TD>
<TD>
<P>
<BR/>0.3&#8224;<BR/>
</P>
</TD>
<TD>
<P>
<BR/>p-value 0.4</P>
</TD>
<TD>
<P>*intention-<BR/>to-treat analysis, group mean imputation (GMI)<BR/>&#8224;calculated from reported data</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2009-07-15 13:57:18 -0400" MODIFIED_BY="[Empty name]" ORDER="7" STUDY_ID="STD-Capoccia-2004">
<TR>
<TD>
<P>PATIENT<BR/>SCL-20 score at 12 mo (mean(SD))</P>
</TD>
<TD>
<P>
<BR/>1.83(0.10) vs 1.75(0.10)</P>
</TD>
<TD>
<P>0.75 vs 0.6*</P>
</TD>
<TD>
<P>-1.08 vs -1.15&#8224;</P>
</TD>
<TD>
<P>-0.07&#8224;</P>
</TD>
<TD>
<P>p-value 0.92</P>
</TD>
<TD>
<P>*data estimated from graph<BR/>&#8224;calculated from reported data</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2010-06-14 11:36:09 -0400" MODIFIED_BY="[Empty name]" ORDER="8" STUDY_ID="STD-Choe-2005">
<TR>
<TD>
<P>PATIENT<BR/>Hemoglobin A1c (%) (mean(SD))</P>
</TD>
<TD>
<P>10.1(1.8) vs. 10.2(1.7)*</P>
</TD>
<TD>
<P>8.0(1.4) vs. 9.3(2.1)</P>
</TD>
<TD>
<P>-2.1(2.5) vs -0.9(2)</P>
</TD>
<TD>
<P>1.2&#8224;</P>
</TD>
<TD>
<P>p-value 0.03</P>
</TD>
<TD>
<P>&#8224;calculated from reported data<BR/>*SIG lower in control group at baseline (p-value 0.046)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2010-06-14 11:35:57 -0400" MODIFIED_BY="[Empty name]" ORDER="9" STUDY_ID="STD-Clifford-2005">
<TR>
<TD>
<P>PATIENT<BR/>Hemoglobin A1c (%)</P>
</TD>
<TD>
<P>7.5 vs. 7.1</P>
</TD>
<TD>
<P>7 vs. 7.1&#8224;</P>
</TD>
<TD>
<P>-0.5 vs 0</P>
</TD>
<TD>
<P>0.5&#8224;</P>
</TD>
<TD>
<P>p-value 0.002*</P>
</TD>
<TD>
<P>&#8224;calculated from reported data</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2010-05-20 23:46:03 -0400" MODIFIED_BY="[Empty name]" ORDER="10" STUDY_ID="STD-Cody-1998">
<TR>
<TD>
<P>PATIENT OUTCOME</P>
<P>Quality of Life SF36<BR/>
</P>
</TD>
<TD>
<P>
<BR/>n/a</P>
</TD>
<TD>
<P>
<BR/>n/a</P>
</TD>
<TD>
<P>
<BR/>n/a</P>
</TD>
<TD>
<P>
<BR/>n/a</P>
</TD>
<TD>
<P>change not statistically significant</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2010-06-14 11:35:38 -0400" MODIFIED_BY="[Empty name]" ORDER="11" STUDY_ID="STD-Finley-2003">
<TR>
<TD>
<P>PATIENT<BR/>1. BIDS score (mean(SD))<BR/>2. % pts with &#8805;50% reduction in BIDS score<BR/>3. % pts with remission (BIDS score &lt; 9)<BR/>4. % patients with reduction in WSDS score</P>
</TD>
<TD>
<P>
<BR/>1. 18.7(5.8) vs 18.3(5.8)<BR/>2. n/a<BR/>3. n/a<BR/>4. n/a</P>
</TD>
<TD>
<P>1. 12.1 vs 9.4&#8224;<BR/>2. 40.7 vs 54.1<BR/>3. 55.6 vs 58.3<BR/>4. 56 vs 67</P>
</TD>
<TD>
<P>1. -6.6(7.3) vs -8.9(8.3)<BR/>2. n/a<BR/>3. n/a<BR/>4. n/a</P>
</TD>
<TD>
<P>1. -2.3&#8224;<BR/>2. n/a<BR/>3. n/a<BR/>4. n/a</P>
</TD>
<TD>
<P>1. p-value 0.23<BR/>2. p-value 0.27<BR/>3. p-value 0.36<BR/>4. p-value 0.36</P>
</TD>
<TD>
<P>&#8224;calculated from reported data</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2010-05-20 23:46:04 -0400" MODIFIED_BY="[Empty name]" ORDER="12" STUDY_ID="STD-Gattis-1999">
<TR>
<TD>
<P>PATIENT<BR/>All cause mortality and heart failure events at 6 mo (# of events)</P>
</TD>
<TD>
<P>n/a</P>
</TD>
<TD>
<P>4 vs 16 (OR 0.22)</P>
</TD>
<TD>
<P>n/a</P>
</TD>
<TD/>
<TD>
<P>p-value 0.005<BR/>(OR 95% CI 0.06, 0.63)</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2010-05-20 23:48:09 -0400" MODIFIED_BY="[Empty name]" ORDER="13" STUDY_ID="STD-Gonzalez_x002d_Martin-2003">
<TR>
<TD>
<P>PATIENT<BR/>1. PAQLQ score (mean(SD)):<BR/>a) emotions domain<BR/>b) activities domain<BR/>c) symptoms domain</P>
<P>2. Spirometry testing (mean(SD)):<BR/>a) FVC<BR/>b) FEV1</P>
</TD>
<TD>
<P>
<BR/>1.<BR/>a) 5.2(0.4) vs 5.2(0.4)&#8225;<BR/>b) 3.8(0.3) vs 4.0(0.3)&#8225;<BR/>c) 4.1(0.5) vs 4.6(0.4)&#8225;</P>
<P>2.<BR/>a) 3.08(0.97) vs 2.66(0.19)<BR/>b) 2.41(0.76) vs 2.34(0.22)</P>
</TD>
<TD>
<P>
<BR/>1.<BR/>a) 6.5 vs 5.3<BR/>b) 6 vs 4.1<BR/>c) 6 vs 4.8</P>
<P>2.<BR/>a) 3.13(1.14) vs 2.85(0.29)<BR/>b) 2.48(0.89) vs 2.51(0.27)</P>
</TD>
<TD>
<P>1.<BR/>a) 1.3 vs 0.1<BR/>b) 2.2 vs 0.1<BR/>c) 1.9 vs 0.2</P>
<P>2.<BR/>a) 0.07 vs 0.19&#8224;<BR/>b) 0.07 vs 0.17&#8224;</P>
</TD>
<TD>
<P>1.<BR/>a) 1.2<BR/>b) 2.1<BR/>c) 1.7</P>
<P>2.<BR/>a) -0.12&#8224;<BR/>b) -0.1&#8224;</P>
</TD>
<TD>
<P>1.<BR/>a) p-value &lt; 0.001<BR/>b) p-value &lt; 0.001<BR/>c) p-value &lt; 0.002</P>
<P>2.<BR/>a) p-value NS*<BR/>b) p-value NS*</P>
</TD>
<TD>
<P>*exact p-value not provided<BR/>&#8224;calculated from reported data<BR/>&#8225; data extrapolated from a graph</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2010-05-20 23:46:05 -0400" MODIFIED_BY="[Empty name]" ORDER="14" STUDY_ID="STD-Goodyer-1995">
<TR>
<TD>
<P>PATIENT OUTCOMES<BR/>
<BR/>Exercise test (1. distance in 6 min and 2. distance till breathless)<BR/>
</P>
</TD>
<TD>
<P>1. 138 vs 145</P>
<P>2. 85 vs 91</P>
</TD>
<TD>
<P>1. 159 vs 123</P>
<P>2. 111 vs 71</P>
</TD>
<TD>
<P>1. 21 vs -22 &#8224;</P>
<P>2. 26 vs -20&#8224;</P>
</TD>
<TD>
<P>1. 43&#8224;</P>
<P>2. 46&#8224;</P>
</TD>
<TD>
<P>p&lt;0.001 (unclear for which outcome)</P>
</TD>
<TD>
<P>&#8224;calculated from reported data</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2010-06-14 11:37:09 -0400" MODIFIED_BY="[Empty name]" ORDER="15" STUDY_ID="STD-Hanlon-1996">
<TR>
<TD>
<P>PATIENT<BR/>SF 36 (Health Related Quality of Life) SF-36 domains: physical functioning, social functioning, physical role function, emotional role function, mental health, energy, pain, general health perception</P>
</TD>
<TD>
<P>1. n/a</P>
</TD>
<TD>
<P>1. n/a</P>
</TD>
<TD>
<P>1. n/a</P>
</TD>
<TD>
<P>1. n/a</P>
</TD>
<TD>
<P>1. p=0.99 (NS all domains)</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2010-05-20 23:46:06 -0400" MODIFIED_BY="[Empty name]" ORDER="16" STUDY_ID="STD-Jaber-1996">
<TR>
<TD>
<P>PATIENT<BR/>1. Fasting plasma glucose (mmol/L)</P>
<P>2. Glycated hemoglobin (%)<BR/>
</P>
<P>3.Quality of life</P>
</TD>
<TD>
<P>1. 11.1 (4.0) vs 12.7 (4.7)</P>
<P>2. 11.5 (2.9) vs 12.2 (3.5)</P>
<P>3. n/a</P>
</TD>
<TD>
<P>1. 8.5 (2.3) vs 11 (3.9)</P>
<P>2. 9.2 (2.1) vs 12.1 (3.7)</P>
<P>3. n/a</P>
</TD>
<TD>
<P>1. -2.6 vs -1.8</P>
<P>2. -2.2 vs -0.1</P>
<P>3. n/a</P>
</TD>
<TD>
<P>1. 0.8&#8224;</P>
<P>2. 2.1&#8224;</P>
<P>3. n/a</P>
</TD>
<TD>
<P>1. p&lt;0.05 (in final fasting plasma glucose)</P>
<P>2. p&lt;0.05 (mean ablsolute change in glycated hemoglobin)</P>
<P>3. no stat sig differences*</P>
</TD>
<TD>
<P>*p-value not reported</P>
<P>&#8224;calculated from reported data</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2010-06-14 11:35:09 -0400" MODIFIED_BY="[Empty name]" ORDER="17" STUDY_ID="STD-Jackson-2004">
<TR>
<TD>
<P>PATIENT<BR/>1. % pts with therapeutic INR<BR/>2. median INR<BR/>3. total bleeding up to 90 days after discharge (% pts)</P>
</TD>
<TD>
<P>
<BR/>1. 42 vs 45<BR/>2. 2.0 vs 2.2<BR/>3. n/a</P>
</TD>
<TD>
<P>
<BR/>1. 67 vs 41<BR/>2. 2.4 vs 2.1<BR/>3. 15 vs 36</P>
</TD>
<TD>
<P>
<BR/>1. 25 vs -4<BR/>2. 0.4 vs -0.1<BR/>3. n/a</P>
</TD>
<TD>
<P>
<BR/>1. 29<BR/>2. 0.5<BR/>3. n/a</P>
</TD>
<TD>
<P>
<BR/>1. p-value 0.01*<BR/>2. p-value 0.84*<BR/>3. p-value 0.009</P>
</TD>
<TD>
<P>*p-value for I vs C at day 8<BR/>
</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2010-05-20 23:46:07 -0400" MODIFIED_BY="[Empty name]" ORDER="18" STUDY_ID="STD-Jameson-1995">
<TR>
<TD>
<P>PROCESS OUTCOMES<BR/>1. # of drugs<BR/>2. doses of drugs/day<BR/>
<BR/>
</P>
</TD>
<TD>
<P>1. 5.6 vs 5.7</P>
<P>2. 9.5 vs 9.9</P>
</TD>
<TD>
<P>1. 5.0 vs 6.2</P>
<P>2. 7.9 vs 10.5</P>
</TD>
<TD>
<P>1. -0.6 vs 0.5</P>
<P>2. -1.6 vs 0.6</P>
</TD>
<TD>
<P>1. 1.1</P>
<P>2. 2.15</P>
</TD>
<TD>
<P>1. p=0.004</P>
<P>2. p=0.007</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2010-05-20 23:46:07 -0400" MODIFIED_BY="[Empty name]" ORDER="19" STUDY_ID="STD-Malone-2001">
<TR>
<TD>
<P>PATIENT<BR/>HRQOL change over 12 mo - SF-36 domains: physical functioning, role physical, bodily pain*, general health perceptions, vitality*, social functioning, role emotional, mental health*, change in health*</P>
</TD>
<TD>
<P>n/a</P>
</TD>
<TD>
<P>n/a</P>
</TD>
<TD>
<P>n/a</P>
</TD>
<TD>
<P>n/a</P>
</TD>
<TD>
<P>*p-value &lt; 0.05</P>
</TD>
<TD>
<P>bodily pain and change in health domains were significantly higher in control group at baseline</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2010-06-14 11:34:49 -0400" MODIFIED_BY="[Empty name]" ORDER="20" STUDY_ID="STD-Mehos-2000">
<TR>
<TD>
<P>PATIENT</P>
<P>1. Systolic blood pressure (mmHg) (mean(SD))<BR/>2. Diastolic blood pressure (mmHg) (mean(SD))<BR/>3. Mean arterial blood pressure (mmHg) (mean(SD))</P>
</TD>
<TD>
<P>
<BR/>1. 157.9(16.4) vs 153.9(14.6) <BR/>2. 91.1(10.8) vs 89.6(9.8) <BR/>3. 113.4(8.0) vs 111.0(6.4) </P>
<P/>
</TD>
<TD>
<P>1. 140.8 vs 146.9 <BR/>2. 80.6 vs 85.8 <BR/>3. 100.7 vs 106.1 </P>
</TD>
<TD>
<P>1. -17.1 vs -7 <BR/>2. -10.5 vs -3.8 <BR/>3. -12.7 vs -4.9 </P>
</TD>
<TD>
<P>1. 10.1 &#8224;<BR/>2. 6.7 &#8224;<BR/>3. 7.8 &#8224;</P>
</TD>
<TD>
<P>1.p-value 0.069<BR/>2. p-value 0.022<BR/>3. p-value 0.01</P>
</TD>
<TD>
<P>&#8224;calculated from reported data</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2010-06-14 11:37:16 -0400" MODIFIED_BY="[Empty name]" ORDER="21" STUDY_ID="STD-Meredith-2002">
<TR>
<TD>
<P>PROCESS - improvement in prescribing<BR/>1. any medication use (% pts)<BR/>2. therapeutic duplication (% pts) <BR/>3. cardiovascular medication use (% pts)<BR/>4. psychotropic medication use (% pts)<BR/>5. NSAID use (% pts)</P>
</TD>
<TD>
<P>
<BR/>
<BR/>1. n/a<BR/>2. n/a<BR/>3. n/a<BR/>4. n/a<BR/>5. n/a</P>
</TD>
<TD>
<P>
<BR/>
<BR/>1. n/a<BR/>2. n/a<BR/>3. n/a<BR/>4. n/a<BR/>5. n/a</P>
</TD>
<TD>
<P>
<BR/>
<BR/>1. 50 vs 38<BR/>2. 70.8 vs 23.5<BR/>3. 55 vs 17.6<BR/>4. 40.3 vs 31.6<BR/>5. 42.2 vs 52.1</P>
</TD>
<TD>
<P>
<BR/>
<BR/>1. 12<BR/>2. 47.3<BR/>3. 37.4<BR/>4. 8.8<BR/>5. -10</P>
</TD>
<TD>
<P>
<BR/>
<BR/>1. p-value 0.05, 95% CI 0-24<BR/>2. p-value 0.003, 95% CI 20.2-74.5<BR/>3. p-value 0.02, 95% CI 9-65.7<BR/>4. p-value &gt; 0.2, 95% CI -9.7-27.4<BR/>5. p-value &gt; 0.2, 95% CI -30.4-10.5</P>
</TD>
<TD>
<P>calculated from reported values</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2010-06-14 11:26:47 -0400" MODIFIED_BY="[Empty name]" ORDER="22" STUDY_ID="STD-Odegard-2005">
<TR>
<TD>
<P>PATIENT<BR/>1. HbA1C at 6 mo (end of intervention) (%) (mean(SD))<BR/>2. HbA1C at 12 mo (6 mo usual care follow-up) (%)(mean(SD))</P>
</TD>
<TD>
<P>1. 10.2(0.8) vs 10.6(1.4)<BR/>2. 10.2(0.8) vs 10.6(1.4)</P>
</TD>
<TD>
<P>1. 8.7 vs 8.8&#8225;<BR/>2. 8.2 vs 8.3&#8225;</P>
</TD>
<TD>
<P>1. -1.5 vs -1.8&#8224;<BR/>2. -2 vs -2.3&#8224;</P>
</TD>
<TD>
<P>1. 0.3&#8224;<BR/>2. 0.3&#8224;</P>
</TD>
<TD>
<P>p-value 0.61</P>
</TD>
<TD>
<P>&#8224;calculated from reported data<BR/>&#8225; data extrapolated from a graph</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2010-06-14 11:27:03 -0400" MODIFIED_BY="[Empty name]" ORDER="23" STUDY_ID="STD-Okamoto-2001">
<TR>
<TD>
<P>PATIENT</P>
<P>*Note-authors did not define units for all outcomes; based on other data reported in study, it is assumed that data is reported as (mean(SD)).*</P>
<P>
<BR/>1. Systolic blood pressure (mmHg)<BR/>2. Diastolic blood pressure (mmHg)<BR/>3. QOL - SF-36 domains: physical functioning, role-physical*, bodily pain, general health, vitality, social functioning, role-emotional, mental health</P>
</TD>
<TD>
<P>1. 144.23(18.4) vs 142.91(18) <BR/>2. 82.79(11.2) vs 82.13(11.4) <BR/>3. n/a</P>
</TD>
<TD>
<P>1. 135.10(15.3) vs 141.66(17.90) <BR/>2. 77.65(11.2) vs 80.67(10.2) <BR/>3. n/a</P>
</TD>
<TD>
<P>1. -9.13(17.1) vs -1.32(15.7)<BR/>2. -5.14(9.2) vs -1.46(10.1) <BR/>3. n/a</P>
</TD>
<TD>
<P>1. 7.81 &#8224;<BR/>2. 3.68 &#8224;<BR/>3. n/a</P>
</TD>
<TD>
<P>1. p-value &lt; 0.001<BR/>2. p-value &lt; 0.001<BR/>3. *p-value SIG</P>
</TD>
<TD>
<P>&#8224;calculated from reported data</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2010-06-14 11:27:16 -0400" MODIFIED_BY="[Empty name]" ORDER="24" STUDY_ID="STD-Park-1996">
<TR>
<TD>
<P>PATIENT OUTCOMES<BR/>1. Systolic Blood Pressure (mmHg)</P>
<P>2. Diastolic Blood Pressure (mmHg)<BR/>3. Health Status Questionnaire (HSQ)<BR/>
<BR/>
</P>
</TD>
<TD>
<P>1. 155 (21.1) vs 147.9 (18.6) </P>
<P>2. 87.9 (9.9) vs 83.3 (8.5) </P>
<P>3. n/a</P>
</TD>
<TD>
<P>1. 143.2 (11.5) vs 148.6 (20.1) </P>
<P>2. 83.2 (8) vs 83.7 (10.9) </P>
<P>3. n/a</P>
</TD>
<TD>
<P>1. -11.8 vs 0.7</P>
<P>2. -4.7 vs 0.4 </P>
<P>3. n/a</P>
</TD>
<TD>
<P>1. 12.5</P>
<P>2. 5.1</P>
<P>3. n/a</P>
</TD>
<TD>
<P>1. no p-value reported</P>
<P>2. no p-value reported</P>
<P>3. p&lt;0.05 only in energy/fatigue category (no sig in other 7 categories)</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2010-06-14 11:27:55 -0400" MODIFIED_BY="[Empty name]" ORDER="25" STUDY_ID="STD-Paulos-2005">
<TR>
<TD>
<P>PATIENT<BR/>1. Total cholesterol (mg/dL)<BR/>2. Triglycerides (mg/dL)<BR/>3. % pts with decrease in total cholesterol<BR/>4. % pts with decrease in triglycerides</P>
</TD>
<TD>
<P>1. 205.1(44.7) vs 203.2(40.6) <BR/>2. 190.7(88.7) vs 163.6(116.4) <BR/>3. n/a<BR/>4. n/a</P>
</TD>
<TD>
<P>1. 178(31.1) vs 199.1(37.6) <BR/>2. 140.3(47.6) vs 193.2(108.0) <BR/>3. 72.8 vs 33.3<BR/>4. 77.3 vs 27.8<BR/>
</P>
</TD>
<TD>
<P>1. -27.1(41.1) vs -1.4(37.2) <BR/>2. -50.5(80.3) vs 29.6(118.5) <BR/>3. n/a<BR/>4. n/a</P>
</TD>
<TD>
<P>1. 25.7 <BR/>2. 80.0 <BR/>3. n/a<BR/>4. n/a</P>
</TD>
<TD>
<P>1. p-value 0.0266*<BR/>2. p-value 0.0169*<BR/>3. p-value n/a<BR/>4. p-value n/a</P>
</TD>
<TD>
<P>*p-value for change in intervention group over study period<BR/>
</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2010-06-14 11:28:04 -0400" MODIFIED_BY="[Empty name]" ORDER="26" STUDY_ID="STD-Peterson-2004">
<TR>
<TD>
<P>PATIENT<BR/>cholesterol levels - mmol/L (mean(SD))</P>
</TD>
<TD>
<P>
<BR/>4.8(0.70) vs 4.8(0.9) </P>
</TD>
<TD>
<P>
<BR/>4.4(0.6) vs 4.6(0.8)</P>
</TD>
<TD>
<P>
<BR/>-0.4 VS -0.2&#8224; </P>
</TD>
<TD>
<P>
<BR/>0.2&#8224; </P>
</TD>
<TD>
<P>
<BR/>p-value 0.24*</P>
</TD>
<TD>
<P>
<BR/>*p-value for I vs C at follow-up<BR/>&#8224;calculated from reported data</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2010-06-14 11:28:18 -0400" MODIFIED_BY="[Empty name]" ORDER="27" STUDY_ID="STD-Rickles-2005">
<TR>
<TD>
<P>PATIENT<BR/>&#8805;50% improvement in BDI-II score (# (%) pts)</P>
</TD>
<TD>
<P>
<BR/>n/a</P>
</TD>
<TD>
<P>
<BR/>21 (75) vs 21 (65.6)</P>
</TD>
<TD>
<P>
<BR/>n/a</P>
</TD>
<TD>
<P>
<BR/>n/a</P>
</TD>
<TD>
<P>
<BR/>p-value NS*</P>
</TD>
<TD>
<P>
<BR/>*exact value not reported</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2010-06-14 11:28:47 -0400" MODIFIED_BY="[Empty name]" ORDER="28" STUDY_ID="STD-Sadik-2005">
<TR>
<TD>
<P>PATIENT<BR/>1. mean distance walked in two min test @ 12 mo (meters)<BR/>2. QOL - SF-36 domains: physical functioning, role-physical*, bodily pain*, general health, vitality*, social functioning*, role-emotional*, mental health*</P>
</TD>
<TD>
<P>1. 124 vs 120.8 <BR/>2. n/a</P>
</TD>
<TD>
<P>1. 140.2 vs 117.2 <BR/>2. n/a</P>
</TD>
<TD>
<P>1. 16.2 vs -3.6 &#8224;<BR/>2. n/a</P>
</TD>
<TD>
<P>1. 19.8 &#8224;<BR/>2. n/a</P>
</TD>
<TD>
<P>1. p-value 0.001&#8225;<BR/>2. *p-value SIG</P>
</TD>
<TD>
<P>&#8224;calculated from reported data<BR/>&#8225;p-value for I vs C at 12 months</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2010-06-14 11:34:19 -0400" MODIFIED_BY="[Empty name]" ORDER="29" STUDY_ID="STD-Sarkadi-2004">
<TR>
<TD>
<P>PATIENT<BR/>1. Hemoglobin A1c at 12 months (end of study) (%)<BR/>2. Hemoglobin A1c at 24 months (follow-up) (%)</P>
</TD>
<TD>
<P>1. 6.5 vs. 6.5&#8224;<BR/>2. 6.5 vs. 6.5&#8224;</P>
</TD>
<TD>
<P>1. 6.3 vs. 6.4&#8224;<BR/>2. 6.2 vs. 6.6&#8224;</P>
</TD>
<TD>
<P>1. -0.2 vs. -0.1&#8224;<BR/>2. -0.3 vs. 0.15&#8224;</P>
</TD>
<TD>
<P>1. 0.1&#8224;<BR/>2. 0.4&#8224;</P>
</TD>
<TD>
<P>1. p-value NS*&#8225;<BR/>2. p-value 0.023&#8225;</P>
</TD>
<TD>
<P>*actual value not provided<BR/>&#8224;values extrapolated from graph<BR/>&#8225;p-value for I vs C at the end of study period<BR/>
</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2010-06-14 11:30:17 -0400" MODIFIED_BY="[Empty name]" ORDER="30" STUDY_ID="STD-Schneider-1982">
<TR>
<TD>
<P>PATIENT<BR/>1. Systolic blood pressure (mmHg)<BR/>2. Diastolic blood pressure (mmHg)</P>
</TD>
<TD>
<P>1. 169 vs 162 <BR/>2. 98 vs 97 </P>
</TD>
<TD>
<P>1. 139 vs 153 <BR/>2. 89 vs 92 </P>
</TD>
<TD>
<P>1. -20 vs -9 &#8224;<BR/>2. -9 vs -5 &#8224;</P>
</TD>
<TD>
<P>1. 11 &#8224;<BR/>2. 4 &#8224;</P>
</TD>
<TD>
<P>1. p-value &lt;0.05*<BR/>2. p-value &lt;0.05*</P>
</TD>
<TD>
<P>*p-value for I vs C at 12 mo<BR/>&#8224;calculated from reported data</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2010-06-14 11:30:51 -0400" MODIFIED_BY="[Empty name]" ORDER="31" STUDY_ID="STD-Solomon-1998">
<TR>
<TD>
<P>PATIENT<BR/>1. Systolic Blood Pressure - 1st measurement (mmHg) (mean(SD))<BR/>2. Systolic Blood Pressure - 2nd measurement (mmHg) (mean(SD))<BR/>3. Diastolic Blood Pressure - 1st measurement (mmHg) (mean(SD))<BR/>4. Diastolic Blood Pressure - 2nd measurement (mmHg) (mean(SD))<BR/>5. BORG Scale - pre-challenge score<BR/>6. BORG Scale - post-challenge score<BR/>
</P>
</TD>
<TD>
<P>1. 146.7(16.8) vs 146.2(17.0) <BR/>2. 144.4(17.2) vs 146.4(16.3) <BR/>3. 84.6(13.2) vs 87.0(10.9) <BR/>4. 85.0(13.0) vs 86.0(10.4) <BR/>5. 2.63(2.33) vs 2.03(1.71)<BR/>6. 0.7(0.092) vs 0.68(0.94)<BR/>
</P>
</TD>
<TD>
<P>1. 138.5(13.9) vs 144.9(21.3) <BR/>2. 138.2(12.9) vs 144.0(20.1) <BR/>3. 80.2(9.6) vs 83.2(11.5) <BR/>4. 80.6(8.7) vs 83.3(11.5) <BR/>5. 2.24(2.46) vs 2.44(2.26)<BR/>6. 0.87(1.10) vs 1.24(1.48)<BR/>
</P>
</TD>
<TD>
<P>1. -8.2 vs -1.3 <BR/>2. -6.2 vs -2.4 <BR/>3. -4.4 vs -3.8 <BR/>4. -4.4 vs -2.7 <BR/>5. -0.39 vs 0.41&#8224;<BR/>6. 0.17 vs 0.56&#8224;</P>
<P/>
</TD>
<TD>
<P>1. 6.9 &#8224;<BR/>2. 3.8 &#8224;<BR/>3. 0.6 &#8224;<BR/>4. 1.7 &#8224;<BR/>5. 0.8&#8224;<BR/>6. 0.39&#8224;<BR/>
</P>
</TD>
<TD>
<P>1. p-value 0.044&#8225;<BR/>2. p-value NS**<BR/>3. p-value NS**<BR/>4. p-value NS**<BR/>5. p-value NS**<BR/>6. p-value NS**<BR/>
</P>
</TD>
<TD>
<P>&#8224;calculated from reported data<BR/>&#8225;p-value for I vs C at the end of intervetion<BR/>*p-value for I vs C at end of intervention<BR/>** actual p-values not reported<BR/>
</P>
<P/>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2010-06-14 11:31:22 -0400" MODIFIED_BY="[Empty name]" ORDER="32" STUDY_ID="STD-Sookaneknun-2004">
<TR>
<TD>
<P>PATIENT<BR/>1. Systolic blood pressure (mmHg) (mean(SD))<BR/>2. Diastolic blood pressure (mmHg) (mean(SD))<BR/>3. % patients controlled for systolic blood pressure and diastolic blood pressure</P>
</TD>
<TD>
<P>
<BR/>
<BR/>1. 144.76(19.69) vs 142.41(19.81) <BR/>2. 85.72(13.56) vs<BR/>85.86(12.94) <BR/>3. 22.9 vs 17.9</P>
<P/>
</TD>
<TD>
<P>1. 121.47(14.90) vs<BR/>124.77(17.97) <BR/>2.71.55(10.80) vs<BR/>74.23(11.87) <BR/>3. 66.1 vs 57.3<BR/>
</P>
</TD>
<TD>
<P>
<BR/>1. -23.29(19.10)<BR/>vs -18.64(17.67) <BR/>2. -14.18(11.20) vs -11.73(10.08) <BR/>3. 43.2 vs 39.4</P>
</TD>
<TD>
<P>1. 4.65 &#8224;<BR/>2. 2.45 &#8224;<BR/>3. 3.8%</P>
</TD>
<TD>
<P>1. p-value &lt;0.001<BR/>2. p-value &lt;0.001<BR/>3. p-value 0.061</P>
</TD>
<TD>
<P>&#8224;calculated from reported data</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2010-06-14 11:33:10 -0400" MODIFIED_BY="[Empty name]" ORDER="33" STUDY_ID="STD-Taylor-2003">
<TR>
<TD>
<P>PROCESS<BR/>1. # of medications at 12 mo (mean(SD))<BR/>2. #of inappropriate prescriptions<BR/>for all MAI domains</P>
<P>PATIENT<BR/>1. # (%) pts at goal for hypertension<BR/>2. # (%) pts at goal for diabetes<BR/>3. # (%) pts at goal for dyslipidemia<BR/>4. # (%) pts at goal for anticoagulation<BR/>5. QOL - SF-36 domains: physical functioning,<BR/>social functioning, physical role function, emotional role function, mental health, energy, pain, general health perception</P>
</TD>
<TD>
<P>PROCESS<BR/>1. 6.3(2.2) vs 5.7(1.7)<BR/>2. 831 vs 895<BR/>
</P>
<P>PATIENT<BR/>1. 3 (12.5) vs 9 (31)<BR/>2. 3 (23.1) vs 9 (56.3)<BR/>3. 2 (10.5) vs 3 (15.8)<BR/>4. 1 (25) vs 3 (50)<BR/>5. n/a<BR/>
<BR/>
</P>
</TD>
<TD>
<P>PROCESS<BR/>1. 4.7(2.0) vs 6.2(2.0)<BR/>2. 264 vs 978</P>
<P>
<BR/>PATIENT<BR/>1. 22 (91.7) vs 8 (27.6)<BR/>2. 13 (100) vs 5 (26.7)<BR/>3. 14 (77.8) vs 1 (5.9)<BR/>4. 4 (100) vs 1 (16.7)<BR/>5. n/a</P>
</TD>
<TD>
<P>PROCESS<BR/>1. -1.6 vs 0.5&#8224;<BR/>2. -567 vs 83&#8224;<BR/>
<BR/>
</P>
<P>PATIENT<BR/>1. 19 (79.2) vs -1 (-3.4)&#8224;<BR/>2. 10 (76.9) vs -4 (-29.6)&#8224;<BR/>3. 12 (67.3) vs -2 (-9.9)&#8224;<BR/>4. 3 (75) vs -2 (-33.3)&#8224;<BR/>5.n/a</P>
</TD>
<TD>
<P>PROCESS<BR/>1. 2.1&#8224;<BR/>2. 650&#8224;</P>
<P>PATIENT<BR/>1. 20 (82.6)&#8224;<BR/>2. 14 (106.5)&#8224;<BR/>3. 14 (77.2)&#8224;<BR/>4. 5 (108.3)&#8224;<BR/>5. n/a</P>
</TD>
<TD>
<P>PROCESS<BR/>1. p-value 0.002*<BR/>2. not reported</P>
<P>PATIENT<BR/>1. p-value 0.001*<BR/>2. p-value 0.001*<BR/>3. p-value 0.001*<BR/>4. p-value 0.048*<BR/>5. p-value NS (all domains)</P>
</TD>
<TD>
<P>&#8224;calculated from reported data<BR/>*p-value for I vs C<BR/>at 12 mo</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2010-05-20 23:46:16 -0400" MODIFIED_BY="[Empty name]" ORDER="34" STUDY_ID="STD-Tsuyuki-2002">
<TR>
<TD>
<P>HEALTH PROFESSIONAL<BR/>% patients reaching a composite outcome&#8224;<BR/>
</P>
</TD>
<TD>
<P>n/a</P>
</TD>
<TD>
<P>57 vs. 31%<BR/>(odds ratio 3.0)</P>
</TD>
<TD>
<P>n/a</P>
</TD>
<TD>
<P>n/a</P>
</TD>
<TD>
<P>p-value &lt;0.001 95% CI 2.2-4.1</P>
</TD>
<TD>
<P>&#8224;composite score of complete cholesterol panel done by PCP OR new prescription for cholesterol lowering medication OR increase in dosage of cholesterol lowering medication</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2010-06-14 11:33:18 -0400" MODIFIED_BY="[Empty name]" ORDER="35" STUDY_ID="STD-Van-Veldhuizen-1995">
<TR>
<TD>
<P>PATIENT OUTCOMES<BR/>Mean Blood glucose levels (mg/dl)</P>
<P>(Group II=1st; Group III=2nd; Control=3rd)</P>
</TD>
<TD>
<P>164&#8224; vs 168&#8224; vs 189&#8224;</P>
</TD>
<TD>
<P>140&#8224; vs 152&#8224; vs 158&#8224;</P>
</TD>
<TD>
<P>-24&#8224; vs -16&#8224; vs -31&#8224;</P>
</TD>
<TD>
<P>Gp II vs C = 7*</P>
<P>GpIII vs C =15*</P>
</TD>
<TD>
<P>Pts in intervention groups achieved lower average weekly blood glucose values than control group (p&lt;0.05)</P>
</TD>
<TD>
<P>&#8224;values extrapolated from graph</P>
<P>*calculated</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2010-06-14 11:37:18 -0400" MODIFIED_BY="[Empty name]" ORDER="36" STUDY_ID="STD-Weinberger-2002">
<TR>
<TD>
<P>PATIENT (PC vs PFM vs UC)*<BR/>1. unadjusted PERFs at 12 mo (% predicted) (mean(SD)) <BR/>2. overall HRQOL with asthma, COPD</P>
</TD>
<TD>
<P>1. 63.8(21.6) vs 61.2(22) vs 60.4(22)<BR/>2. n/a</P>
</TD>
<TD>
<P>1. 65.5(19.5) vs 64.2(21.5) vs 61.6(22.6)<BR/>2. n/a</P>
</TD>
<TD>
<P>1. -1.7 vs -3 vs -1.2&#8224;<BR/>2. n/a</P>
</TD>
<TD>
<P>1. 1.3 (PC vs PFM), 0.5 (PC vs UC)&#8224;<BR/>2. n/a</P>
</TD>
<TD>
<P>1. p-value 0.006 across all groups, 0.28 for PC vs PFM at 12 mo<BR/>2. p-value NS</P>
</TD>
<TD>
<P>*PC = pharmaceutical care program<BR/>PFM = peak flow meter monitoring program<BR/>UC = usual care program<BR/>&#8224;calculated from reported data</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<CONT_OUTCOME CHI2="2.328592053322523" CI_END="-3.8345672504563146" CI_START="-8.795766511257147" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="-6.315166880856731" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.02" MODIFIED="2010-05-20 22:01:28 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.5070657127849592" P_Q="1.0" P_Z="6.046661491791291E-7" Q="0.0" RANDOM="YES" SCALE="29.242806556518914" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="363" TOTAL_2="371" UNITS="" WEIGHT="100.0" Z="4.98972082844396">
<NAME>Systolic Blood Pressure (mmHg)</NAME>
<GROUP_LABEL_1>Intervention group</GROUP_LABEL_1>
<GROUP_LABEL_2>Control group</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.0256613186777255" CI_START="-21.22566131867773" EFFECT_SIZE="-10.100000000000001" ESTIMABLE="YES" MEAN_1="-17.1" MEAN_2="-7.0" MODIFIED="2010-03-19 17:51:26 -0400" MODIFIED_BY="[Empty name]" ORDER="204" SD_1="18.0" SD_2="16.0" SE="5.676462121975467" STUDY_ID="STD-Mehos-2000" TOTAL_1="18" TOTAL_2="18" WEIGHT="4.971205069708681"/>
<CONT_DATA CI_END="-4.266925381451066" CI_START="-11.353074618548934" EFFECT_SIZE="-7.8100000000000005" ESTIMABLE="YES" MEAN_1="-9.13" MEAN_2="-1.32" MODIFIED="2010-03-19 14:26:57 -0400" MODIFIED_BY="[Empty name]" ORDER="197" SD_1="17.1" SD_2="15.7" SE="1.8077243492718513" STUDY_ID="STD-Okamoto-2001" TOTAL_1="164" TOTAL_2="166" WEIGHT="49.01767992336118"/>
<CONT_DATA CI_END="2.0141927747631754" CI_START="-9.614192774763175" EFFECT_SIZE="-3.8000000000000003" ESTIMABLE="YES" MEAN_1="-6.2" MEAN_2="-2.4" MODIFIED="2010-03-19 14:29:06 -0400" MODIFIED_BY="[Empty name]" ORDER="196" SD_1="18.0" SD_2="16.0" SE="2.9664793948382653" STUDY_ID="STD-Solomon-1998" TOTAL_1="63" TOTAL_2="70" WEIGHT="18.202644825953502"/>
<CONT_DATA CI_END="0.054008802467843786" CI_START="-9.354008802467842" EFFECT_SIZE="-4.649999999999999" ESTIMABLE="YES" MEAN_1="-23.29" MEAN_2="-18.64" MODIFIED="2010-03-19 14:26:35 -0400" MODIFIED_BY="[Empty name]" ORDER="198" SD_1="19.1" SD_2="17.67" SE="2.4000485925111192" STUDY_ID="STD-Sookaneknun-2004" TOTAL_1="118" TOTAL_2="117" WEIGHT="27.80847018097665"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.3318550286833846" CI_END="-1.6685673957214526" CI_START="-4.5711905866617775" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="-3.119878991191615" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.03" MODIFIED="2010-04-25 02:35:53 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.5064459582769849" P_Q="1.0" P_Z="2.5163624260356677E-5" Q="0.0" RANDOM="YES" SCALE="9.55" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="363" TOTAL_2="371" UNITS="" WEIGHT="100.0" Z="4.2133270883691765">
<NAME>Diastolic Blood Pressure (mmHg)</NAME>
<GROUP_LABEL_1>Intervention group</GROUP_LABEL_1>
<GROUP_LABEL_2>Control group</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.16678671819981883" CI_START="-13.233213281800182" EFFECT_SIZE="-6.7" ESTIMABLE="YES" MEAN_1="-10.5" MEAN_2="-3.8" MODIFIED="2010-03-19 14:34:15 -0400" MODIFIED_BY="[Empty name]" ORDER="205" SD_1="10.0" SD_2="10.0" SE="3.3333333333333335" STUDY_ID="STD-Mehos-2000" TOTAL_1="18" TOTAL_2="18" WEIGHT="4.934778429016186"/>
<CONT_DATA CI_END="-1.5959622370936724" CI_START="-5.764037762906327" EFFECT_SIZE="-3.6799999999999997" ESTIMABLE="YES" MEAN_1="-5.14" MEAN_2="-1.46" MODIFIED="2010-03-19 14:32:23 -0400" MODIFIED_BY="[Empty name]" ORDER="199" SD_1="9.2" SD_2="10.1" SE="1.0633041113739596" STUDY_ID="STD-Okamoto-2001" TOTAL_1="164" TOTAL_2="166" WEIGHT="48.49647379736254"/>
<CONT_DATA CI_END="1.7037261932944596" CI_START="-5.1037261932944595" EFFECT_SIZE="-1.7000000000000002" ESTIMABLE="YES" MEAN_1="-4.4" MEAN_2="-2.7" MODIFIED="2010-03-19 14:34:13 -0400" MODIFIED_BY="[Empty name]" ORDER="201" SD_1="10.0" SD_2="10.0" SE="1.736626907505759" STUDY_ID="STD-Solomon-1998" TOTAL_1="63" TOTAL_2="70" WEIGHT="18.18076263321753"/>
<CONT_DATA CI_END="0.27391392915345136" CI_START="-5.17391392915345" EFFECT_SIZE="-2.4499999999999993" ESTIMABLE="YES" MEAN_1="-14.18" MEAN_2="-11.73" MODIFIED="2010-03-19 14:33:04 -0400" MODIFIED_BY="[Empty name]" ORDER="200" SD_1="11.2" SD_2="10.08" SE="1.389777542158599" STUDY_ID="STD-Sookaneknun-2004" TOTAL_1="118" TOTAL_2="117" WEIGHT="28.387985140403735"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.3301032454006338" CI_END="-0.09213319901298056" CI_START="-1.4055613739997264" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.7488472865063535" ESTIMABLE="YES" I2="24.817866322941352" I2_Q="0.0" ID="CMP-002.04" MODIFIED="2010-04-25 02:35:53 -0400" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.24878699573756147" P_Q="1.0" P_Z="0.025421575136484714" Q="0.0" RANDOM="YES" SCALE="2.39" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.060803772491206325" TOTALS="YES" TOTAL_1="133" TOTAL_2="127" UNITS="" WEIGHT="100.0" Z="2.2349356278851125">
<NAME>Decrease in HbA1C (%)</NAME>
<GROUP_LABEL_1>Intervention group</GROUP_LABEL_1>
<GROUP_LABEL_2>Control group</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.21026063463992817" CI_START="-2.1897393653600723" EFFECT_SIZE="-1.2000000000000002" ESTIMABLE="YES" MEAN_1="-2.1" MEAN_2="-0.9" ORDER="202" SD_1="2.5" SD_2="2.0" SE="0.5049783430547754" STUDY_ID="STD-Choe-2005" TOTAL_1="41" TOTAL_2="39" WEIGHT="35.549612358050474"/>
<CONT_DATA CI_END="0.15998517745561347" CI_START="-1.1599851774556136" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="-0.5" MEAN_2="0.0" MODIFIED="2010-03-23 19:10:54 -0400" MODIFIED_BY="[Empty name]" ORDER="206" SD_1="2.5" SD_2="2.0" SE="0.3367333189086597" STUDY_ID="STD-Clifford-2005" TOTAL_1="92" TOTAL_2="88" WEIGHT="64.45038764194952"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2010-06-16 09:12:03 -0400" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Pharmacist services targeted at health professionals versus the delivery of no comparable service</NAME>
<OTHER_OUTCOME COLS="7" ID="CMP-003.01" MODIFIED="2010-06-16 09:12:03 -0400" MODIFIED_BY="[Empty name]" NO="1" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="NO">
<NAME>Outcomes Table: 2009 Review</NAME>
<TR>
<TH>
<P>Primary outcomes</P>
</TH>
<TH>
<P>Pre-intervention<BR/>(I vs C)</P>
</TH>
<TH>
<P>Post-intervention<BR/>(I vs C)</P>
</TH>
<TH>
<P>Change due<BR/>to intervention <BR/>(I vs C)</P>
</TH>
<TH>
<P>Result interval<BR/>(I - C)</P>
</TH>
<TH>
<P>Significance Measure</P>
</TH>
<TH>
<P>Notes</P>
</TH>
</TR>
<OTHER_DATA MODIFIED="2009-07-04 18:43:55 -0400" MODIFIED_BY="[Empty name]" ORDER="47" STUDY_ID="STD-Diwan-1995">
<TR>
<TD>
<P>PROCESS<BR/>number of Rx of lipid-lowering drugs/month <BR/>
</P>
</TD>
<TD>
<P>Women:</P>
<P>25.6 vs 22</P>
<P>Men:</P>
<P>20 vs 17</P>
</TD>
<TD>
<P>Women:</P>
<P>35.5 vs 21</P>
<P>Men:</P>
<P>28 vs 20.6</P>
</TD>
<TD>
<P>Women:</P>
<P>9.9 vs -1&#8224;</P>
<P>Men:</P>
<P>8 vs 3.6&#8224;</P>
</TD>
<TD>
<P>Women: 10.9&#8224;</P>
<P>Men: 4.4&#8224;</P>
</TD>
<TD>
<P>n/a*</P>
<P>Stat sig change in # of Rxs among women</P>
</TD>
<TD>
<P>*exact value not reported<BR/>&#8224;calculated from reported data</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2009-02-27 20:17:37 -0500" MODIFIED_BY="Olga Mostovetsky" ORDER="48" STUDY_ID="STD-Freemantle-2002">
<TR>
<TD>
<P>PROCESS<BR/>increase in # of pts treated according to practice guidelines</P>
</TD>
<TD>
<P>
<BR/>n/a</P>
</TD>
<TD>
<P>
<BR/>n/a</P>
</TD>
<TD>
<P>
<BR/>n/a</P>
</TD>
<TD>
<P>
<BR/>5.2% <BR/>(OR = 1.24)</P>
</TD>
<TD>
<P>
<BR/>95% CI 1.7, 8.7 <BR/>(OR 95% CI 1.07-1.42)</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2010-06-16 09:10:19 -0400" MODIFIED_BY="[Empty name]" ORDER="49" STUDY_ID="STD-Hall-2001">
<TR>
<TD>
<P>PROCESS<BR/>1. change in omeprazole use due to intervention<BR/>2. change in metronidazole use due to intervention<BR/>
</P>
</TD>
<TD>
<P>
<BR/>1. n/a<BR/>2. n/a</P>
</TD>
<TD>
<P>
<BR/>1. n/a<BR/>2. n/a</P>
</TD>
<TD>
<P>
<BR/>1. n/a<BR/>2. n/a</P>
</TD>
<TD>
<P>1. -0.02 dose units per year<BR/>2. -0.005 dose units per year</P>
</TD>
<TD>
<P>1. 95% CI -0.12, 0.08<BR/>2. 95% CI -0.025, 0.015</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2009-02-28 13:18:24 -0500" MODIFIED_BY="Olga Mostovetsky" ORDER="50" STUDY_ID="STD-Ilett-2000">
<TR>
<TD>
<P>PROCESS<BR/>Antibiotic prescribing (# all ABX RXs)</P>
</TD>
<TD>
<P>5182 vs 6666</P>
</TD>
<TD>
<P>7262 vs 9654</P>
</TD>
<TD>
<P>-2080 vs -2988</P>
</TD>
<TD>
<P>908</P>
</TD>
<TD>
<P>p-value n/a*</P>
</TD>
<TD>
<P>*not reported</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2010-06-16 09:10:04 -0400" MODIFIED_BY="[Empty name]" ORDER="51" STUDY_ID="STD-Stergachis-1987">
<TR>
<TD>
<P>PROCESS <BR/>number of Rx per 1000 enrollees per physician</P>
<P>(1. piroxicam, 2. ibuprofen, 3. salicylates)<BR/>
</P>
</TD>
<TD>
<P>1. 58 vs 27</P>
<P>2. 167 vs 194</P>
<P>3. 142 vs 114</P>
</TD>
<TD>
<P>1. 55 vs 40</P>
<P>2. 183 vs 202</P>
<P>3. 213 vs 125</P>
</TD>
<TD>
<P>1. -3 vs 13&#8224;</P>
<P>2. 16 vs 8&#8224;</P>
<P>3. 71 vs 11&#8224;</P>
</TD>
<TD>
<P>1. -16&#8224;</P>
<P>2. 8&#8224;</P>
<P>3. 60&#8224;</P>
</TD>
<TD>
<P>1. ns* (p-value n/a)</P>
<P>2. ns* (p-value n/a)</P>
<P>3. sig* (p-value n/a)</P>
</TD>
<TD>
<P>*exact value not reported<BR/>&#8224;calculated from reported data</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2009-02-26 19:29:46 -0500" MODIFIED_BY="Olga Mostovetsky" ORDER="52" STUDY_ID="STD-Turner-2000">
<TR>
<TD>
<P>PROCESS<BR/>1. utilization of ACEIs in patient receiving digoxin and <BR/>furosemide for CHF (# of patients)<BR/>2. targeted daily dose of ACEIs (# of patients)</P>
</TD>
<TD>
<P>1. 71 vs 40<BR/>2. 52 vs 29</P>
</TD>
<TD>
<P>1. 72 vs 38<BR/>2. 59 vs 28</P>
</TD>
<TD>
<P>1. 1 vs -2&#8224;<BR/>2. 7 vs -1&#8224;<BR/>
</P>
</TD>
<TD>
<P>1. 3&#8224;<BR/>2. 8&#8224;</P>
</TD>
<TD>
<P>1. p-value NS*<BR/>2. p-value 0.14<BR/>
</P>
</TD>
<TD>
<P>*exact value not reported<BR/>&#8224;calculated from reported data</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2010-06-16 09:12:03 -0400" MODIFIED_BY="[Empty name]" ORDER="53" STUDY_ID="STD-Watson-2001">
<TR>
<TD>
<P>prescribing of ibuprofen, diclofenac and naproxen as % of total NSAID prescribing (mean %(SD)) <BR/>(intervention vs mailed guideline vs no intervention)</P>
</TD>
<TD>
<P>78.1(2.6) vs 79.0(4.9) vs 77.0(7.6)</P>
</TD>
<TD>
<P>82.7(2.6) vs 81.2(3.7) vs 80.3(7.2)</P>
</TD>
<TD>
<P>4.6 vs 2.2 vs 3.3&#8224;</P>
</TD>
<TD>
<P>1. 2.1 (intervention vs no intervention)<BR/>2. 1.6 (intervention vs mailed guideline)</P>
</TD>
<TD>
<P>1. 95% CI -0.8, 5.0<BR/>2. 95% CI -1.4, 4.7</P>
</TD>
<TD>
<P>&#8224;calculated from reported data</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2010-06-11 13:55:13 -0400" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2010-06-11 13:55:13 -0400" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAeAAAAEACAMAAABcTlUlAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2010-06-11 13:55:13 -0400" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAWEAAAXeCAIAAAAxTgkzAABR+UlEQVR42u3dvW4kxd/F8ZFICBw4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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK MODIFIED="2009-03-02 19:43:14 -0500" MODIFIED_BY="[Empty name]">
<FEEDBACK_ITEM ID="FBK-01" MODIFIED="2009-03-02 19:43:14 -0500" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2009-03-02 19:43:14 -0500" MODIFIED_BY="[Empty name]">Pharmacist interventions</TITLE>
<DATE_SUBMITTED>
<DATE DAY="" MONTH="" YEAR=""/>
</DATE_SUBMITTED>
<FEEDBACK_SUMMARY MODIFIED="2009-03-02 19:43:14 -0500" MODIFIED_BY="[Empty name]">
<P>Where and how pharmacist can intervent in e-prescribing to reduce or prevent doctor's errors?</P>
<P>I certify that I have no affiliations with or involvement in any organisation or entity with a direct financial interest in the subject matter of my criticisms.</P>
</FEEDBACK_SUMMARY>
<FEEDBACK_REPLY MODIFIED="2009-03-02 19:43:14 -0500" MODIFIED_BY="[Empty name]">
<P>Reply from Dr. Lisa Bero,</P>
<P>E-prescribing is not within the scope of our review as not all e-prescribing interventions involve pharmacists and, in fact, none of the studies in our review involved e-prescribing. However, we will mention in the discussion update that pharmacists have a potential role in e-prescribing and cite some work that Helene Lipton has done in this regard. This has been published in abstract; a full paper is being prepared. <BR/>I certify that I have no affiliations with or involvement in any organisation or entity with a direct financial interest in the subject matter of my criticisms.</P>
</FEEDBACK_REPLY>
<FEEDBACK_CONTRIBUTORS MODIFIED="2009-03-02 19:43:14 -0500" MODIFIED_BY="[Empty name]">
<P>Lay Hook Kam, pharmacist</P>
</FEEDBACK_CONTRIBUTORS>
</FEEDBACK_ITEM>
</FEEDBACK>
<APPENDICES MODIFIED="2010-06-07 11:50:00 -0400" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2010-06-07 11:49:24 -0400" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2010-06-07 11:49:24 -0400" MODIFIED_BY="[Empty name]">EPOC search strategy (Phase I of review)</TITLE>
<APPENDIX_BODY MODIFIED="2009-11-24 16:42:32 -0500" MODIFIED_BY="[Empty name]">
<P>20 March 2007</P>
<P>(pharmacy or pharmacies)</P>
<P>(pharmacist*)</P>
<P>(limit to yr=1999-2007)</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2010-06-07 11:49:43 -0400" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2010-06-07 11:49:43 -0400" MODIFIED_BY="[Empty name]">MEDLINE/EMBASE search strategy (Phase II of review)</TITLE>
<APPENDIX_BODY MODIFIED="2009-11-24 18:50:40 -0500" MODIFIED_BY="[Empty name]">
<P>Database: Ovid MEDLINE(R) &lt;1950 to March Week 4 2008&gt;<BR/>Search Strategy:<BR/>--------------------------------------------------------------------------------<BR/>1 Pharmacy/ (7133)<BR/>2 Pharmacists/ (7094)<BR/>3 Community Pharmacy Services/ (1561)<BR/>4 (pharmacy or pharmacies or pharmacist?).tw. (26558)<BR/>5 or/1-4 (33073)<BR/>6 Outpatients/ (4996)<BR/>7 Ambulatory Care/ (29634)<BR/>8 (outpatient? or clinic? or ambulatory).tw. (232669)<BR/>9 or/6-8 (244132)<BR/>10 5 and 9 (2527)<BR/>11 randomised controlled trial.pt. (252479)<BR/>12 random$.tw. (403476)<BR/>13 control$.tw. (1640371)<BR/>14 intervention$.tw. (283147)<BR/>15 evaluat$.tw. (1307567)<BR/>16 or/11-15 (3081343)<BR/>17 10 and 16 (1269)<BR/>18 animal/ (4234665)<BR/>19 human/ (10283089)<BR/>20 18 not (18 and 19) (3195568)<BR/>21 17 not 20 (1268)<BR/>22 limit 21 to yr="1999 - 2008" (810)<BR/>
<BR/>***************************<BR/>
</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2010-06-07 11:50:00 -0400" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2010-06-07 11:50:00 -0400" MODIFIED_BY="[Empty name]">EMBASE search strategy (Phase II of review)</TITLE>
<APPENDIX_BODY MODIFIED="2009-11-24 16:42:33 -0500" MODIFIED_BY="[Empty name]">
<P>Database: EMBASE &lt;1980 to 2008 Week 13&gt;<BR/>Search Strategy:<BR/>--------------------------------------------------------------------------------<BR/>1 Pharmacy/ (20653)<BR/>2 Pharmacist/ (20352)<BR/>3 Clinical Pharmacy/ (2338)<BR/>4 (pharmacy or pharmacies or pharmacist?).tw. (28822)<BR/>5 or/1-4 (47390)<BR/>6 Outpatient/ (18861)<BR/>7 Outpatient Care/ (11815)<BR/>8 Ambulatory Care/ (6629)<BR/>9 (outpatient? or clinic? or ambulatory).tw. (178841)<BR/>10 or/6-9 (188274)<BR/>11 5 and "12".mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer name] (1831)<BR/>12 Randomized controlled trial/ (155932)<BR/>13 random$.tw. (365568)<BR/>14 experiment$.tw. (710140)<BR/>15 (time adj series).tw. (6431)<BR/>16 (pre test or pretest or posttest or post test).tw. (6933)<BR/>17 impact.tw. (205541)<BR/>18 intervention$.tw. (250052)<BR/>19 chang$.tw. (1151986)<BR/>20 evaluat$.tw. (1119409)<BR/>21 effect$.tw. (2558556)<BR/>22 compar$.tw. (1897202)<BR/>23 control$.tw. (1399426)<BR/>24 or/12-23 (5527329)<BR/>25 11 and 24 (1338)<BR/>26 Nonhuman/ (3042239)<BR/>27 25 not 26 (1255)<BR/>28 limit 27 to yr="1999 - 2008" (944)<BR/>
<BR/>***************************<BR/>
</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS MODIFIED="2009-03-02 19:43:14 -0500" MODIFIED_BY="[Empty name]"/>
</COCHRANE_REVIEW>